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Summary
Infection by Proteus mirabihs can seriously complicate the care of patients 
undergoing long-term indwelling bladder catheterisation. The urease-producing 
bacteria colonize the catheter surfaces forming extensive biofilm communities and are 
capable of generating ammonia from urea and elevating the pH of the urine and 
biofilm. Under these conditions crystals of calcium and magnesium phosphates form 
in the urine and within the bacterial biofilm on the indwelling device leading to its 
encrustation and blockage. Urine can leak around the outside of the blocked catheter 
and patients become incontinent. Alternatively, urine is retained within the bladder, 
causing painful distension of the bladder. Reflux of infected urine to the kidneys can 
lead to serious symptomatic episodes such as pyelonephritis, septicaemia and 
endotoxic shock. All available types of indwelling catheter are vulnerable to this 
problem and currently there are no effective procedures available for its control.
While the basic mechanism has been established for catheter encrustation we 
still need to know more about some of the fundamental aspects of the process. Little is 
known about the early events and the precise mechanisms which P. mirabihs uses to 
colonize catheter surfaces. The factors that control the rate at which crystalline 
biofilm forms on the catheters are also unknown. The aims of this study were to 
establish the sequence of events in the early stages of crystalline P. mirabihs biofilm 
formation on the range of currently available catheters for use with patients; to 
determine the role of Mannose-Resistant Proteus-like fimbriae (MR/P fimbriae) in P. 
mirabilis crystalline biofilm formation on catheters; to investigate how the pH at 
which calcium and magnesium phosphates precipitate from urine, the nucleation pH 
(pHn) can be manipulated and to determine the effect of this parameter on the rate of 
catheter encrustation.
Using a laboratory model of the catheterised bladder, scanning electron 
microscopy and X-ray microanalysis, the initial stages of P. mirabihs crystalline 
biofilm development was observed on catheter surfaces. All-silicone, silicone-coated 
latex, hydrogel-coated latex and hydrogel/silver-coated latex catheters rapidly 
acquired a microcrystalline ‘foundation layer’ comprised predominantly of calcium 
phosphate, upon which, P. mirabihs crystalline biofilm subsequently developed. A 
similar ‘foundation layer’ was observed on the encrusted surfaces of hydrogel/silver- 
coated catheters removed from long-term catheterised patients. The catheters 
impregnated with nitrofurazone briefly delayed the onset of crystalline biofilm 
formation, while all-silicone and hydrogel-coated latex catheters inflated with 
triclosan (3 mg/ml in Na2 CC>3 ) were able to maintain acidic urine pH and prevent 
crystalline biofilm development for the 7 day experimental period.
There is evidence that MR/P fimbriae are involved in initiating infection in 
non-catheterised urinary tracts. The role of these adhesins in crystalline biofilm 
formation on indwelling catheters however, has not been investigated. Using bladder 
models infected with a wild type P. mirabihs strain able to express MR/P fimbriae 
and its derived MR/P-negative mutant, time to catheter blockage experiments and 
scanning electron microscopy revealed that MR/P fimbriae were not essential for P. 
mirabilis colonization of catheter surfaces or the development of crystalline P. 
mirabihs biofilm. Although the wild type and mutant strain initiated biofilm 
formation in different ways both rapidly blocked all-silicone catheters with crystalline 
material. The overriding factor in catheter blockage was the generation of alkaline 
urine, raising the pH above that at which crystalline formations develop.
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Previously it has been demonstrated that the pHn of human urine can be elevated by 
dilution and by increasing its citrate content. In the present study the effect of dilution 
and adding citrate on the pHn of artificial was assessed. Furthermore, the effect on the 
rate of encrustation on all-silicone catheters was examined in laboratory models 
supplied with these urines and infected with urease-positive P. mirabilis, Providencia 
rettgeri and Proteus vulgaris. The pHn of urine could be elevated from pH 6.7 in neat 
urine to pH 8.4 in urine diluted to 1:6. When neat, 1:1, 1:2 and 1:3 diluted urines were 
supplied to bladder models significant increases in catheter lifespan were recorded at 
each ascending dilution. Increasing the citrate content of the 1:1 diluted urine from 0 
to 3.0 g/L citrate elevated the pHn from pH 7 to pH 9.1. Scanning electron microscopy 
of catheter sections revealed crystalline material in the biofilms could be virtually 
eliminated for at least 7 days in models supplied with urine with pHns of >pH 8.5. 
Time to catheter blockage experiments showed the rate of catheter encrustation 
became significantly reduced as the pHn of urine increased. Catheters in models 
supplied with urine containing citrate concentrations of 1.5 mg/ml (pHn >8.4) or more 
drained freely for the whole 7-day experimental period. Bladder models supplied with 
urine containing 1.5 mg/ml citrate and infected with Proteus vulgaris and a potent 
urease-producing isolate of Providencia rettgeri also drained freely for significantly 
longer than respective control experiments.
The urinary pHn of long-term catheterised patients infected with P. mirabilis 
varies considerably. If the urinary pHn in these patients could be elevated consistently 
above that produced in P. mirabilis infected urine, it would prevent or significantly 
reduce episodes of catheter blockage. The effect of supplementing the daily diet of a 
healthy volunteer with citrate-containing drinks on urinary pHn and the rate of 
catheter encrustation was determined using the bladder model. A significant elevation 
in the pHn to 8.1 was recorded in the urine when the volunteer consumed 2 L of a 
citrate-containing drink as part of their daily fluid intake. Furthermore, the mean 
lifespan of catheters from P. mirabilis infected bladder models supplied with this 
urine was nearly five times longer (P <0.05) than those supplied with urine collected 
on a standardised fluid intake of 1.3 L/24 h. This was encouraging as the pH of the 
bladder model urine was consistently more alkaline than is ‘normal’ for long-term 
catheterised patients infected with P. mirabilis. The citrate drinks strategy will not of 
course eliminate the causative organisms of encrustation from the catheterised urinary 
tract but would be a long-term suppressive therapy. Despite this, it has intrinsic 
advantages in that it doesn’t involve the use of antimicrobials and it is effective 
whatever urease producer is inducing the encrustation. The selection of resistant 
organisms will thus not be a problem. Will the strategy be effective in the long-term? 
Will it create other problems? Only experience will answer these questions. At this 
stage however, it seems to offer the exciting prospect of control of a complication that 
undermines the quality of life for so many elderly and disabled people.
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Introduction
1.1. Urinary incontinence, the catheter and bladder management
The International Continence Society (ICS) describes urinary incontinence (UI) as ‘a 
condition where involuntary loss of urine is a social or hygienic problem and is 
objectively demonstrable’ (Andersen et al., 1992). Individuals suffering from severe, 
chronic incontinence have a considerably impaired quality of life. The complications 
that can arise in the management of urinary incontinence also pose serious threats to 
the health of many elderly and disabled people.
1.1.1. The prevalence of urinary incontinence
A working party of the Royal College of Physicians estimated that around three 
million people in the UK suffer from urinary incontinence. It is particularly common 
in the elderly with as many as 25% of the patients in residential homes and 40% of 
those in nursing homes being affected (Royal College of Physicians, 1995). 
Demographic analysis suggests that by 2030 the proportion of over 60 year olds in 
Britain will increase to about one third of the population (Greengross et al., 1997). 
Given the ageing population, urinary incontinence is likely to become more of a 
problem in the coming years.
1.1.2. The indwelling urinary catheter
Indwelling urinary catheters (IUC’s) are used to manage chronic urinary incontinence 
and urinary retention in the elderly and for patients disabled by neurological disease, 
strokes and spinal cord injury. They also have important short-term roles in hospitals 
for the accurate urinary measurement of unconscious patients and as an aid to urethral 
repair after prostatic or gynaecological surgery (Stickler, 1996). Catheters have a long
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history in urological care and their origins can be traced back over 2000 years to the 
Hippocratic era of ancient Greece (Moog et al., 2004). Initially they were fashioned 
out of various materials (including tanned animal skins), although malleable metals 
appeared to be the preferred option (Abdel-Halim, 1990). In the 19th century rubber 
catheters were produced by the vulcanization of latex, and by the early 20th century 
Dr. Frederick Foley designed and developed the self-retaining catheter (Foley, 1929; 
Foley, 1937). The catheters used today are essentially the same as those developed by 
Foley seventy years ago.
The basic design consists o f a hollow drainage tube approximately 40 cm in length. 
Catheters are available in various sizes having a range of external diameters, which 
are measured in Charriere (Ch) units. One Ch unit is equivalent to 0.33 mm so the 
commonly used size 12 Ch catheter has an external diameter of 4 mm. The tube is 
usually inserted into the bladder via the urethra (Figure 1) and is held in position by 
means of the retention balloon, which is generally inflated with 10 ml of water after 
insertion. Urine drains through the catheter lumen from the bladder and collects in an 
external drainage bag. Suprapubic catheterisation also involves the use of the Foley- 
type catheter. In these cases the catheter is inserted through a narrow channel created 
surgically in the abdominal wall, just above the pubic bone. The balloon is 
subsequently inflated to hold the device in place and the catheter will remain 
indwelling. Some patients prefer this method of catheterisation but IUC’s are 
generally used more widely (Kohler-Ockmore and Feneley, 1996).
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Figure 1. Male urinary tract catheterised with a Foley-type catheter
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1.1.3. Prevalence of indwelling bladder catheters
Prevalence studies have revealed the extent to which Foley catheters are used for 
bladder management in healthcare facilities worldwide. Jepsen et a l  (1982) for 
example performed such a study in hospitals in eight European countries and reported 
that 11% of patients were undergoing indwelling catheterisation. Zimakoff et a l  
(1993) found that 13.2% of hospital patients in Denmark were cathetensed. A survey 
of residents in nursing homes in Maryland (USA) found that 7.5% had bladder 
catheters (Warren et a l, 1989). Figures from similar institutions in Denmark and the 
UK were 4.9% and 9% respectively (Zimakoff et a l , 1993; McNulty et a l , 2003). It 
is also clear that many patients in community care in their own homes have Foley 
catheters. Getliffe and Mulhall (1991) found for example that 4% of this group in the 
UK were cathetensed.
The extensive use of indwelling bladder catheters has occurred in spite of concerns 
over the risks they pose to patients. In his 1958 editorial, Paul Beeson warned of the 
dangers of indwelling catheterisation and its relation to serious infections of the upper 
urinary tract. “At times the catheter is indispensable for therapy, and there are many 
good indications for its use. Nevertheless the decision to use this instrument should 
be made with the knowledge that it involves risk of producing a serious disease which 
is often difficult to treat” (Beeson, 1958). In spite of grave concerns surrounding the 
use of indwelling catheters, studies have indicated that many patients are catheterised 
unnecessarily, or remain catheterised for longer than is necessary. In a prospective 
study of 202 patients attending a US hospital, Jain et al. (1995) concluded that the 
decision to catheterise was unjustified in 21% of cases. In addition they concluded 
that 47% of the 912 patient days where catheters were in place were unjustified.
5
...............................................................................................................................................Introduction
Recent guidelines on incontinence management published by The Department of 
Health reiterated the need for proper use of the indwelling catheter. They stressed that 
only after all other avenues are exhausted should catheterisation be considered, and 
that the patients need for continuing catheterisation should be regularly assessed and 
the catheter removed as soon as possible (Panknin and Althaus, 2001). However, 
Huang et al. (2004) demonstrated that many catheters are still left indwelling for 
longer than is necessary. They also demonstrated the benefits of proper catheter 
management with the timely removal of the devices, significantly reduces the rates of 
infection, the use of antimicrobial therapy and costs.
1.2. Complications of long-term catheterisation
Long-term catheterisation of the urinary tract causes increased morbidity and 
mortality in patients. It can lead to trauma of the lower urinary tract, bladder 
carcinoma, infective bladder and kidney stones, urinary tract infection, bacteriuria, 
pyelonephritis, bacteraemia and septicaemia. In addition they impose a heavy 
workload on healthcare workers and place a significant financial burden on healthcare 
services (Stickler and Zimakoff, 1994).
1.2.1. Urethral necrosis
The physical presence of a urinary catheter causes pressure necrosis, basically 
meaning erosion of the bladder and urethral mucosa (Larsen et al., 1989; Larsen et al., 
1997; Stoffel and McGuire, 2006). Pressure necrosis of the lower urinary tract in 
spinal cord injured (SCI) patients can also be caused by extrusion of the inflated 
balloon from the bladder due to recurring detrusor contractions. Replacing the device 
with a larger bore catheter does not resolve the situation and can even exacerbate the
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situation (Andrews and Shah, 1998). Although the problem can sometimes be 
resolved through suprapubic catheterisation, an irrevocably damaged urethra may 
require radical surgery to redirect urine flow and return continence (Andrews and 
Shah, 1998; Stofifel and McGuire, 2006). Cases of urethral necrosis have been 
reported being more prevalent in women patients as there is a lack of alternative 
external collection devices for this group (Andrews and Shah, 1998). Trop and Benett 
(1992) reported that 92% of women with long-term catheters eventually suffered with 
urethral erosion.
1.2.2. Bladder carcinoma
A number of studies have reported a high incidence of bladder cancer among 
individuals with spinal cord injuries (SCI). El-Masri and Fellows (1981) for example 
examined the medical records of 6000 patients who had attended the spinal injury unit 
at Stoke Mandeville Hospital and found 25 cases of bladder carcinoma. This rate was 
20-fold greater than would be expected from consideration of the rate of disease in the 
general population. Similar results have been reported by spinal cord units in the USA 
(West et al., 1999; Groah et al., 2002). It is probable that several factors are 
responsible for the increased rate of bladder cancer in this group. It should also be 
recognized that many paraplegic are injured in their youth and some endure 
catheterisation for up to 30-40 years. Akaza et al. (1984) proposed that the mere 
implantation of the catheter, which could lead to chronic inflammation of the bladder 
mucosa for many years, was the stimulus for carcinogenesis. Tricker et al. (1991) 
found nitrosamines in the infected urine of catheterised spinal-injured patients. These 
powerful carcinogens are generated in the urine by the metabolic activity of the 
bacterial flora. They may well also have a role in the development of these cancers.
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1.2.3. Urinary tract infection, bactenuria and bacteraemia
Catheter-associated urinary tract infections (CAUTI) account for approximately 40% 
of hospital infections (Haley et al., 1985; Harbarth et al., 2003). While catheters are a 
convenient way to drain urine from a disabled bladder, they also form a bridge for 
bacteria from a contaminated external environment to infect a vulnerable body cavity. 
The incidence of bacteriuria in catheterised patients increases with duration of 
catheterisation. Garibaldi et al. (1974) examined daily urine specimens from 405 
newly catheterised patients in a US community hospital. They reported that the 
prevalence of bacteriuria increased each day after catheterisation, and after a period of 
only 10 days 50% of these patients were bacteriuric. Once organisms have infected 
the residual urine in the bladder, they multiply rapidly and reach > 105 cfu/ml within a 
few days (Stark and Maki, 1984). Saint (2000) combined the data from several studies 
that examined the rates of bacteriuria in individuals catheterised from 2 to 10 days. 
The pooled cumulative incidence of bacteriuria in the duration of these short-term 
catheterised patients was 26%.
Other reports have demonstrated that after continuous catheterisation for 1 month 
virtually 100% of individuals will have bacteriuria, and in many cases mixed 
communities of species will be present in the urine (Warren e/ al., 1982). Jewes et al. 
(1988) monitored 115 community dwelling patients in the UK and found that after 8 
weeks with an indwelling catheter all except 2 patients (who were both on antibiotic 
therapy) were positive for bacteriuria. This study also reported bacteriuria increased 
with the duration of catheterisation. It is important to state however, that the majority 
of bacteriuric episodes do not develop into symptomatic urinary tract infection. 
Tambyah et al. (2000) studied 1497 patients and reported that 14.9% developed
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CAUTI, described as >105 organisms per ml urine. Only 7.7% of these however, were 
symptomatic infections. Kunin et al. (1987a) also found a small proportion of those 
with bacteiuria developed symptomatic UTI. They reported that although 74% of 
elderly catheterised nursing home patients were positive for CAUTI less than 2% 
presented with febrile episodes.
Several other studies have shown that CAUTI can lead to bloodstream infection 
(bacteraemia). A multi-centre prevalence survey on hospitalized patients carried out 
by Jepsen et al. (1982) reported that the development of bacteraemia was five-times 
higher in patients with UTI than those without, and this could be directly related to the 
use o f an indwelling urinary catheter. Jewes et al. (1988) found that transient, 
asymptomatic bacteraemia occurred in 10.2% of catheterised patients after routine 
catheter changes. Coello et al. (2003) studied device related bacteraemia in 73 UK 
hospitals. Although they reported that intensive care units and special baby care units 
had high incidence of bacteraemia, they also found that in general medicine, general 
surgery, geriatric medicine and urology in non-teaching hospitals bacteraemia from 
CAUTI caused 20.9% of all episodes. The development of sepsis in 126 catheterised 
patients was studied retrospectively by Rosser et al. (1999). They reported that in 15.8 
% of these patients, urosepsis (inflammation of the upper urinary tract causing 
bacterial seeding of the blood) was responsible, with patient age and duration of 
catheterisation among the significant risk factors. Those without sepsis had a catheter 
in place for a mean of 16.6 days while those that developed urosepsis had a catheter in 
place for a mean of 29.3 days.
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1.2.4. Bladder and kidney stones
The formation of mineralized aggregates in the urinary tract o f individuals undergoing 
long-term bladder catheterisation is relatively common. Their formation can be due to 
factors including nutrition or metabolic imbalance (idiopathic), or can be the result of 
chronic infection with urease-producing bacteria (Grifith et al., 1976; Bichler et al., 
2002; Siener and Hesse, 2002; Siener et al., 2005). In SCI patients elevated calcium 
levels in urine (hypercalcuria) caused by immobilization is common in the first three 
months after injury and the risk of forming metabolic bladder and kidney stones is 
highest in this period (DeVivo et al., 1984; Chen et al., 2001). The presence of an 
indwelling catheter however, significantly increases the risk of developing infected 
bladder and kidney stones. In a retrospective study of 1336 SCI patients over 25 
years, Chen et al. (2001) reported that individuals with indwelling catheters were nine 
times more likely to form bladder stones in the first year than those who were 
catheter-free and had bladder control. In a 15-year study of 1359 SCI patients in 
Australia, Donellan and Bolton (1999) reported that 3.5% of patients were treated for 
upper urinary tract calculi. Those that developed kidney stones had a significantly 
higher incidence of indwelling catheter use (49%), and also bladder stones (52%). Ku 
et al. (2006) followed 140 male SCI patients over a 17-year period from 1987 to 2003 
and recorded the incidence of renal and bladder stones. They reported that 28% and 
15% of those studied developed renal and bladder stones respectively. The 
multivariate analysis of their data showed that age at injury, type of injury and the 
presence of an indwelling catheter were all significant risk factors in stone 
development.
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Infective stones are caused by chronic infection of the urinary tract with urease- 
producing bacteria, particularly Proteus mirabilis. They consist of mineralised or 
amorphous aggregates of struvite (magnesium ammonium phosphate) and apatite 
(calcium phosphate) (McLean et al., 1985; Bichler et al., 2002). The formation of 
infective stones occurs when urease-producing bacteria hydrolyse urea and turn urine 
alkaline causing precipitation of the calcium and magnesium salts out of solution (see 
Section 1.6.). Dumanski et al. (1994) using purified P. mirabilis capsular 
polysaccharide (CPS), showed that the anionic nature of the bacterial CPS attracts 
magnesium ions onto the cell surface. This can act as a nidus for crystallization with 
the development of the crystalline microcolony, which continues as the bacteria 
proliferate (Stickler and Zimakoff, 1994). Sabbuba et al. (2004) used pulse field gel 
electrophoresis of restriction enzyme digests of bacterial DNA to show that the strains 
of P. mirabilis in infected bladder stones in catheterised patients had identical 
genotypes to strains colonizing their indwelling catheters. Bacteria dwelling in these 
infection stones are difficult to treat with antimicrobials and cause particular problems 
if situated in the kidney. Here they can cause episodes of pyelonephritis, renal 
abscesses and septicaemia (Stickler and Zimakoff, 1994).
1.2.5. Increased mortality
In a prospective study of catheterised patients at a US hospital, Platt et al. (1982) 
reported that mortality rates in patients with CAUTI were almost three times that in 
those without CAUTI. Kunin et al. (1992), in a prospective study of a large 
population of nursing-home residents in Ohio reported similar findings. Patients with 
an indwelling catheter for 76% or more of their time were found to be three times 
more likely to be dead within a year than matched controls. They also reported that
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incidence of hospitalization, the length of hospitalization and requirement of 
antimicrobial therapy were all three times greater in the catheterised patients.
1.2.6. Pyelonephritis
Ascending infection from the bladder to the kidneys causing pyelonephritis is a 
serious complication of catheterisation. Persistent and recurring episodes of 
pyelonephritis are dangerous as they can lead to permanent renal damage and renal 
failure. Warren et al. (1988) in a post-mortem study of 75 elderly patients who had 
died in nursing homes, reported that 38% of those with an indwelling catheter in place 
at time of death had acute pyelonephritis compared to only 5% of those without an 
indwelling catheter. In a further autopsy study Warren et al. (1994) reported that 
patients catheterised for >90 days were significantly more at risk from chronic renal 
inflammation than those catheterised for <90 days. Larsen et al. (1997) reviewed the 
medical records of 142 chronically catheterised and non-catheterised SCI patients. 
The overall conclusions were that those with indwelling catheters had significantly 
more episodes of pyelonephritis and evidence of renal damage.
1.2.7. Catheter blockage
Blockage in the flow of urine through the catheter is a serious complication in the care 
of catheterised patients. It can lead to incontinence with urine leaking around the 
outside of the catheter. Alternatively urine is retained resulting in painful distension of 
the bladder. Reflux of infected urine to the upper tract can then induce episodes of 
pyelonephritis and bloodstream infections (Stickler and Zimakoff, 1994). Good 
management will ensure that patients are fitted with catheters of the appropriate size
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and length, as catheters that are too long may develop ‘kinks’ or twists, which may 
prevent urine flow (Godfrey, 2000). Drainage bags should not be placed too far below 
the bladder as to create negative pressure and suck the walls of the bladder into the 
eye-let (Lowthian, 1998). The walls of the bladder can also occlude the eyehole when 
bladder spasms cause contraction of the bladder around the catheter (Lowthian, 1998). 
The most common cause of catheter blockage however, results from the build-up of 
crystalline bacterial biofilms that develop on the catheter surfaces (Section 1.6). As 
with infection-induced stone formation the problems arise from urease-producing 
bacteria that turn the urine alkaline. The elevated pH causes precipitation of 
magnesium and calcium phosphates from the urine which accumulate on the internal 
and external catheter surfaces (Hedelin et al., 1984; Cox et al., 1987; Morris and 
Stickler, 1997). Up to 50% of long-term catheterised patients block their catheters as a 
result of the build up of crystalline biofilm material on their devices (Cools and Van 
der Meer, 1986; Kunin et al., 1987b; Kohler-Ockmore and Feneley, 1996).
Kunin et al. (1987b) used the terms ‘blockers’ and ‘non-blockers’ to describe the 
catheter encrusting habits of long-term catheterised patients. Blockers consistently 
and recurrently formed significant encrustation on their devices within days or weeks 
of the catheter being introduced. In contrast, the catheters of ‘non-blockers’ did not 
become occluded with encrustations. In a further study Kunin (1989) followed 32 
long-term catheterised elderly women in a US nursing home half of whom were ‘non­
blockers’ and the other half made up o f ‘blockers’ and ‘intermediates’. Catheters were 
removed at two-week intervals after which, the flow-rate and level of encrustation on 
the catheters were determined. They reported that ‘blockers’, ‘non-blockers’ and 
‘intermediates’ retained their particular status during the study period. ‘Blockers’
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required more frequent catheter changes, and the removed devices had significant 
encrustation with poor flow rates. The micobiological evaluation of their urine 
showed that Proteus group organisms including (P. mirabilis, Providencia stuartii, 
and Morganella morganii) were isolated from 100% of ‘blockers’ urine, 80% of 
‘intermediates’ and 60% of ‘non-blockers’, and the mean pH of urine from ‘blockers’ 
was significantly more alkaline than that of ‘non-blockers’. Getliffe (1994a) studied 
the catheter encrustation in 42 community dwelling patients by visually examining 
catheters removed after 6-week intervals. Patients were classed as ‘blockers’ if they 
blocked two or more of their catheters during the study period or ‘non-blockers’ if 
they did not. They found that 42% of patients could be regarded as ‘blockers’, with a 
significantly higher proportion of women blocking their catheters than men. They also 
reported that there was no relationship between catheter size, type (hydrogel-coated 
and silicone-elastomer) and ‘blocker’ status. ‘Blockers’ often needed re- 
catheterisation < 6 weeks. Other studies have also reported similar levels of catheter 
blockage (Cools and Van der Meer, 1986). Kohler-Ockmore and Feneley (1996) 
studied the prevalence of morbidity in long-term catheterised patients over two 
successive years in three healthcare districts in the UK. This study found 48% of 
patients experienced catheter blockage.
1.2.8. Increased workload and financial burden
The complications of long-term catheterisation can significantly increase the 
workloads of healthcare workers and impose a heavy financial cost on healthcare 
services. In their 2-year study estimating the prevalence of morbidity in long-term 
catheterised patients Kohler-Ockmore and Feneley (1996) reported that one district 
nurse had 223 daytime emergency referrals in a 6-month study period. The total
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number of emergency referrals for catheter complications in a population of 467 
patients in the 6-month period was 506. The majority of these cases were due to 
catheter blockage. The cost of nosocomial catheter-associated UTI in terms of 
hospitalization was assessed by Tambyah et al. (2002). In their report which observed 
1,497 newly catheterised patients it was estimated that each episode of CAUTI cost 
$589. However, most of these infections were asymptomatic and not caused by potent 
urease-producing species that significantly exacerbate CAUTI and cause the more 
severe catheter related problems. The cost of treating CAUTI in these patients would 
be expected to be much higher.
U . Infection and biofilms
The continent bladder helps to maintain a healthy urinary tract as the intermittent 
voiding of urine flushes out invading microbes and keeps it free from infection most 
of the time. The introduction of the indwelling catheter disrupts the normal voiding 
action of the bladder and compromises the hosts natural defence mechanisms, leaving 
the urinary tract vulnerable to infection.
1.3.1. Infection
The microflora that invades the catheterised urinary tract is diverse in nature. Initial 
colonization is usually with single species such as Eschericia coli, Enterococcus 
faecalis or Staphylococcus epidermidis (Tabmbyah et al., 1999; Matsukawa et al., 
2005). With time the urinary flora becomes more complex and eventually mixed 
communities develop which commonly include Gram-negative nosocomial organisms 
such as Proteus, Pseudomonas, Providencia and Klebsiella (Clayton et al., 1982;
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Warren et al., 1982). Microbial infection of the urinary tract in the catheterised patient 
occurs in two ways. Infections via the intra-lumenal route occur when bacteria enter 
the bladder through the catheter from an infected drainage system. The extra-lumenal 
route of infection occurs when bacteria migrate through the periurethral space 
between the catheter and the urethral epithelium (Kass and Schneiderman, 1957; 
Nickel et al., 1985; Stamm, 1991). The introduction of the closed drainage system to 
prevent contamination of the urinary tract reduced UTI via the intra-lumenal route 
(Kunin, 1966).
Keeping the urine collection system sterile however, especially in long-term 
catheterisation is virtually impossible as taps need to be opened to drain the urine and 
junctions between catheter and collection bags have to be disconnected when bags are 
changed. Nickel et al. (1985a) studied the importance of the intra-lumenal and extra- 
lumenal routes of infection by Ps. aeruginosa in catheterised rabbits. They reported 
that bacteriuria (>105 organisms per ml urine) occurred between 32-48 hours in the 
rabbits when the drainage system was infected, compared with 72-168 hours via the 
extra-lumenal route. They concluded that in patients catheterised for very short time 
periods, maintaining a sterile drainage system was fundamental in preventing 
bacteriuria. In long-term catheterisation however, the most important route of 
infection would be via the extra-lumenal route. It was interesting that electron 
microscopy of catheters removed from these rabbits showed that the spread of 
biofilm-associated organisms was instrumental in ascending the catheter and causing 
infection in both intra-lumenal and extra-lumenal routes. Other studies have shown 
that the main routes of infection are different between men and women. Daifuku and 
Stamm (1984) studied 35 catheterised men and women in an intensive care unit and
16
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reported that the majority of women studied became infected via the extra-lumenal 
route. These infections were caused by the spread of bacterial from the rectal area to 
the periurethral area. In contrast, men were more likely to become contaminated 
through cross infection via the intra-lumenal route. The infecting strains originated 
from the periurethral area but not by organisms migrating from their rectal skin. In a 
later study however, Tambyah et al. (1999) found no difference between men and 
women in this respect. Their results suggested that in both sexes the main route of 
infection was along the outside of the catheter, with two-thirds of patients acquiring 
infection in this way.
The complex urinary microflora of long-term catheterised patients is difficult to 
eliminate with antibiotics (Clayton et al., 1982). In addition as most of these 
infections are asymptomatic for most o f the time antibiotic therapy is often withheld. 
It is common practice to use antibiotics only when the evidence suggests that 
infection has spread to the kidneys or bloodstream (Kunin, 1987a). As a result, 
infected urine flows through the catheters for up to 3-month periods at a time. The 
catheters provide attractive, unprotected sites for bacterial adherence. Once attached 
and washed in a gentle flow of nutrient urine, the sessile organisms thrive and 
produce extensive biofilm communities (Stickler, 1996).
1.3.2. Biofilms
In aquatic habitats bacteria show a strong basic instinct to colonize available surfaces 
as biofilms. They can be found in environmental, industrial and medical situations. 
Costerton (1999) described the basic formation of the biofilm and its clinical 
relevance -  “Bacteria that attach to surfaces aggregate in a hydrated polymeric matrix
17
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of their own synthesis to form biofilms. Formation of these sessile communities and 
their inherent resistance to antimicrobial agents are at the root of many persistent and 
chronic bacterial infections”. In the biofilm mode of growth they are able to colonize 
favourable environments rather than be washed away, while the cells embedded in the 
biofilm are also protected from a range of environmental stresses. These include 
nutrient limitation, fluid shear forces, toxic chemicals, antimicrobial agents, 
desiccation, UV irradiation, predation by protozoa or phagocytes and changes in pH 
and temperature (De Beer, 1994; Costerton et al., 1995; Wimpenny and Colasanti, 
1997; Danese, 2002; Donlan, 2002).
The architecture, exopolysaccharide (EPS), diffusion gradients, bulk flow rates, 
spacial arrangement of bacterial cells and the inhabitant species of a biofilm promote 
a variety of microenvironments throughout the biofilm giving the structure a 
heterogeneous nature (Costerton et al., 1995; Jenkinson and Lappin-Scott, 2001; 
Stoodley et al., 2002; Donlan and Costerton, 2002; Stoodley and Stoodley, 2005). The 
distribution of microenvironments within biofilms has been demonstrated in a number 
of studies. Using microelectrodes Costerton et al. (1994) for example demonstrated 
the variability in dissolved oxygen levels throughout Ps. aeruginosa biofilms. They 
found significantly contrasting concentrations of dissolved oxygen at the 
biofilm/liquid interface (almost 100% of that recorded in the bulk liquid), while the 
biofilm/solid interface deep within the biofilm was virtually anaerobic. Such 
microenvironments within biofilms are known to allow diverse species to form 
mutually beneficial relationships where together they are capable of degrading 
complex compounds and nutrients that would not be utilized by individual species 
alone (Nielsen et al., 2000).
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The early concept of the biofilm structure came from research carried out on 
freshwater and laboratory biofilms (Costerton et al., 1978; Lawrence et al., 1991; 
Costerton et al., 1995). The water mosaic model they described showed the biofilm as 
microcolonies of cells arranged in three-dimensional mushroom-like structures 
infiltrated with a network of water channels. The water channels were thought to be 
important as they allowed for the transport of nutrients, gasses and waste products 
into and out of the biofilm. Subsequent studies have shown that biofilm architecture is 
diverse, depending on a range of factors including the inhabitant species, cell- 
signalling, EPS production, and environmental factors including the availability of 
nutrients, and liquid shear forces (Stoodley et al., 2002; Wimpenny and Colasanti, 
1997).
1.3.2.1. Biofilm development
Many studies have attempted to elucidate the mechanisms by which biofilm formation 
is initiated. The cells from the surrounding bulk fluid come into contact with the 
surface usually as a result of hydrodynamic forces, Brownian motion or cell motility. 
Non-specific factors are then thought to facilitate adherence to the substrata including 
electrostatic charges and Lifshitz-Van der Waals forces, before specific interactions 
between the bacterial cell and the surface preserve its attachment (Busscher and van 
der Mei, 1997; Dunne, 2002). Initially cells form a reversible attachment to the 
surface allowing a possible return to the planktonic state. The cells that initiate 
biofilm formation become ‘irreversibly’ attached when EPS production is up- 
regulated anchoring them to the surface. These cells multiply and begin colonization 
of the surface developing into microcolonies that form the early architecture of the
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sessile community (Costerton, 1999; Sauer et al., 2002; Stoodley et al., 2002; 
Shachter, 2003).
Specific interactions between cell and surface are mediated through cell surface 
associated appendages such as pili, curli, fimbriae, various adhesins and flagella 
(Dunne, 2002). Pratt and Kolter (1998) demonstrated that flagella and type 1 pili in E. 
coli were essential in biofilm formation on PVC surfaces. Their evidence suggested 
that flagella were required to provide the initial contact and possibly overcome any 
repulsive forces encountered at the surface, while type 1 pili were necessary for 
adherence and biofilm formation. O’Toole and Kolter et al. (1998) demonstrated the 
importance of flagella and type IV pili in the early stages of Ps. aeruginosa biofilm 
development on PVC surfaces. Type IV pili are associated with ‘twitching motility’ 
which bacteria use to move over surfaces and is driven by extension and retraction of 
the surface attached pili (Burrows, 2005). O’Toole and Kolter et al. (1998) monitored 
biofilm development over the initial 8 hours and demonstrated that wild type strains 
were able to colonize the surface and form aggregates and microcolonies (the basic 
structure of biofilms) as cells congregated on the surface. A mutant strain unable to 
produce flagella was a poor surface colonizer. A pilus-minus mutant strain on the 
other hand, was able to colonize the surface in a similar fashion to the wild type 
initially, but did not show twitching motility and was unable to aggregate into 
microcolonies.
1.3 2.2. Biofilm phenotype
Cells in biofilms are known to be phenotypically different from planktonic cells and 
show different gene expression patterns than free-swimming cells. The early work of
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Davies et al. (1993) demonstrated that attachment to a surface altered gene expression 
in Ps. aeruginosa. The expression of the genes involved in the synthesis of the EPS 
alginate was shown to be up-regulated in cells newly attached to a Teflon surface. 
Sauer and Camper (2001) examined physiological changes in Ps. putida in the switch 
from planktonic to sessile growth in first 6 hours of attachment to silicone surfaces. 
They found 15 proteins were up-regulated and 30 proteins were down regulated while 
overall 40 genes were differentially expressed following initial attachment. Further 
studies by Sauer et al. (2002) demonstrated that multiple phenotypes are expressed by 
Ps. aeruginosa during biofilm formation. They suggested there were five stages of 
biofilm development: (i) reversible attachment, (ii) irreversible attachment (iii) 
maturation-1 (iv) maturation-2, and (v) dispersion. On average a 35% difference in 
protein expression between the stages was observed. They also found that cells lost 
their motility at stage (ii) before regaining motility at stage (v). When protein profiles 
of cells at each biofilm stage were compared with planktonic cultures those in the 
maturation-2 stage were the most distinct from planktonic cells expressing over 800 
proteins at a six-fold increase. The protein profiles of cells from the dispersion stage 
were more similar to those in planktonic cultures than those in the maturation-2 stage.
Schembri et al. (2003) used micro-array methods to monitor the global gene 
expression patterns (with particular emphasis on genes associated with cell structure 
and biofilm formation), of E. coli in sessile growth on glass surfaces compared to 
planktonic growth. They found that 79 genes were significantly altered in sessile 
growth compared to planktonic growth. The Ag43 surface protein known to promote 
auto-aggregation and biofilm formation was expressed at significantly higher levels in 
the sessile community than in planktonic growth. They also reported increased
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expression of the genes under the control of the rpoS-encoded sigma factor. These 
genes are involved in cellular responses to a range of stresses including chemical 
agents and nutrient depletion and are related to slow growth.
1.3.2.3. Quorum sensing
The expression of a number of bacterial genes is known to be under the control of 
cell-signalling chemicals known as quorum sensing (QS) molecules. These molecules 
diffuse freely across cell membranes and between cells. In dense bacterial 
populations, when the concentration of these QS molecules exceeds a threshold, a 
regulatory effect over genes under their control takes place (Kjelleberg and Molin, 
2002; Abraham, 2006; Spoering and Gilmore, 2006). A number of cell signalling 
molecules in both Gram-negative and Gram-positive bacteria have been identified. In 
Gram-negative species, QS is under the control of acylated homoserine lactone (AHL) 
molecules, while in Gram-positive species QS is known to be controlled by the auto­
inducer peptide (AI-2) and the competence signalling peptide (CSP). CSP is known to 
promote complementation (uptake of naked DNA from the environment), which may 
be a selective advantage to cells in stressful environments. It has also been 
demonstrated in having a role in biofilm formation (Petersen et al., 2004). Although 
AHLs are absent in Gram-positive species, AI-2 is also found in Gram-negative 
species suggesting a means of interspecies communication (Abraham, 2006). The 
presence of signalling molecules or peptides in bacterial biofilms is well documented, 
and they are thought to have a multi-factorial role including, virulence, biofilm 
formation, disruption of other competing bacteria, cell lysis, and the dissemination of 
biofilm cells (Kjelleberg and Molin, 2002; Suntharalingam, 2005; Abraham, 2006; 
Spoering and Gilmore, 2006). McLean et al. (1997) demonstrated the presence of
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AHLs in naturally occurring biofilms. Using Agrobacterium tumefaciens A 136 as an 
AHL-responsive reporter strain in ‘cross-feeding’ assays, they showed that these 
molecules diffused through agar from biofilms forming on limestone rocks found in a 
Texas river. These biofilms were composed of Pseudomonas species including Ps. 
putida and Ps. fluorescens. Using similar ‘cross-feeding’ assays, Stickler et al. 
(1998a) demonstrated that AHLs could be detected in bacterial communities 
colonizing indwelling urinary catheters removed from patients.
Davies et al. (1998) studied the role of cell-signalling systems in Ps. aeruginosa 
biofilm formation. They compared the biofilm forming ability of a wild type strain to 
a lasl mutant that was unable to produce N-(3-oxododecanoyl)-L-homoserine lactone. 
Biofilms formed by the wild type were composed of mushroom shaped microcolonies 
with cells spatially separated within. The lasl mutant however, could only form flat 
shallow biofilms of tightly packed cells (approximately 20% of the thickness of the 
wild type biofilm) under the same growth conditions. When these biofilms were 
treated with the detergent sodium dodecyl sulphate (0.2 %) the wild type biofilm was 
unaffected. In contrast the biofilm formed by the mutant detached from the surface 
within 5 minutes of the detergent introduction. When synthetic AHL was introduced 
to the mutant culture it produced a biofilm identical to the wild type with spatially 
separated cells. The biofilm also became recalcitrant to treatment with the detergent, 
supporting the theory that biofilm structure is an important factor in resistance to 
antibacterial agents. It has also been suggested that quorum sensing is involved in the 
dispersal of cells from the biofilm (Donlan, 2001).
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1.3.2.4. Biofilms on medical devices
Infections associated with implanted medical devices are characteristically persistent 
and retractile to antibiotic therapy. The nature of these infections results from the 
properties of the biofilms that develop on the surfaces of these devices. Biofilms that 
form on implanted medical devices are extremely difficult to eradicate as they evade 
host immune responses such as phagocytosis and also the effect of antimicrobial 
chemical agents (Costerton et al., 1995; Stickler and McLean, 1995; Donlan, 2001). 
Biofilms forming on implanted medical and prosthetic devices are becoming ever 
more clinically relevant as an increasing number of individuals have such devices in 
place. These devices which include replacement joints, heart valves, artificial hearts, 
vascular shunts, contact lenses, stents and lines, venous and urinary catheters and 
breast implants are manufactured from a range polymers and metals. Darouiche 
(2001) postulated that 5 major principles are important in the formation of device 
related biofilms: (1) different bacteria may adhere differently to the same device 
material; (2) the same bacteria may adhere differently to different device material; (3) 
the same bacteria may adhere differently to the same device material placed under 
different circumstances, including the medium in which the device is placed (e.g. 
hydrophobic vs. hydrophilic medium), type of flow, and temperature; (4) in vitro 
inhibition of bacterial colonization of the device does not ensure anti-infective 
efficacy in vivo; and (5) the clinical benefit of a particular surface-modifying 
approach may vary from one application to another.
Essentially implants act as ‘foreign bodies’ once they are incorporated into host 
tissue. It has been demonstrated that a range of proteins present in body fluids
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including collagen, albumin, fibrinogen, fibronectin, vitronectin, laminin and a-1- 
microglobulin readily adsorb onto the surfaces of implants forming ‘conditioning 
layers’ (Barbucci and Magnani, 1994; Stickler and McLean, 1995; Santin et al., 1997; 
Reid, 1999). These adsorbed proteins can trigger inflammation when the immune 
system response attracts neutrophils and macrophages to the device (Stickler and 
McLean, 1995). Tang and Eaton (1993) used a mouse model (implanted with 
polyethelene terephthalate film) to demonstrate that the acute immune response was 
initiated by the fibrinogen content of the conditioning layer that adsorbed to the 
surface. In a further study Tang et al. (1996) identified that a specific region (D yl90- 
202) of fibrinogen was responsible for phagocyte interaction. The adsorbed proteins 
also offer ‘binding sites’ for bacteria to adhere when epitopes present on their surfaces 
are recognized by specific bacterial adhesins. This has been demonstrated in a number 
of studies. Host proteins including fibrinogen, fibronectin and collagen are known to 
interact with ‘microbial surface components recognising adhesive matrix molecules’ 
(MSCRAMMs) of Staphylococcus aureus allowing them to adhere to host cells and 
implanted devices that are coated with these proteins (Vaudaux et al., 1993; Foster 
and Hook, 1998; Arrecubieta et al., 2006).
1.3.25. Resistance to antimicrobial agents
Studies have shown that bacterial cells dwelling within the biofilm have an increased 
resistance to antibacterial agents, which is thought to be dependent on a number of 
factors. Poor diffusion into the biofilm (determined by the architecture and nature of 
the EPS matrix), the phenotypic nature of biofilm cells - a proportion of which will be 
dormant or very slow growing, and the composition of the inhabitant bacterial 
consortia have all been suggested as resistance mechanisms (Mah and O’Toole, 2001;
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Donlan and Costerton, 2002; Dunne, 2002). Nickel et al. (1985b) used a laboratory 
model to grow Ps. aeruginosa (previously isolated from a CAUTI) biofilms on latex 
discs using artificial urine as the growth media. They found that viable cells were 
recoverable from the biofilm even after a 12-hour period of exposure to the antibiotic 
tobramycin at a concentration of 1,000 pg/ml. This concentration was far in excess of 
the 50 pg/ml tobramycin concentration required to kill the planktonic Ps. aeruginosa 
cells removed from the same experimental system. Gristina et al. (1987) reported that 
viable cells from Staphylococcus epidermidis biofilms grown on steel discs could be 
recovered after 8 hours exposure to tobramycin at a concentration of 1,000 pg/ml. 
When these cells were recovered from the biofilm and re-suspended in a planktonic 
state the tobramycin minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) were recorded at <0.5 pg/ml, and were identical to 
the cells in the original broth cultures.
Diffusion limitation in biofilms can result from a reduction in the fluid flow within the 
biofilm matrix and by the increased diffusion distances resulting from the biofilm 
architecture (Stewart, 2003). Hoyle et al. (1992) showed that the EPS of Ps. 
aeruginosa biofilms provided a physical barrier to the diffusion of the [3-lactam 
antibiotic piperacillin. Studies have also shown that the biofilm matrix can act as a 
diffusion barrier by inactivating antibacterial compounds. Using microelectrodes to 
monitor chlorine penetration into Ps. aeruginosa and K. pneumoniae biofilms, de 
Beer et al. (1994) found that diffusion of chlorine into the biofilm decreased with 
depth into the matrix. The chlorine concentration at the deepest parts of these biofilms 
was as low as 20% of the concentration of the chlorine in the bulk liquid. They found 
that alginate (a major exopolysaccharide associated with Ps. aeruginosa biofilms) was 
able to bind chlorine and effectively neutralize its effect, reducing its penetration
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through the biofilm. Even when antimicrobial agents penetrate the biofilm matrix 
readily and in significant concentrations it does not mean they will be effective on the 
sessile biofilm community. Dunne et al. (1993) demonstrated that Staphylococcus 
epidermidis biofilms were completely penetrable with vancomycin and rifampin at 
concentrations in excess of their respective MBC’s. However, viable cells were 
retained within the biofilm matrix even after 72 h exposure to rifampin in excess of 
the MBC concentration. When the MIC’s and MBC’s of these biofilm cells were 
tested they were significantly higher than for planktonic cells. In these circumstances 
it is thought the ‘phenotype’ of the biofilm cells increases their resistance.
The MICs and MBCs of contemporary antibiotics are based on exponentially growing 
planktonic cell cultures (Fux et al., 2005). Studies have shown however, that 
compared to cells at the peripheral areas of the community, bacterial cells deep within 
the biofilm matrix grow much slower or adopt a dormant non-growing phenotype 
(Wentland et al., 1996; Sternberg et al., 1999; Sauer and Camper, 2001). This slow 
growth is thought to be due to the reduced availability of nutrients (Donlan and 
Costerton, 2002; Mah and O’ Toole, 2001). The growth rate of cells has been shown 
to greatly determine the effect the antimicrobial agents, and may therefore be a major 
factor why bacterial biofilms are extremely difficult to eradicate (Eng et al., 1991). In 
addition to this, studies have shown that persister cells (dormant cells with spore-like 
attributes) are present in bacterial populations. Persister cells are highly tolerant to a 
range of environmental and physical challenges and are known to be present in 
biofilm communities (Keren et al., 2004). This would further explain the inherent 
recalcitrant nature of bacterial biofilms.
27
Introduction
Bacterial cells that are susceptible to antibacterials may also be ‘protected’ from these 
agents by other species within a mixed community biofilm. Anderl et a l  (2000) 
examined the penetration of the p-lactam antibiotic ampicilin, and also ciprofloxacin 
into filter disks through biofilms of a p-lactamase producing wild type K. pneumoniae 
able to degrade ampicilin, and a mutant strain unable to produce P-lactamase. They 
reported that ciprofloxacin penetrated both biofilms while ampicillin only penetrated 
the mutant biofilm suggesting that P-lactamase activity was the important factor in 
preventing penetration. Other reports have also shown that synergistic interactions in 
multispecies biofilms also confer increased resistance to antimicrobial agents. 
Burmolle et a l  (2006) demonstrated that multi-species biofilms composed of marine 
isolates of Microbacterium phyllosphaerae, Shewanella japonica, Dokdonia 
donghaensis and Acinetobacter iwoffii produced biofilms of considerably more 
biomass when grown together than when grown as single species. When hydrogen 
peroxide or tetracycline was added to the biofilms grown in microtitre wells the 
relative activity of the multi-species biofilms was markedly higher compared with the 
single species biofilms. In conclusion, the overall evidence surrounding the increased 
resistance of biofilm associated cells to antimicrobials suggests that the basis for 
antibacterial resistance in bacterial biofilms is a multifactorial phenomena, and it is 
likely to be distinct depending on the antibacterial being considered.
1.4. Attempts to prevent catheter-associated urinary tract infection
A variety of approaches have been used to try and prevent the infection of the 
catheterised urinary tract. The most effective of these strategies has been the 
introduction of the closed drainage system. Attempts to block the routes of infection 
with antibacterial agents have met with limited if any success (Kunin, 1997).
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1.4.1. Closed drainage system and drainage bag disinfection
In the early days of catheterisation, it was common practice for catheters to drain into 
open bottles or buckets under the patient’s bed. Under these conditions infection was 
inevitable after 3-4 days. Kunin and McCormack (1966) showed that a novel 
disposable closed drainage system in which urine flowed from the catheter, through a 
tube attached to a collection bag, reduced infection rates to 20 - 50 % in patients being 
catheterised for short periods (up to 13 days). These systems were not closed for the 
duration of catheterisation of course as it was necessary, every eight hours or so, to 
open the tap on the bag to empty the urine. Attempts were made to prevent 
contamination of the urine in the bag by adding disinfectant to the bag each time it 
was emptied. Gillespie et al. (1983) used chlorhexidine to maintain the sterility of the 
drainage bag in catheterised patients. Although the drainage bags in these patients 
remained sterile, there was no significant difference in the rates of CAUTI in patients 
with chlorhexidine treated collection bags compared to patients whose collection bags 
were not treated with the disinfectant. In a similar study Thompson et al. (1984), 
evaluated the potential of hydrogen peroxide to disinfect urine collection bags of 
catheterised patients as a means to prevent CAUTI developing. This study also 
reported a significant reduction in bag contamination but there was no significant 
reduction in CAUTI between patients where collection bags were treated with 
hydrogen peroxide and controls. In general although the closed drainage system may 
prevent infection in the very short-term, those catheterised for extended periods will 
inevitably become bacteriuric via the extra-lumenal route.
Colonization of the peri-urethral skin by urinary tract pathogens is an important risk 
factor for CAUTI (Garibaldi et al., 1980; Daifuku and Stamm, 1984). It would seem
29
Introduction
to be sensible to perform regular cleaning of the urethral meatus with antibacterial 
agents. Well -  controlled prospective trials of this approach however, have failed to 
demonstrate any benefit (Burke et al., 1981; Burke et al., 1983). In their earlier study 
Burke et al. (1981) demonstrated that twice-daily cleansing of the urethral meatus 
with povidone-iodine solution and application of povidone-iodine ointment was not 
effective in reducing the incidence of bacteriuria. In total, 16.0 % of patients 
undergoing this treatment acquired bacteriuria compared to 12.4 % in patients in the 
control group who received no meatal care, daily infection rates were 5.9 % and 4.5 % 
per day in test and control groups respectively. Cleansing once daily with soap and 
water resulted in 12.2 % of patients acquiring bacteriuria versus 8.1 % in the control 
group receiving no cleansing of the urethral meatus. In a later study Burke et al. 
(1983) used a poly-antibiotic ointment in meatal care, and also concluded that if there 
was any benefit at all in using this ointment it was small.
1.4.2. Bladder washouts
A number of antibacterial agents have also been evaluated as a means to control 
CAUTI. The technique of bladder washing generally involves the instillation of an 
antibacterial solution (50-100ml) through the catheter into the bladder. The catheter is 
then clamped and after 20 -  30 minutes the clamp released to allow the solution to 
drain out. There is little evidence that this procedure is effective in preventing or 
controlling CAUTI. For example Clayton et al., (1982) reported that when a 
combination of kanamycin and colistin was used as a bladder washout on a patient 
infected with K. pneumoniae, the infecting organism was replaced by a kanomycin 
resistant strain of P. mirabilis. Davies et al. (1987) reported that repeated bladder 
washouts with chlorhexidine solution over a 3-week period in catheterised patients
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had no effect on bacterial numbers determined from urine samples. Moreover, 
episodes of infection with Proteus spp. (important pathogens in the catheterised 
urinary tract), increased in patients using the chlorhexidine washout. Stickler et al. 
(1987) demonstrated in experiments in a laboratory model of the bladder that clinical 
isolates of Providencia stuartii, Ps. aeruginosa, P. mirabilis, K. pneumoniae and 
Streptococcus faecalis all resisted washouts with chlorhexidine solution. They also 
investigated the effects of chlorhexidine on the urinary flora of catheterised patients. It 
was demonstrated that any antibacterial activity in the urinary flora was minimal and 
temporary.
The infection control team at a Southampton Hospital devised a policy designed to 
comprehensively block all possible routes of infection of the catheterised bladder. The 
policy was based on the antiseptic chlorhexidine. Daily washes with chlorhexidine 
were used to disinfect the peri-urethral skin. A gel containing chlorhexidine was 
applied daily to the catheter insertion site and the antiseptic was instilled into the 
drainage bag each time it was emptied. After an apparent initial drop in the incidence 
of CAUTI an outbreak of infections involving over 90 patients occurred with a 
chlorhexidine resistant, multi-drug resistant strain of P. mirabilis (Walker and Lowes, 
1985; Dance et a l, 1987). The outbreak was only controlled when the policy was 
abandoned. Warren et al. (1978) investigated the use of a double-lumen catheter to 
deliver a continuous irrigation of the bladder with neomycin and polymixin. They 
reported no differences in the rate of CAUTI in test and control patients. The 
incidence of infection for both groups was approximately 5% per day. More 
importantly there was a marked difference in the bacterial flora colonizing the
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different groups, with levels of organisms resistant to the antibiotics significantly 
higher in the group using the irrigation.
1.4.3. Administration of prophylactic antibiotics
The evidence suggests that antibiotics are not effective in preventing bacteriuria in 
patients undergoing long-term catheterisation (Clayton et al., 1982). Garibaldi et al. 
(1974) reported that the use of systemic antibiotics in catheterised patients had a 
limited effect, and only prevented bacteriuria in patients in the first 4 days of 
catheterisation. The rate of bacteriuria after this time was not significantly different 
between individuals receiving, and those not receiving antibiotic therapy. They also 
reported that those treated with antibiotics were more likely to harbour antibiotic 
resistant strains. In a follow-up study Britt et al. (1977), reported that patients 
receiving prophylactic antibiotics during short-term catheterisation after 
gynecological surgery had reduced episodes of bacteriuria compared to a placebo 
group (3 out of 96 patients versus 9 out of 100 patients respectively). However, at 
time of discharge from hospital there was no significant difference between 
bacteriuria in the groups (8 out of 82 in treated group versus 8 out of 75 in untreated 
group). The majority of CAUTI are asymptomatic, and the general consensus on the 
use of antibiotics is that they should only be administered when symptoms suggest 
that invasive infection of the kidneys or bloodstream has occurred (Warren, 1991; 
Tambyah and Maki, 2000; Trautner et al., 2005).
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1.5. Proteus mirabilis -  a particularly dangerous organism in the catheterised 
urinary tract
Proteus mirabilis is an opportunist pathogen and will cause infections in wounds, 
bums, and of the urinary tract, when its normal defence mechanisms have been 
impaired (Penner, 1984). It causes particularly severe problems in individuals 
undergoing long-term catheterisation. In these individuals it is responsible for 
blockage of the catheter, a complication which results in increased morbidity and 
mortality (Mobley and Warren, 1987; Kunin, 1989; Hedelin et al., 1991; Kohler- 
Ockmore and Feneley, 1996; Stickler, 1996). The bacterium can be found in aquatic 
and soil environments, sewage, and as part of the natural gut flora of animals and 
humans (Penner, 1984). P. mirabilis possesses a battery of virulence factors including 
agglutinins, flagella, proteases, haemolysins, siderophores and the enzyme urease 
(Rozalski et al., 1997). It is also capable of producing swarmer-cells which can 
migrate over surfaces and have been implicated in pathogenesis (Mobley and Belas, 
1995).
Swarming behaviour in P. mirabilis occurs when vegetative swimmer-cells 
differentiate into elongated, highly flagellated and highly motile swarmer-cells. These 
differentiated cells can be 10-80 times the length of swimmer cells, possess 1 0 3- 1 0 4 
flagella (compared to 4-10 peritrichious flagella in swimmer-cell), and become 
multinucleate (Mobley and Belas, 1995). Various environmental cues and induced 
gene expression are required for the differentiation process including contact with a 
solid surface, a high population density, inhibition of flagella rotation and cell-cell 
signalling (Mobley and Belas, 1995; Rozalski et al., 1997; Rather, 2005). The 
increased motility observed in the swarming phenomenon is the result of multi-
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cellular coordination. On solid surfaces adjacent swarmer-cells interweave their 
flagella to form helical structures and produce large amounts of extracellular slime 
that forms a matrix through which the integrated raft of cells can migrate rapidly via 
coordinated flagella movement (Stahl et al., 1983; Jones et al., 2004). After a period 
of swarming, migration stops and cells at the perimeter of the swarming edge divide 
into swimming-cells in a process called consolidation. When population density and 
slime production are sufficient cells will differentiate once again and resume 
swarming behaviour. Repetition of these events produces the characteristic rings of 
growth as the organism swarms over agar plates. The role of swarming in colonization 
of the catheterised urinary tract is not fully understood at present. A number of studies 
however, have shown that P. mirabilis can swarm over the surfaces of a wide variety 
of catheter materials. It is possible that swarming may be a factor in the migration of 
the bacteria from the urethral meatus to the bladder. Stickler and Hughes (1999) used 
‘catheter bridges’ to demonstrate that P. mirabilis was able to swarm over a range of 
catheter surfaces including all-silicone, silicone-coated latex, hydrogel-coated latex 
and hydrogel/silver-coated latex. They found that P. mirabilis could migrate over 10 
cm of catheter surface within a 24 hour period. In these experiments the speed of 
migration was highest over the hydrophilic surfaces of hydrogel catheters. In a similar 
study Sabbuba et al. (2002) used catheter bridges to demonstrate that P. mirabilis and 
P. vulgaris were capable of migrating over the surfaces of hydrogel-coated latex, 
hydrogel/silver-coated latex, silicone-coated latex and all-silicone catheter materials, 
faster than nine other urinary tract pathogens. Jones et al. (2004) reported that non- 
swarming transposon-generated mutants of P. mirabilis had impaired ability to 
migrate over catheters compared to the parental wild type strain. The role of
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swarming in pathogenesis has also been considered in urinary tracts that have been 
compromised by the presence of an indwelling urinary catheter.
Allison et al. (1992) examined the role of swarming in the invasion of human 
urothelial cell cultures. Swarmer cells were found to be more invasive than vegetative 
cells. Additionally they showed mutants defective in motility and swarming were less 
invasive than wild type strains. They also examined the role of other virulence factors 
(flagellin and haemolysin) that are up-regulated in swarmers and found that they were 
not relevant to the entry into the epithelial cells. Jansen et al. (2003) used green 
fluorescent protein expression and confocal microscopy to observe P. mirabilis cell 
morphotypes invading the urinary tract of transurethrally infected mice. Their 
observations of kidney, ureter and bladder tissues revealed a very low percentage of 
swarmer cells (0.14%) were present (none at all observed in ureters), and concluded 
that the swimmer-cell was the predominant morphotype in ascending UTI. In contrast, 
Allison et al. (1994) intravenously infected mice with wild type P. mirabilis, two 
mutant strains with different abnormal swarming behaviour, a non-swarming but 
motile mutant and a swarming but non-haemolytic mutant. Histological examination 
of kidney sections of the mice revealed that wild type P. mirabilis and the non- 
haemolytic mutant swarmer-cells were the predominant morphotype found in the 
kidney tissue. The non-swarming mutant strains were less virulent compared to the 
swarming strains. In the same study they also observed the rates of ascending UTI by 
directly infecting the bladders of mice with the test strains. They demonstrated that 
wild type and non-haemolytic mutant were able to colonize the kidneys of infected 
mice while none of the non-swarming mutants were able to colonize the kidney.
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Other virulence factors which are thought to be important in P. mirabilis pathogenesis 
are the surface associated appendages. Two major fimbrial types expressed by P. 
mirabilis are Mannose-Resistant Proteus-like fimbriae (MR/P fimbriae) and 
Mannose-Resistant Klebsiella-like fimbriae (MR/K fimbriae). The expression of 
MR/P fimbriae is phase-variable and has been suggested to play a role in acute 
pyelonephritis (Bahrani et al., 1994; Li et al., 2002). MR/P fimbriae belong to the 
type IV pili family, a group of retractable adhesive appendages, synthesized by a 
range of pathogenic and environmental Gram-negative bacteria (Burrows, 2005). 
Their presence can be detected by their ability to agglutinate a range of red blood cell 
types (including human, bovine, and chicken) in the presence and absence of mannose 
(Bahrani et al., 1994). The process of extension and retraction through the cell 
envelope is driven by ATP-dependent assembly and dis-assembly of the pili structural 
subunits, and they are involved in specific and non-specific binding to tissue, abiotic 
surfaces such as glass, plastic, and metal (Burrows, 2005). Type IV pili allow 
twitching motility across surfaces, DNA uptake, and biofilm formation. It is thought 
they are important in cytotoxicity as they allow invading cells to be drawn adjacent to 
host cells where contact-dependent secretion systems can take place (O’Toole and 
Kolter, 1998; Burrows, 2005). It has been suggested that both MR/P and MR/K 
fimbriae may be important in CAUTI. Mobley and Chippendale (1990) used 
haemagglutination to examine the presence of MR/P and MR/K fimbriae expressed in 
P. mirabilis isolates from patients with acute pyelonephritis, catheter-associated UTI 
and from faecal samples. They demonstrated that MR/P fimbriae were expressed in all 
isolates while MR/K fimbriae were not always expressed.
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Sareneva et al. (1990) demonstrated that an MR/P fimbriae expressing strain bound 
strongly to tubular epithelial cells of human kidney tissue and to exfoliated epithelial 
cells. In contrast strains expressing MR/K fimbriae bound to the Bowman’s capsule, 
glomeruli and interstitial tissue of the kidney sections but only weakly to exfoliated 
epithelial cells. In the same study however, they showed the MR/P strain did not 
agglutinate human or bovine red blood cells in the presence of human urine (MR/K 
agglutination was not inhibited). They concluded that urine contains low molecular 
weight molecules that inhibit MR/P binding in vivo, which may be a factor in the low 
rates of P. mirabilis infection in normal individuals. As MR/K agglutination was not 
affected in the presence of urine they suggest these fimbriae were responsible for 
mediating initial adherence in vivo, especially in the catheterised urinary tract i.e. 
directly to the catheter surface or where localized damage to the urinary tract may 
occur. This hypothesis supports previous work carried out by Mobley et al. (1998) 
who monitored weekly urine samples from 51 long-term catheterised patients. They 
found that Pv. stuartu was the most prevalent isolate in urine samples and that strains 
expressing MR/K fimbriae were more likely to cause bacteriuric episodes of long 
duration (> 12 weeks) than episodes of short duration (1 week or less). Strains that did 
not express MR/K were more likely to be present in urine for short periods. They also 
demonstrated using in vitro adherence assays that MR/K strains adhered better to 
silicone-coated latex catheters than strains not expressing MR/K fimbriae.
Bahrani et al. (1991) infected mice with P. mirabilis to determine the role of MR/P 
fimbriae and flagella in ascending UTI. They used an enzyme-linked immunosorbent 
assay (ELISA) of the serum of the previously challenged mice to reveal an immune 
response against purified MR/P and flagella, thus demonstrating that both were
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expressed during the ascending UTI. Bahrani et al. (1994) also transurethrally 
inoculated mice with a wild type MR/P+ and an MR/P' mutant and assessed 
colonization and virulence in the urinary tract after a 1 week challenge. The results 
showed that wild type P. mirabilis colonized urine, bladder and kidneys in 
significantly higher numbers than the mutant strain. Histopathological findings 
suggested that the mutant strain also caused less damage to uroepithelium cells and 
did not cause pyelonephritis.
Zunino et al. (2001) transurethrally co-challenged sixteen mice with equal titres of a 
wild type clinical P. mirabilis isolate and its isogenic mutant unable to express MR/P 
fimbriae. They isolated bacteria colonizing the kidneys and bladder after 7 days and 
found the wild type out-competed the mutant in both parts of the urinary tract. In the 
same study they intravenously inoculated mice with the test organisms and found that 
after seven days 16 of 17 mice infected with the wild type had infected kidneys 
(presence of abscesses or recovery of bacteria from tissue), compared to only 12 of 24 
mice inoculated with the mutant strain. They also demonstrated that the wild type 
strain adhered to uroepithelial cells in significantly higher numbers after a 1 hour 
incubation period.
Jansen et al. (2004) presented evidence that MR/P fimbriae expression is important 
during ascending UTI and biofilm formation. The authors used a wild type parent 
strain (P. mirabilis HI4320) and phase-locked (MR/P on or MR/P off) isogenic 
mutants of the parent strain. Results showed that wild type P. mirabilis expressed 
MR/P fimbriae when introduced into the urinary tract of mice, and the majority of 
bacteria colonizing bladder, ureter and kidney tissue (removed from the mice at 2  and
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4 days), expressed MR/P fimbriae. They also found that all three strains were able to 
colonize the bladders of mice, but adhered to distinct areas demonstrating that other 
virulence factors are important in urinary tract colonization. In the same study they 
observed early-stage biofilm formation on glass cover slips. Phase locked on MR/P 
strains formed cell aggregates and typical 3-dimensional biofilms at 18 hours while 
wild type and MR/P phase-locked off strains only adhered to the glass surface as 
single cells. When they examined 48 hour biofilm formation in PVC microtitre wells 
the biofilms of the parent strain and the phase-locked off MR/P strain were similar, 
while the MR/P phase-locked on strain had formed a better biofilm. When the same 
strains were grown on cover slips for seven days however, the wild type formed much 
thicker biofilms (~ 63 pm) compared to biofilms formed by phase-locked on and 
phase-locked off MR/P strains (-10pm). They concluded that MR/P fimbriae 
expression is important in auto-aggregation of cells and enhancement of biofilm 
formation in the early stages, but needs to be controlled for mature biofilm formation 
to take place. It seems therefore that while several studies have implicated MR/P 
fimbriae in the pathogenesis of UTI in the uncompromised urinary tract, there is no 
direct evidence supporting their role in CAUTI.
The most significant P. mirabilis virulence factor associated with complications in 
CAUTI is the enzyme urease, which is induced by urea (Nicholson et al., 1993; 
Dattelbaum et al., 2003). Urease action is the driving force for the formation of the 
crystalline biofilm that block catheters (Section 1.6). The enzyme is also thought to 
play a significant part in UTI. Jones et al. (1990) demonstrated the contribution of 
urease in infection using a mouse model infected with wild type P. mirabilis HI4320 
strain and its urease-negative derivative. Quantitative results showed that not only was
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the wild type strain more obstinate in the urinary tract of infected mice compared to 
the mutant strain, but was isolated in significantly higher numbers than the mutant 
from the urine, bladder and kidneys. In a similar study Johnson et al. (1993) also 
reported that the P. mirabilis strain was significantly more persistent in the bladder 
and kidneys of infected mice compared to the urease-negative strain. The wild type 
also caused significantly more episodes of renal pathology including pyelonephritis, 
renal abscesses and epithelial necrosis than the urease-negative strain. Urease is also 
known to be important for the function of other P. mirabilis virulence factors e.g. P. 
mirabilis protease enzymes that degrade host immunoglobulins IgA and IgG. These 
proteins are present in the urine and protect host membranes and tissues from bacteria 
and bacterial products (Rozalski et al., 1997). P. mirabilis proteases work optimally at 
pH 8.0 and it is thought that elevation of urinary pH by urease action allows for 
maximum proteolytic enzyme activity on the IgA and IgG (Rozalski et al., 1997).
1.6. Proteus mirabilis and other urease producers in the encrustation of 
catheters
The care of patients undergoing long-term catheterisation is seriously compromised 
by infection with urease-producing bacteria, particularly P. mirabilis. Urease action 
on urea generates two molecules of ammonia to each molecule of carbon dioxide. 
These moieties form ammonium and bicarbonate ions and the net result is an increase 
in the concentration of OH" ions and the generation of alkaline urine as shown below.
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CO(NH2)2 + h 2o  ■ » 2NH3 + co2
1
2NH3 + 2H20  « * 2NH4+ + 20H'
co2 + HzO ♦ » H2CQ3 « - H* + HC03'
Under these conditions dissolved solutes including ionic calcium, magnesium and 
phosphate precipitate out of the urine in the form of ammonium magnesium 
phosphate or struvite, [NH4MgP0 4 6 H2 0 ], and calcium phosphate species such as 
carbonate apatite [CaiofPO^CCb], (Hedelin et al., 1984; Mobley and Warren, 1987; 
Kunin, 1989; McLean et al., 1996). These phosphates are deposited on the internal 
and external surfaces of the catheter and become incorporated into the biofilm matrix 
forming crystalline biofilms (Cox et al., 1987; Hedelin et al., 1991; Morris et al., 
1997; Morris and Stickler, 2001). The crystalline biofilm can eventually prevent the 
device from draining. In the majority of these cases the only option is replacement of 
the catheter with a new device. Removing an encrusted catheter however, can be 
extremely painful for the patient, causing trauma to the urinary tract (Morris and 
Stickler, 1998b). Fragments of the crystalline biofilm can remain in the bladder, 
acting as a reservoir for the colonization and encrustation of the replacement device. 
Catheter replacement in patients infected with these urease-producing species is 
generally only effective for short periods until the replacement catheter itself 
succumbs to the ongoing encrustation process.
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A number of urease-producing bacterial species including P. mirabilis, P. vulgaris, 
Pv. rettgeri, Morganella morganii, K. pneumoniae, and Ps. aeruginosa can be 
responsible for CAUTI. The most common organism isolated from the urine of long­
term catheterised patients suffering from recurrent catheter blockage is P. mirabilis 
(Mobley and Warren, 1987; Kunin, 1989). It is also the species most commonly found 
on patients* encrusted catheters (Stickler et a l,  1993). Stickler et a l  (1998) tested the 
encrusting ability of a number other urease-producing species using in vitro bladder 
models. They reported that P. mirabilis, P. vulgaris and Pr. rettgeri were all capable 
of elevating urinary pH and causing extensive catheter encrustation while M  
morganii, K. pneumoniae and Ps. aeruginosa failed to produce alkaline urine and any 
appreciable crystalline biofilm. Hedelin et a l  (1991) determined the composition of 
catheter encrustation, urinary pH and also the bacteriology of 11 long-term 
catheterised patients. They reported that patients with mean urinary pH values above a 
critical value of 6.8 were particularly subject to catheter encrustation and blockage. 
The elevated urinary pH was linked to the presence of persistent urease-producing P. 
mirabilis. They also found that calcium phosphate made up the bulk of deposits on 
catheters in patients with mean urinary pH <6.7, while magnesium phosphate made up 
the bulk of deposits > pH 6.8. In a subsequent study Burr and Nuseibeh (1993), 
determined a range of urinary parameters including calcium, magnesium, phosphate 
and pH in the urine samples collected from 40 long-term catheterised spinal cord 
injured patients, half of whom blocked their catheters regularly. From the data 
collected they calculated that the main risk factors connected to catheter blockage 
were a urinary pH > 6.9, and urinary concentrations of ammonium > 20 mM/L and 
calcium > 2.45 mM/L. Their general conclusions were that urease-producing bacteria
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and urinary calcium concentration were the most important factors in catheter 
blockage.
The pH value at which calcium and magnesium phosphates come out of solution in a 
sample of urine has been termed the nucleation pH (pHn) (Choong et al., 1999). These 
authors compared the voided pH (pHv) and pHn of urine samples from long-term 
catheterised patients that either blocked or did not block their catheters. The results 
were interesting in that the mean pHns of non-blockers and blockers were similar 
(7.46 and 7.38 respectively). However, the pHvs between these groups varied 
significantly with non-blockers having more acidic (pHv 5.97) urine than blockers 
(pHv 7.63). They concluded that the ‘safety margin’ (pHn - pHv) observed in blockers 
urine was much reduced compared to that of the non-blockers, and this was important 
in the development of encrustation.
A prospective study recently carried out by Mathur et al. (2006a), examined the 
lifespan of catheters from 21 long-term catheterised patients with urease-producing 
Proteus species in their urinary flora. They also determined the voided pH (pHv) and 
nucleation pH (pH„) of weekly urine recorded in samples obtained from the patients. 
They found that the times catheters took to block in the patients varied from 2-98 
days. Patients were designated as slow encrusters (mean catheter life-span of >28 
days) or rapid encrusters (mean catheter life-span of <28 days). The mean pHv, pHn 
and safety margin (pHn -  pHv) values were calculated for the two groups. The analysis 
revealed that while rapid encrusters appeared to have a higher mean pHv (7.20) than 
slow encrusters (6.91) this difference was not statistically significant. The mean pHn 
of rapid encrusters (7.32) however, was significantly lower then the mean pHn (8.08)
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of those where catheters blocked less frequently (P = 0.002). Further analysis of this 
data (Mathur et al., 2006b) showed that there was a significant correlation between 
catheter lifespan and urinary pHn, the higher the pHn the longer the catheter took to 
block. Another important point from these studies was that there was considerable 
variability in the pHn values of the weekly urine samples obtained from these patients. 
This led the authors to suggest that the ‘critical pH’ described by Hedelin et a l  (1991) 
or the risk factor of a pH >6.9 described by Burr and Nuseibeh (1993) were not set in 
stone and could be manipulated. Strategies to elevate the pH„ and reduce the rates of 
catheter encrustation in long-term catheterised patients thus seemed possible.
1.7. Urine composition, diet and their role in encrustation
Studies investigating ways of reducing the metabolic stone formation in the urinary 
tract have shown that significant risk factors include high calcium and high oxalate 
excretion in the urine, low citrate excretion and low urine output (Seltzer et al., 1996; 
Borghi, 2002; Siener and Hesse, 2002; Honow et al., 2003; Meschi et al., 2004; 
Siener and Hesse, 2005). These studies have also demonstrated that urinary 
composition can be manipulated successfully by dietary intervention, significantly 
reducing the stone-forming potential in patients predisposed to metabolic urolithiasis. 
Increasing urinary citrate excretion in stone-forming patients as a means of preventing 
urolithiasis is already a recognised therapy. Citrate is a key intermediate in the citric 
acid cycle essential in aerobic respiration, but is also excreted freely in urine. It is a 
natural ‘chelating agent’, forming soluble complexes with various metal ions 
including calcium and magnesium, and is an inhibitor of calcium oxalate stone 
formation (Pak, 1987; Siener and Hesse, 2005).
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Preventing or reducing encrustation in long-term catheterised patients infected with 
urease-producing bacteria by elevating citrate excretion is an attractive proposition. 
Wang et al. (1993) previously demonstrated that urease-induced crystallization in 
urine in vitro can be markedly delayed in urine supplemented with citrate. In synthetic 
and human urine containing no citrate the initiation of crystal formation by jack bean 
urease occurred at pH 6.54 and 6.68 respectively. When these urines were 
supplemented with 4 mM of citrate the initiation of crystal nucleation did not occur 
until pH 8.52 and 8.64 respectively. When they compared urine from two healthy 
volunteers with natural varying citrate concentrations, they also found that crystal 
nucleation occurred at a higher pH in the urine with the higher citrate concentration. 
In a further study Wang et al. (1994) also demonstrated that potassium citrate ingested 
orally significantly increased the concentration of citrate in urine in healthy 
volunteers.
Sutler et al. (2005) also demonstrated the relationship between the concentration of 
important urinary solutes and pH„ using in vitro experiments. By manipulating the 
calcium, magnesium and phosphate concentrations in urine they showed that a degree 
of control over urinary pHn could be achieved relatively easily. The concentration of 
the solutes had an inverse relationship on urinary pHn. In addition, when citrate was 
added to the urine, its ability to form soluble complexes with the metal ions resulted 
in significant increases in pHn. What was important in this study was that the pHn of 
volunteers’ urine could be elevated simply by increasing their consumption of water. 
In addition, when they increased the dietary citrate intake of the healthy volunteer, by 
introducing 500 ml of orange juice into the diet each evening, they found that citrate 
excreted in the urine gradually increased during the test period from 0.35 mg/ml at the
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beginning to 1.21 mg/ml at the end (1 week). Importantly, the pHn of the urine voided 
increased from pH 7.24 to over pH 8.2 during this period.
1.8. Attempts to control catheter encrustation
A variety of different approaches have been implemented to try and control catheter 
encrustation. The fact that urease-induced catheter blockage is still prominent in the 
catheterised community however, suggests that effective measures have yet to be 
identified.
1.8.1. Acidification of urine
Solutions aimed at dissolving catheter encrustation have been used with varying 
degrees of success. There are however, a number of citric acid based solutions 
currently available including Suby G (approximately 3.2% citric acid, ~ pH 4) and 
solution R (approximately 6% citric acid). Saline solutions are also widely used in 
bladder irrigation to remove obstruction and prevent clot retention after surgery but 
are thought to have little effect on encrustation (Evans and Godfrey, 2000; Shaw et 
al., 2004; Getliffe, 1994 and Getliffe et al., 2000). Evidence demonstrating the 
efficacy of the citric acid solutions is hard to find. As with the antiseptic bladder 
washouts the technique usually involves the instillation of 50-100 ml of the solution 
into the bladder through the catheter. The solution is retained in the bladder for about 
15 minutes by clamping the catheter. The idea is that in this time the encrustation will 
dissolve in the citric acid (Getliffe et al., 2000). Kennedy et al. (1992) performed a 
clinical study to assess the ability of three bladder maintenance solutions (Suby G, 
Solution R and saline) to reduce catheter encrustation. They concluded that none of
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the solutions tested were effective at preventing catheter encrustation. They also failed 
to eliminate bacteria from the urinary tract and had no effect on urease-producing 
species. Irrigation of the urinary tract with these acidifying washouts may also have 
adverse effects on the patient and are thought to include damage to the bladder 
mucosa due to the acidic nature of the washout and physical damage caused by the 
actual method of installation (Kennedy et al., 1992). Despite these findings bladder 
maintenance solutions are still widely used. McNulty et al. (2006) reported that 55% 
of nursing staff and 45% of other staff in registered care homes in three health 
districts in England regularly used bladder washouts or catheter maintenance 
solutions.
The possibility of lowering urinary pH through consumption or intravenous addition 
with acidifying compounds to prevent alkalization of the urine has also had little 
success. McDonald and Murphy (1959) administered daily doses of ascorbic acid (2.5 
g) to patients and found it reduced urinary pH from about 6.0 to 5.6. A later study by 
Murphy et al. (1965) however, established that if the patients were infected with 
urease-producing bacteria, the oral ascorbic acid failed to reduce the urinary pH. This 
effect was confirmed by Bibby and Hukins (1993). These workers showed that the 
addition of acid (HC1) to urine containing the enzyme urease was rapidly neutralized 
by the hydrolysis of more urea to ammonia. They calculated that to neutralize the 
amount of ammonia produced from the urea excreted per day by a normal adult, 
something like 2-3 L of 0.1M HC1 would be required. Dietary acidification of urine is 
clearly not a feasible strategy to control catheter encrustation.
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Many nurses advise their patients to drink cranberry juice as a possible remedy for 
catheter encrustation. Morris and Stickler (2001) examined the efficacy of this 
strategy. They collected urine from volunteers during control periods when they were 
drinking their normal volume of fluids and when they had supplemented their daily 
fluids with either 500 ml of cranberry juice or water. The amounts of calcium and 
magnesium deposited on catheters were determined when the urines from these 
volunteers were supplied to bladder models infected with P. mirabilis. The results 
demonstrated that drinking 500 ml of cranberry juice on top of the normal fluid intake 
reduced encrustation on catheters compared to that observed under the normal fluid 
intake. However, they found that drinking an extra 500 ml of water was just as 
effective. These experiments also showed that the mean urinary pH of volunteers was 
not significantly acidified after drinking cranberry juice. It was concluded that 
increased fluid intake was the most important factor in reducing catheter encrustation.
1.8.2. Novel biomaterials
The development of a novel urinary catheter biomaterial with properties that can 
inhibit bacterial colonization has so far proved unsuccessful. In recent years, catheters 
with hydrophilic hydrogel coatings have become commonplace in the catheterised 
community with some studies suggesting they reduce bacterial attachment (Park et 
al., 2002; Tunney and Gorman, 2002). However, comprehensive studies have shown 
that to date no catheter material has been produced that can avoid colonization by 
crystalline P. mirabilis biofilms (Morris et al., 1997; Morris and Stickler, 1998a; 
Stickler et al., 2002). A clinical study by Bull et al., (1991) found that while patients 
preferred hydrogel-coated latex to silicone-coated latex catheters, encrustation and 
blockage was more prevalent in the hydrogel-coated devices.
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The reason why novel coatings are ineffective could partly be due to the promotion of 
bacterial adherence by the host protein conditioning layer that covers the surface of 
many devices soon after their insertion (Barbucci and Magnani, 1994; Stickler and 
McLean, 1995; Santin et al., 1997). In relation to this, Tenke et al. (2004) examined 
the encrustation resisting abilities of catheters coated with heparin in bladder models 
infected with P. mirabilis. The basis of the heparin coating relies on its anticoagulant 
properties that inhibit host protein adhesion and its strong electronegativity which 
repels bacterial cells (Tenke et al.y 2004). Although this coating showed significant 
reductions in encrustation on ureteral stents from clinical trials, heparin-coated 
catheters in the bladder models infected with P. mirabilis blocked at similar times to 
untreated silicone catheters.
1.8.3. Antibacterial catheters
Over the years several attempts have been made to produce catheters impregnated or 
coated with antimicrobial agents, the primary aim being to prevent CAUTI. Only two 
such catheters however, a silicone catheter impregnated with nitrofurazone and a 
catheter coated in metallic silver, have been used in clinical practice. Although their 
use is widespread particularly in the USA, there is considerable controversy over their 
efficacy. Previous clinical trials have suggested significant benefits in using 
antibacterial catheters to prevent CAUTI. However, these studies have consistently 
failed to stand up to professional scrutiny. In a comprehensive Cochrane database 
review of clinical trials involving silver-alloy catheters Brosnahan et al. (2004) 
concluded that the evidence in reducing infection was weak and the trials were of 
poor quality. Trautner et al. (2005) suggested that clinical trials using bacteriuria as 
the measure for infection are fundamentally flawed, as >90 % of bacteriuric episodes
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in catheterised patients are asymptomatic. They point out that trials showing that 
antimicrobial catheters significantly reduced episodes of symptomatic bacteraemia or 
pyelonephritis would be far more valuable. Many trials are also carried out in short­
term catheterisation events (<14 days) and wrongly presume that the same effect will 
occur in long-term (>30 days) catheterised patients (Trautner et al., 2005). Johnson et 
al. (2006) reviewed the efficacy of nitrofurazone and silver-containing catheters. They 
concluded that on the evidence presented the currently marketed antimicrobial 
catheters may prevent bacteriuria in hospitalized patients during short-term 
catheterisation. They concluded that the majority of studies failed to provide data 
regarding their effect on morbidity, mortality, symptomatic UTI and bacteraemia. 
They also stated that the effectiveness of these catheters is variable and depends on 
the type of antimicrobial coating, type of patient control group, and type of control 
catheters compared against. There is no evidence to date that nitrofurazone or silver- 
alloy catheters prevent P. mirabilis infection. Conversely, there is evidence to suggest 
that P. mirabilis is able to block both these catheter types with crystalline biofilm 
(Morris et al., 1997; Morris and Stickler, 1998a).
Attempts to control catheter encrustation with antimicrobial catheters must ensure that 
the antimicrobial agent is active for at least 6-12 weeks, the scheduled placement 
period of catheters. Bibby et al. (1995) suggested that the catheter balloon could be 
used as a reservoir for large amounts of an antibacterial agent and that the membrane 
of the balloon could act to control the slow release of the agent into the urine over 
prolonged periods. They were also able to show that mandelic acid could diffuse 
through the balloon in this way. Unfortunately mandelic acid has poor activity on P. 
mirabilis (King and Stickler, 1992). In contrast the biocide triclosan is extremely
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active against this species with minimum inhibitory concentrations of 0.5 pg/ml 
having been reported against isolates of P. mirabilis from encrusted catheters 
(Stickler, 2002). Stickler et al. (2003a) demonstrated that triclosan prevented P. 
mirabilis crystalline biofilm formation on all-silicone catheters inserted into in vitro 
bladder models. In this study catheter balloons were inflated with 10 mg/ml triclosan 
solution for the duration of the experiments or inflated with a similar concentration of 
the triclosan solution for 24 hours before it was replaced with sterile water. The 
catheters in both sets of experiments drained freely for a 7-day experimental period 
and scanning electron microscopy observations of catheter sections revealed little 
evidence of bacterial colonization or encrustation. Jones et al. (2006) demonstrated 
that inflating the retention balloons of catheters with triclosan prevented biofilm 
formation of a number of other urinary tract pathogens including E. coli, K. 
pneumoniae and S. aureus on catheter surfaces using similar laboratory models. They 
also showed that concentrations of triclosan recovered in the voided urine in the 
models varied between 0.02 and 0.16 mg/L. However, a number of bacterial species 
including Ps. aeruginosa and the potent urease producer Pv. rettgeri, were highly 
resistant to triclosan. In light of this, the future use of triclosan may be limited as 
selection for these organisms could occur. Another problem with prolonged exposure 
of bacterial species to antibacterials (especially in sub-inhibitory doses), is the 
development of resistance in susceptible species. If triclosan is utilised in the control 
of encrustation in long-term catheterised patients it would therefore be essential to 
monitor the urinary flora of resident organisms.
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1.8.4. Urease inhibitors
Several chemical compounds that can be consumed orally that inhibit urease action 
have been evaluated as potential agents in preventing catheter encrustation. Morris 
and Stickler (1998b) studied the effect of varying concentrations of acetohydroxamic 
acid (AHA) and fluorofamide on P. mirabilis induced catheter encrustation using 
laboratory bladder models. They demonstrated that urine supplemented with either of 
these urease inhibitors was able to reduce urine alkalinity and encrustation. In their 
study concentrations of AHA (0.1 mg/ml) and fluorofamide (1.0 pg/ml) significantly 
reduced the amount of calcium and magnesium salts deposited on catheters compared 
to that in controls in 24-hour experiments. Previous studies have revealed however, 
that several hydroxamates are mutagenic and possible carcinogens, which has 
prevented their clinical use (Rosenstein and Hamilton-Miller, 1984). Although 
fluorofamide is not reported to be mutagenic, it is slightly toxic (Millner et al., 1982). 
As long-term catheterised patients infected with urease-producing species would 
require ongoing treatment to prevent their catheters from encrusting, the possible 
toxicity of these urease inhibitors means they are unlikely to be considered as an 
option. Wang et al. (2006) reported that resveratrol (a naturally occurring plant 
compound found in several food stuffs including grapes) was active against several 
virulence factors of P. mirabilis including urease activity. The effect of resveratrol on 
catheter encrustation however, has not yet been studied. As a naturally occurring 
compound resveratrol appears an attractive alternative in preventing catheter 
encrustation and further studies are therefore warranted on its efficacy.
52
Introduction
1.9. What are the current problems and areas of uncertainty?
Despite many attempts to prevent and control catheter encrustation it remains a major 
complication in the care of many elderly and disabled people. While the basic 
mechanism has been established we still need to know more about some of the 
fundamental aspects of the process. Little is known about the early events and the 
precise mechanisms which P. mirabilis uses to colonize catheter surfaces. The factors 
that control the rate at which the crystalline biofilm forms on the catheters are also 
unknown. The expansion of our knowledge and understanding of these processes 
would be advantageous in devising future strategies aimed at reducing catheter 
encrustation.
1.10. Aims of the study
• To establish the sequence of events in the early stages of crystalline P. 
mirabilis biofilm formation on the range of catheters currently available for 
use with patients.
• To determine the role of Mannose-Resistant Proteus-Like, (MR/P) fimbriae in 
the colonization of catheters.
• To investigate how the nucleation pH of urine can be manipulated and 
determine the effect of variation in this parameter on the rate of catheter 
encrustation.
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2.1. Chemicals
The chemicals used in this study, unless otherwise stated were purchased from Fisher 
Chemicals (Loughborough, UK).
2.2. Catheters
All catheters used in this study were purchased from Bard Ltd (Crawley U.K), except 
for nitrofurazone impregnated catheters which were obtained from Coloplast 
(Humlebaek, Denmark). All catheters were of size 14 Ch.
23. Growth media
A number of different culture media were used for isolation, culture and enumeration 
of bacterial species described in this thesis. Cysteine Lactose Electrolyte Deficient 
(CLED) agar (Oxoid Ltd, Basingstoke UK), inhibits swarming behaviour and was 
used in obtaining single colonies in enumeration and identification purposes. 
Chromogenic UTI (CUTI) agar (Oxoid) has been developed especially for the 
identification of urinary tract pathogens, and was used in conjunction with CLED agar 
for identification and enumeration of catheter biofilm associated bacteria from clinical 
catheters. CUTI agar is CLED based allowing for growth of single colonies, but also 
contains two chromogenic substrates X-Glucose, and Red-Galactose. These 
chromatogens are cleaved by bacterial enzymes P-glucosidase and (3-galactosidase 
respectively, giving colonies a characteristic morphological colour depending on 
which enzyme(s) they produce. Tryptone Soya Agar (TSA, Oxoid) was used to 
determine the presence of swarming behaviour from bacteria isolated from clinical
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catheter specimens, and also to determine P. mirabilis growth and swarming 
behaviour in triclosan minimum inhibitory concentration (MIC) tests.
Tryptone Soya Broth (TSB, Oxoid) was used as a nutritional supplement in artificial 
urine. Luria-Bertani broth (LB broth, Sigma-Aldrich) was used as growth media for 
all haemagglutination assays and for P. mirabilis strains tested in autoaggregation 
assays.
Artificial urine (supplemented with 1 g/L TSB) was the preferred growth media used 
in the preparation of P. mirabilis cultures to be inoculated into bladder models. TSA 
supplemented with 5% defibrinated horse blood (Fisher Scientific) and 0.3% yeast 
extract (Oxoid) and Brain Heart Infusion Agar (BHI) supplemented with 0.3% yeast 
extract were the two types of media used to culture the control strains of 
Streptococcus sanguis GW2 and Actinomyces naeslundii 12104 (kindly donated by 
Dr. Pauline Handley, University of Manchester, UK) used in 
coaggregation/autoaggregation assays.
2.4. Bacterial strains
A number of bacterial strains were used during this study. P. mirabilis NSM6 was a 
clinical isolate from an encrusted catheter donated by Dr. Nicola Morris. P. mirabilis 
HI4320 (wild type) and its fimbrial mutant mrp' HI4320 and urease-negative mutant 
ure- HI4320, were kindly supplied by Professor Harry L. T. Mobley, Division of 
Infectious Diseases, Department of Medicine, University of Maryland School of 
Medicine, Baltimore, Maryland. The wild type strain was isolated from the urine of an 
infected catheterised patient. Other P. mirabilis isolates (used in haemagglutination 
assays) originating from catheter biofilm, urine and stool samples of catheterised
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patients and also from environmental sources were supplied by Dr. Nora Sabbuba and 
Dr. Marc Suller. P. mirabilis SJ2 was donated by Dr. Steve Jones. Providencia 
rettgeri (SDMI) and Proteus vulgaris (SDM2) were both isolated from catheters of 
patients attending urology outpatients clinic at Southmead Hospital, Bristol, UK. The 
stocks of bacterial isolates were stored at - 80°C in 5% glycerol. Confirmation of 
isolates were identified by Gram stain and the appropriate BBL CRYSTAL 
biochemical analysis kit (Becton Dickenson, Maryland, USA).
2.5. Growth conditions of isolates and strains used in bladder models
Prior to use in experiments all strains were grown initially overnight on CLED agar at 
37°C. In the majority of cases cultures were prepared for the bladder model by 
subsequently transferring 4 or 5 of the overnight colonies into a culture flask 
containing sterile artificial urine (100 ml), and incubated on a rotaiy shaker at 150
a
rpm for 4 hours giving a cell density of approximately 10 colony forming units per 
ml (cfu/ml).
The inocula of HI4320 and mrp~ HI4320 strains for experiment in the bladder model 
were prepared by static incubation for 12 hours in culture flasks containing sterile 
artificial urine (100 ml) at 25°C or in sterile artificial urine supplemented with 4 pg/ml 
of the urease inhibitor fluorofamide (Tocris Cookson Ltd., Bristol, UK).
2.6. Viable cell counts
Cell numbers from cultures and bacterial suspensions were estimated using the 
methods described by Miles and Misra (1938). Samples to be enumerated were 
serially diluted in quarter strength ringers solution (Oxoid) to a maximum of 10' of
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the original dilution with triplicate 3 X 10 pi aliquots of each dilution deposited onto 
dry CLED agar plates. The enumeration of bacteria isolated from biofilms residing on 
clinically derived catheters was carried out by spread plate method. Here, serial 
dilutions were carried out on samples as described above and 100 pi aliquots were 
deposited onto separate dry CLED and CUTI plates and spread aseptically with a 
glass spreader to ensure adequate dispersal of the inocula.
2.7. Isolation and enumeration of bacteria from patient’s catheters
Catheters removed from patients attending clinics at Southmead Hospital were stored 
at 4°C overnight until transportation to the laboratory for characterisation and 
enumeration of their bacterial flora. Catheters were sectioned at two sites along the 
catheter length (unless otherwise stated) with 1 cm specimens removed from the 
eyehole area and from a site 15 -  16 cm down from the eyehole. Sites were chosen at 
opposite ends of the catheters to lower the risk of overlooking spatially dispersed 
isolates. Sections were sonicated for five minutes (Transsonic T310, Camlab Ltd., 
Cambridge, UK) in sterile universal containers with 10 ml of quarter strength ringers 
solution (Oxoid LTD, Basingstoke, UK), to break up the crystalline deposits. 
Sonicated samples were thoroughly vortex-mixed for two minutes and serially diluted 
from neat to a maximum of 1 O'7 dilutions. A series of plates containing CLED agar 
and Chromogenic UTI agar were spread with 100 pi of each dilution. In addition, a 
TSA plate was inoculated with 10 pi o f the neat sample to detect any swarming 
bacteria. Plates were incubated for 24 hours and 48 hours. Identification of bacterial 
isolates was determined using Gram staining and BBL CRYSTAL test kits. The 
numbers of viable cells per millimetre o f catheter length (cfu/mm) were calculated. 
The isolates from the biofilm communities were stored at -80°C in 5% glycerol. The
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determination of biofilm communities on hydrogel silver-coated catheters described in 
results section 3.1.4. were carried out by Dr. Nora Sabbuba, Cardiff University.
2.8. Minimum inhibitory concentration (MIC) of triclosan
The MIC of triclosan against P. mirabilis NSM6 and two other clinical isolates (P. 
mirabilis HI4320 and P. mirabilis SJ2) was tested in TSA agar. Initially 0.5 g of 
triclosan (CIBA speciality chemicals, Basel, Switzerland), was dissolved in 10 ml of 
100% dimethyl sulfoxide (DMSO), giving a concentration of 50 mg/ml. Aliquots of 
this solution were then mixed aseptically into molten TSA agar, and poured into Petri 
dishes to give a range of plates containing 0.1, 0.2, 0.3 and 0.4 fig/ml final triclosan 
concentrations. Plates were left to stand overnight. P. mirabilis strains were grown on 
CLED agar overnight at 37°C with 4-5 colonies subsequently transferred to culture 
flasks containing TSB (100 ml) and incubated for 4 hours at 37°C under gentle 
aeration. At 4 hours, aliquots of the cultures were diluted in TSB 100-fold and then 10 
pi aliquots containing approximately 104 cells spotted in triplicate onto the relevant 
agar plates. Control plates used in these tests included DMSO in TSA (at the same 
DMSO concentration as in the 0.4 pg/ml triclosan agar), and TSA only. All were 
incubated overnight at 37°C prior to inspection.
2.9. Artificial urine
A standard artificial urine based on that described by (Griffith et al. 1976) was 
prepared in deionised water using the following major constituents g/L: 0.49 calcium 
chloride; 0.65 magnesium chloride hexahydrate; 4.6 sodium chloride; 2.3 di-sodium 
sulphate; 0.65 tri-sodium citrate dihydrate; 0.02 di-sodium oxalate; 2.8 potassium di­
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hydrogen phosphate; 1.6 potassium chloride; 1.0 ammonium chloride; and 25.0 urea. 
The urine pH was adjusted to pH 6.1 using NaOH before addition of 5.0 g/L gelatine 
and supplemented with lg/L TSB. In experiments where fluorofamide was used to 
inhibit the effect of urease activity, the urea analogue was dissolved in deionised 
water and sterilised using a 0.2 pm pore size capsule filter (Sartorious, Goettingen, 
Germany) prior to its addition to the standard urine at 4 pg/ml final concentration. 
When dilutions of the standard urine were required in experiments, the constituents 
were fractioned accordingly upon addition. Urine that contained increased citrate 
concentrations was achieved by manipulation of the tri-sodium citrate content. In 
experiments where citrate content of the artificial urine was manipulated the pH was 
adjusted to pH 6.3.
2.10. The bladder model set-up and experimental procedure
The physical models of the catheterised bladders have been previously been described 
by Stickler et al. 1999. They were assembled in the same way for all experiments. 
Essentially, they consist of a glass chamber (bladder) contained within a water-jacket 
maintained at 37°C. The entrance of the chamber is sealed with a rubber stopper. 
Silicone tubing (ureter) connects the chamber to a urine reservoir (kidneys) via a 
503U peristaltic pump (Watson & Marlow, Falmouth, UK). At the base of the 
chamber is an outlet port fitted with a 30 cm length of silicone tubing acting as a 
urethra. Prior to experiments the models were sterilised by autoclaving at 121°C for 
15 minutes. Catheters were inserted aseptically via the urethra. Catheter balloons were 
inflated normally with 10 ml sterile deionised water and attached to drainage tube and 
collection bag. The models were typically assembled in sets and held in position with 
clamps and stands. The collection bag tubes were secured (taped) to the workbench
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under enough tension as to allow the retention balloon of the catheter to form a 
watertight seal with the internal surface of the chamber. The bladder chambers were 
then primed with urine from the aspirator via the peristaltic pump up to the catheter 
eyehole level. At this stage the pump was switched off and a 10 ml aliquot of urine 
removed from the model and replaced with a 10 ml inoculum of the relevant bacterial 
culture. Models were allowed to incubate for 1 hour to allow the bacterial population 
to establish itself in the chamber before the pump was restarted (time 0, experiment 
start). The rate that urine was supplied to the bladder models at the start was pre­
determined and varied according to each experiment. The experimental set-up of 
bladder models and a schematic diagram of the bladder model are shown in Figure 2 
and 3 respectively.
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Figure 2. Experimental bladder models assembled in series
The photograph shows: (A) The inlet supplying urine and bladder model seal, (B) bladder 
chamber, (C) urethra, (D) catheter leaving urethra, (E) catheter/drainage tube junction and 
inflation port, (F) drainage tube leading to drainage bag (bag not shown), (G) peristaltic 
pump, (H) aspirator containing sterile urine.
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rigure 3. Bladder model set-up
lladder models were typically arranged in series and inter-connected using silicone tubing attached 
o the water jacket inlets/outlets. Models were held in position via clamp/stand. Aspirators supplied 
terile urine to the models via peristaltic pump through silicone tubing acting as the ureter. Catheters 
vere secured to the workbench using tape under enough tension to ensure a watertight seal between 
he retention balloon and the bladder model inner surface.
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2.11. Production of catheter sections for analysis
Catheters were sectioned for a number of purposes including high and low vacuum 
electron microscopy, the enumeration of adhering bacteria on the catheter surface and 
characterisation of the bacterial flora from biofilms on catheters of clinical origin. 
Sections 1cm in length, were cut from four regions of the catheter: A-the eyehole 
region; B-immediately below the eyehole; C-immediately below the retention 
balloon; D-16 cm down from the eyehole. Figure 4 shows a Foley type catheter with 
the location of the sample sites indicated. Before removing catheters from bladder 
models the urine was removed from the bladder chamber using a pipette. Catheters 
were carefully disconnected from the drainage bag and the contents of the retention 
balloon removed using a 10 ml syringe. The end of the catheter (housing the balloon 
inflation port) was separated with a scalpel, allowing the catheter body to be carefully 
removed through the inlet end of the bladder model chamber with forceps. Catheter 
sections used in low vacuum SEM analysis or for enumeration of attached bacteria 
were sectioned transversely only. Sections destined for high vacuum SEM analysis 
were additionally sectioned longitudinally (B-D only) in order to expose the internal 
lumen.
2.12. Enumeration of bacterial cells on catheters from experiments in the 
bladder model
Catheter sections (described in 2.11.), were removed from the models at the end of 
each experiment and placed into sterile universal containers pre-filled with 10ml 
Ringer’s solution (Oxoid UK, Ltd). The samples were subsequently exposed to 5 
minutes of gentle sonication in a sonic waterbath (Camlab, Cambridge UK) followed
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by 2 minutes of vortex mixing and serially diluted with 10 |il aliquots dropped onto 
CLED agar plates incubated overnight at 37°C for enumeration. The calculated viable 
cfu/ml was proportional to numbers of viable cells colonizing the catheter surface per 
millimetre of catheter length.
2.13. High vacuum scanning electron microscopy (HVSEM)
Catheter sections were fixed in 2.5% glutaraldehyde (Agar Scientific, Essex, UK) in 
0.1M SOrrensen buffer pH 8 for 4 hours at room temperature or overnight at 4°C. 
SOrrensen buffer was prepared by initially making 1 L stock solutions in deionised 
water of: (A) 14.196 g di-sodium hydrogen orthophosphate and (B) 13.609 g 
potassium di-hydrogen orthophosphate. Stock solutions were mixed at a ratio of 
95%:5% (A:B) to give the required pH. Subsequently, sections were washed in 0.1 M 
SOrrensen buffer for 15 minutes and exposed to a second fixing/background staining 
process using a 2% osmium tetroxide in 0.1 M SOrrensen buffer (1:1) for 1 hour. A 
further 15 minute wash in deionised water was carried out prior to dehydration of the 
samples using an ascending ethanol series (70%, 90% and 2 x 100%), and finally 
sublimation dehydration using hexamethyldisilazane (HMDS), i.e. 100% 
ethanol:HMDS (1:1), and finally 100 % HMDS x 2 (15 minutes each step). The 
samples were left to air dry overnight before being gold sputter coated using an 
Edwards S150B sputter coater (BOC Edwards, Crawley, UK), and visualised using a 
Philips XL-20 scanning electron microscope (FEI UK Ltd., Cambridge, UK) 
accelerating voltage 15kv-25kv. SOrrensen buffer pH 6 (15%:85%, A:B) was used in 
the fixation of samples from urease-inhibited experiments where urine remained 
acidic.
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Figure 4. Catheter sectioning sites (image shows hydrogel-coated latex 
catheter)
Section A (eyehole region), section B (immediately below eyehole), section C 
(immediately below retention balloon), and section D (16 cm below eyehole). Below 
main image are examples of catheter sections which include the eyehole and lumenal 
section (with dotted line indicating sectioning for HVSEM).
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2.14. Low vacuum scanning electron microscopy (LVSEM)
Sections of catheter analysed under low vacuum SEM were not subjected to any 
further processing after sectioning. Samples were placed in eppendorf tubes 
containing moist tissue paper to alleviate the effects of dehydration on specimens 
while awaiting examination. In the majority of cases, samples were examined within 
the hour after removal from the bladder model, but on occasion overnight storage at 
4°C in the moistened eppendorf tube was required before microscopy. The extent of 
encrustation/biofilm formation on the catheter sections was determined using a JEOL 
JSM 5200 scanning electron microscope (JEOL (UK) Ltd., Welwyn Garden City, 
UK), accelerating voltage 20-25kv.
2.15. Environmental scanning electron microscopy (ESEM) and X-ray 
microanalysis
A selection of samples were analysed using the Philips XL-30 ESEM (FEI UK LTD., 
Cambridge UK) with INCA ENERGY (EDX) X-ray analysis system (Oxford 
Instruments, High Wycombe, UK). X-ray microanalysis was used to determine the 
nature of the initial mineral deposits adhering to selected catheter sections removed 
from all-silicone and HCL catheters at 1 and 4 hours from P. mirabilis NSM6 infected 
bladder models. Sections were washed in deionised H20  before dehydration for 24 hrs 
at 37°C and then carbon sputter-coated using a K450 sputter-coater (Emitech, Kent, 
UK) prior to analysis.
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2.16. Determination of the calcium and magnesium concentration in solution at 
various pH’s
Urine (250 ml, pH 6.1) was heated in a water-bath at 37°C for 1 hour and the pH 
increased stepwise in 0.5 increments to pH 9 using 1M NaOH solution. At each 0.5 
interval 10 ml of the urine was removed into Falcon tubes and centrifuged for 5 
minutes at 3600 rpm using a PK 120 centrifuge (ALC International, Milan, Italy) to 
pellet precipitated material. Aliquots of the supernatant were then serially diluted in 
universal containers with polished deionised H20  to a range including; neat artificial 
urine, 1:10, 1:50, 1:100, 1:200 and 1:500 concentrations to give 4 ml final volumes 
which were stored at 4°C. Using an aa/ae spectrophotometer 457 (Thermo Electron 
Corporation, Waltham, Massachusetts, US) the calcium and magnesium 
concentrations in the urine at each pH increment was determined. Dilutions were 
necessary as calcium and magnesium concentrations were required to be within a 
specific range (between 0.5 and 2 ppm for calcium at 422.7 nm, and between 0.05 and 
0.4 ppm for magnesium at 285.2 nm). The atomic absorbance spectrometer was 
initially calibrated to these ranges with standards purchased from Spectosol (BDH 
Chemicals Ltd., Poole, UK). The polished deionised H20 was also tested for its 
calcium and magnesium content with results adjusted accordingly.
2.16.1. Determination of calcium, magnesium and citrate content in human urine
Calcium and magnesium concentrations were determined from 5 ml aliquots of 
collected human urine that were centrifuged at 3600 rpm for 10 min using a PK 120 
centrifuge (ALC International), and sterilised using a Minisart millipore filter 0.2pm 
pore size (Sartorious) and stored at 4 °C prior to spectroscopic analysis. Samples were
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serially diluted using polished deionised H2O to give final concentrations of neat 
urine, 1:10, 1:50, 1:100, 1:200, 1:400 and 1:800 and their calcium and magnesium 
content determined by atomic absorbance spectroscopy. Citrate was determined using 
a citrate assay kit (Boehringer Mannheim, Darmstadt, Germany). Samples (1 ml) were 
filtered through a Minisart millipore filter 0.2pm pore size (Sartorious) as soon as 
possible or after storage at 4°C. Samples stored at 4°C were returned to approximately 
room temperature before being assayed.
2.17. Haemagglutination assay
The presence of MR/P fimbriae was detected by their ability to agglutinate chicken 
red blood cells (CRBC) in the presence and absence of mannose. The mannose 
resistant haemagglutination (MRHA) assays here are based on methods described by 
Bahrani et al. (1994). P. mirabilis isolates were grown statically in flasks containing 
100 ml sterile Luria Bertani Broth, and passaged three times for 48 hours each at 37°C 
to achieve optimum conditions for MR/P fimbrial expression. Cells were harvested at 
12000 x g for 1 minute using a Genofuge 16M centrifuge (TECHNE, Cambridge, 
UK), and re-suspended to approximately 109 cfu/ml in phosphate buffered saline 
(PBS, pH 7.2 0.85%), and PBS + 50 mM mannose.
Doubling dilutions from neat to 1:16 of the P. mirabilis suspensions were then set up 
in a 96 well u-bottomed microtitre plate, (Bibby Sterlin Ltd., Staffordshire, UK) with 
an equal volume of 3% CRBC suspension (Research Diagnostics Inc., Concord, MA, 
USA). The complete microtitre plate was assembled so that bacterial strains were 
incubated with CRBC in PBS only, CRBC in PBS + 50 mM mannose, tannic acid- 
treated CRBC in PBS, and tannic acid-treated CRBC in PBS + 50 mM mannose. The
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loaded microtitre plates were incubated gently on a platform shaker for 1 hour at room 
temperature. Haemagglutination was determined by blood cells forming a diffuse matt 
in the microtitre well while the formation of a tight button of blood cells in the bottom 
of wells indicated that no haemagglutination had occurred. Wells containing 
corresponding buffers and CRBC were set up as controls.
2.18. Coaggregation/autoaggregation assay
To observe if the phenomenon of autoaggregation occurred in P. mirabilis isolates 
expressing MR/P fimbriae, visual autoaggregation assays were carried out on wild 
type P. mirabilis HI4320, and the mrpA mutant P. mirabilis HI4320 in comparison 
with two known coaggregating strains of Streptococcus sanguis GW2 and 
Actinomyces naeslundii ATCC 12104 (Handley et al., 1985). Methods were based on 
those described Cisar et al. (1979). P. mirabilis strains were grown statically and 
passaged in LB Broth for 6 days (under conditions described in Section 2.17), to 
allow for the optimum expression of MR/P fimbriae. Overnight plate cultures of 
Streptococcus sanguis GW2 and 48 hour plate cultures of Actinomyces naeslundii 
ATCC 12104 were used to inoculate separate flasks of BHI broth (100 ml). The flasks 
were incubated statically at 37°C overnight in an aerobic Gaspak ™ Jar (Becton 
Dickenson) containing a BBL ™ dry anaerobic indicator strip (Becton Dickenson), a 
BBL ™ Gaspak ™ anaerobic hydrogen and carbon dioxide generator envelope 
(Becton Dickenson), and 0.5% palladium catalyst. The growth of urinary strains and 
oral strains were orchestrated so that they would be ready for the assay at the same 
time.
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Cells were harvested at 5000 x g at 4°C for 10 minutes using an Avanti® J-E 
centrifuge (Beckman Coulter UK Ltd., High Wycombe, UK) and washed three times 
in coaggregation buffer consisting of: 1 mM Trizma® Base, 0.1 mM CaCl2, 0.1 mM 
MgCl2, and 0.15 M NaCl. Urinary strains to be assessed in artificial urine (P. 
mirabilis ure HI4320 only) were washed in artificial urine. Bacterial suspensions 
were adjusted to optical densitiy readings of 1.5 using a Helios y UV-Visible 
Spectrophotometer (Unicam, Cambridge, UK) set at 650 nm. Assays were performed 
in sterile test-tubes with the coaggregation control consisting of 2 ml of each oral 
strain (4 ml total), while autoaggregation assays consisted of 4 ml of the urinary P. 
mirabilis strains. Test tubes were vortex mixed for 10 s followed by gentle rolling 
between the palms of the hands for 20 s and the level of coaggregation in oral strains 
and autoaggregation in urinary strains visually assessed using the following criteria:
Score Level of aggregation
0 ............................................No aggregates visible in suspension
+1............................................Small, uniform aggregates in turbid suspension
+2........................................... Easily visible aggregates in turbid suspension
+3........................................... Clearly visible aggregates that settle leaving an
almost clear supernatant
+4........................................... Large aggregates that settle almost
instantaneously to leave clear supernatant
Scores were completed at one hour intervals from the first time of mixing (t=0) up to 
6 hours and then finally at 24 hours. The pH of cell suspensions were taken at t=0 and 
at 24 hours.
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2.19. Determination of nucleation pH (pHn)
Evaluation of the nucleation pH (pHn) of artificial and human urines was based on the 
method described by Choong et al. (1999). In experiments examining the effect of 
increased fluid output and increased citrate concentration, artificial urine was 
maintained at 37°C with samples subsequently alkalinized in increments of 0.20 pH 
units with 1 M sodium hydroxide solution up to a maximum pH of 10. At each 
increment the optical density was measured at 600 nm against a urine blank with a 
Unicam Helios y spectrophotometer (Cambridge, UK).
In subsequent experiments examining the pHn of human volunteer urine the pH of 
samples was reduced to pH 5.0 (urine blank) using concentrated hydrochloric acid 
before being alkalinised in 0.25 increments using 10 M sodium hydroxide. Samples 
were read against the blank at 540 nm. The pHn of a urine sample was determined 
from the resulting plot of pH versus optical density and was defined by an abrupt 
change in the slope of the graph showing an increase in turbidity. Plotting pH versus 
optical density produces two straight line segments which intersect at the pHn. 
Regression lines were calculated by least squares analysis for these two portions of 
the graph and used to determine the pH at their intersection. If the pHn of urines 
calculated by regression analysis failed to correlate with the abrupt rise in absorbance 
recorded from spectrophotometer readings, the pHn was determined as the mean value 
between the initial reading when an abrupt and sustained increase in absorbance 
occurred and the preceding reading.
2.20. Statistical analysis of data
Minitab® Release 14 (Minitab Inc., PA, USA) was the statistical software package of 
choice used on data in this thesis. Unless otherwise stated experiments were
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performed in triplicate and where appropriate the standard error (SE) of the mean was 
indicated. Analysis of variance (ANOVA) executed at the 95% confidence interval 
level was the statistical test of choice for all experiments. Least squares regression 
was the statistical test used to determine the nucleation pH of all relevant urines. 
Pearson correlation of rank was used to determine relationship between nucleation pH 
and catheter lifespan in relevant experiments. To allow ANOVA, least squares 
regression and Pearson correlation of rank to be performed the data was analysed with 
the Minitab programme to confirm normal distribution of the residuals and the equal 
variances of the data. If these assumptions were violated and the data could not be 
transformed alternative statistical tests were applied as indicated.
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3.1. The development of crystalline P. mirabilis biofilms on indwelling urinary 
catheters
Previous studies in the bladder model have concentrated on comparing the rates at 
which different catheters block with crystalline P. mirabilis biofilm (Morris et al. 
1997; Morris and Stickler, 1998a). The aim of the work reported in this section was to 
investigate the sequence in which cells and crystals are laid down on catheter surfaces 
and initiate crystalline biofilm formation. The experiments were performed under 
conditions which simulate the common situation in which patients’ catheters are 
recurrently blocking and have to be replaced frequently. In these cases new catheters 
are introduced into bladders in which urine is heavily infected with P. mirabilis and 
the urinary pH is already elevated (Mathur et al., 2006a).
3.1.1. Crystalline biofilm development in bladder model experiments
Bladder models were fitted with a range of Foley type catheters including, all-silicone 
(AS); hydrogel-coated latex (HCL); silicone-elastomer coated latex (SCL); 
hydrogel/silver-coated latex (HSCL) and a nitrofurazone impregnated catheter (NF). 
Additionally, a series of all-silicone and hydrogel-coated latex catheters (AST and 
HCLT respectively), whose retention balloons were inflated with a 10 ml solution of 3 
mg/ml triclosan in 0.1 M Na2CC>3 were also included. Models were inoculated with 10 
ml of a P. mirabilis NSM6 4 hour culture (approximately 108 cfu/ml), and supplied 
with artificial urine at a rate of 0.5 ml/minute. Triplicate experiments were performed 
in which catheters were removed from models for examination after pre-determined 
intervals of 1 ,2 ,4 ,12 ,18  h. In a further series of experiments catheters were removed 
from models that were operated until they blocked or after 7 days if blockage did not
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occur. Sections (1 cm long) were cut from catheters as described in Figure 4 and 
processed for either low or high vacuum SEM analysis. In the cases of AS, SCL and 
HCL catheters sections from the third replicate experiment were processed for 
enumeration of adherent bacteria. Throughout the experiments, the pH and viable cell 
populations of the residual urine in the model chamber were determined. For all 
catheters studied control models were supplied with sterile urine but not inoculated 
with P. mirabilis NSM6. The results presented in Figure 5 summarize the data on the 
mean times each type of catheter took to block. It can be seen that the five 
commercially available Foley-type catheters all blocked within 40 h. In contrast AST 
and HCLT catheters that were inflated with 3 mg/ml triclosan drained fieely for the 
full 7 day experimental period.
Mean viable cell counts and pH’s of the residual urine sampled throughout the 
experiments are presented in Tables 1 and 2 respectively. Initially the mean viable cell 
numbers in urine of all the models were approximately 108 cfu/ml and mean pH 
values in excess of pH 8. In the urine from models fitted with AS, SCL, HCL and 
HSCL catheters the mean viable counts fluctuated initially but remained between 107- 
108 cfu/ml. Similarly the mean pH of urine from these models remained above 7.0 and 
in all cases was > 8.0 at time of catheter blockage. In models fitted with NF catheters 
mean viable cell counts and pH of urine at 4 hours fell to approximately 106 cfu/ml 
and < pH 7 respectively before recovering to high 107 cfu/ml and > pH 8 at 18 hours. 
When the AS and HCL catheters were inflated with triclosan rather than water, within 
4 hours the number of viable cells in the residual urine fell markedly and the urine had 
become acidic.
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The sensitivity of various P. mirabilis strains to triclosan including NSM6 had been 
previously reported by Jones et al. (2005). The sensitivity of P. mirabilis NSM6 to 
triclosan was also confirmed here prior to experiments and was determined at being 
between 0.1 and 0.2 fig/ml. Figure 6 shows a selection of agar plates containing a 
range of triclosan concentrations and illustrates the effect of triclosan on the growth 
and swarming behaviour on P. mirabilis NSM6 and P. mirabilis SJ2.
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Figure 5. Mean times to catheter blockage in models inoculated with P. mirabilis NSM6
All models were inoculated with 10 ml of artificial urine containing approximately 108 cfu/ml. Mean values ± standard error of 
mean were calculated for results of three replicated experiments. AS indicate all-silicone catheters, HCL, hydrogel-coated latex, 
SCL, silicone elastomer-coated latex, HSCL, hydrogel-silver coated latex, NF, nitrofurazone impregnated catheters, AST and 
HCLT indicate that the retention balloons of the catheters were inflated with 3 mg/ml triclosan rather than water. The arrows 
indicate that in these cases the catheters drained freely for the 7 day period.
Mean viable cell counts (cfu/ml) of residual urine at various times (h)
Catheter type 0 1 2 4 12 18 Blockage *
AS 1.5 ± 1.2 
x lO *
1.1 ±2.1 
x 10*
7.8 ± 2.2 
x 10 7
5.8 ± 1.4 
x 107
7.4 ± 1.9 
x 107
1.3 ± 3.5 
x 10 *
1.1 ±2.2 
x 10 *
SCL 1.6 ± 1.0 
x 10*
1.1 ±2.7 
x 10*
7.0 ±2.7 
x 107
3.0 ± 1.1 
x 107
5.6 ± 1.2 
x 107
1.3 ±2.5 
x 10*
7.2 ± 2.9 
x 10 7
HCL 1.5 ±2.5 
x 10*
1.1 ±3.5 
x 10*
7.6 ±3.1 
x 107
7.8 ±2.5 
x 107
1.1 ± 1.8 
x 10*
1.0 ±2.3 
x 10*
6.5 ± 0.3 
x 10 7
HSCL 1.7 ±0.58 
x 10 *
5.9 ± 2.7 
x 107
4.6 ±2.5 
x 10 7
3.7 ±2.0 
x 107
6.9 ± 1.4 
x 10 7
7.1 ± 1.2 
x 107
9.7 ± 1.7 
x 107
NF 1.6 ±0.74 
x 10 *
3.7 ± 0.24 
x 107
1.3 ± 0.59 
x 107
7.8 ±0.40 
x 10 6
8.0 ± 0.28 
x 10*
8.5 ± 0.23 
x 107
6.5 ±0.81 
x 107
AST (triclosan) 2.2 ± 2.2 
x 10*
2.0 x 10 51 9.0 x 104f <102 <102 < 102 <102
HCLT (triclosan) 1.0 ±3.4 
x 10 *
1.5 ± 1.7 
x l O 7
1.8 ±0.23 
x 10*
9.0 ±0.15 
x 105
9.0 ±0.6 
x l O 3
1.0 ±0.5 
x 104
5.0 ±0.6 
x 10 3
* Samples were taken as soon as possible after blockage o f catheters had occurred, t  No viable organisms were detected in two of the three replicates
Table 1. Mean viable cell counts of P. mirabilis NSM6 from residual urine in the bladder models
Start time samples were obtained by collecting the initial 5ml of voided urine from the drainage bag. All further samples from bladder model 
chamber were taken when experiments were concluded. The mean values were calculated ± standard error of the mean from three replicated 
experiments.
Mean pH of residual urine at various times (h)
Catheter type Start pH 1 2 4 12 18 Blockage *
AS 8.48 7.85 7.26 7.14 7.49 7.7 8.19
±0.03 ±0.23 ±0.29 ±0.21 ±0.14 ±0.35 ±0.08
SCL 8.63 8.1 7.5 7.19 7.2 7.92 8.03
±0.03 ±0.12 ±0.35 ±0.17 ±0.19 ±0.10 ±0.13
HCL 8.46 7.6 7.6 7.4 7.6 8.1 •
00
±0.04 ±0.22 ±0.25 ±0.25 ±0.03 ±0.18 ±0.17
HSCL 8.51 7.52 7.32 7.06 7.46 7.96 8.25
±0.10 ±0.34 ±0.17 ±0.23 ±0.16 ±0.17 ±0.16
NF 8.56 7.06 6.5 6.4 7.38 8.29 8.66
±0.02 ±0.02 ±0.08 ±0.08 ±0.23 ±0.18 ±0.15
AST 8.52 7.02 6.6 6.32 6.2 6.19
t
6.13
±0.01 ±0.17 ±0.17 ±0.06 ±0.03 ±0.04 ±0.03
HCLT 8.48 7.3 6.75 6.48 6.19 6.25
f
6.11
±0.08 ±0.19 ±0.27 ±0.2 ±0.03 ±0.03 ±0.01
* Samples were taken as soon as possible after blockage of catheters had occurred. pH at 7 days
Table 2. Mean urine pH values of residual bladder model urine
Start time samples were obtained by collecting the initial 5ml of voided urine from the drainage bag. All further samples from bladder model 
chamber were taken when experiments were concluded. The mean values were calculated ± standard error of the mean from three replicated 
experiments.
Figure 6. Effect of triclosan on swarming and growth of P. mirabilis strains
(A) P. mirabilis NSM6 limited swarming in the presence of 0.1 pg/ml triclosan 
(arrow indicates extent of swarming edge). (B) P. mirabilis NSM6 positive control 
without triclosan (concentric rings of swarming phenomenon are evident). (C) No 
growth of P. mirabilis NSM6 in the presence of 0.2 pg/ml triclosan. (D) Growth but 
no swarming of P. mirabilis SJ2 in the presence of 0.1 pg/ml triclosan. All strains 
incubated for 24 hours at 37°C on TSA.
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3.1.1.1. Low vacuum SEM evaluation of crystalline biofilm development
The low magnification electron micrographs presented in Figures 7 and 8 illustrate the 
development of crystalline material around the catheter eye-lets and on the lumenal 
surfaces just below the eyeholes (section B). The images indicate that in contrast to 
the control catheters (Figure 9), the AS, SCL, HCL, and HSCL catheters all became 
encrusted within 4 h exposure in the infected bladder models. Similar images (not 
shown) were obtained for section C. The encrustation continued to accumulate as time 
progressed until the catheters eventually occluded. Encrustation at site D developed at 
a much slower rate. Nitrofurazone catheters appeared relatively free from encrustation 
over the initial 12 h period. It is clear however, that after 12 h encrustation proceeded 
rapidly as at mean times of 29.5 h extensive encrustation was seen occluding the 
eyehole and catheter lumen.
The micrographs presented in Figure 10 demonstrate that when the AS and HCL 
catheters were inflated with triclosan they remained free of encrustation even after 
seven days residence in P. mirabilis infected bladder models.
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Figure 7. LVSEM images of P. mirabilis NSM6 induced encrustation at the eyehole of urinary catheters
The images show the extent of encrustation developing around the eyelets of: AS (All-silicone); SCL (silicone elastomer-coated latex); HCL 
(hydrogel-coated latex); HSCL (hydrogel/silver-coated latex); NF (nitrofurazone-impregnated) catheters after various residence times P.
2  mirabilis infected models.
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Figure 8. LVSEM images of P. mirabilis NSM6 encrustation at the lumenal site (B) on a range of urinary catheters
The images show the extent of encrustation in the lumen just below the eyehole of: AS (All-silicone); SCL (silicone elastomer-coated 
latex); HCL (hydrogel-coated latex); HSCL (hydrogel/silver-coated latex); NF (nitrofurazone-impregnated) catheters after various 
residence times P. mirabilis infected models.
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Figure 9. LVSEM of catheters that had been incubated in control 
models
The images show sections of catheters removed from after 3 0 - 4 0  hours from 
models that had been supplied with urine but not inoculated with P. mirabilis.
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Figure 10. LVSEM micrographs of catheters that had been inflated with triclosan
The retention balloons of AS and HCL catheters were inflated with triclosan (3mg/ml) in P. mirabilis infected models. The images show 
the surfaces around the eye-lets and in the lumen just below the eye-holes (section B) of catheters removed from the models at various 
times up to seven days. Controls (A l/Bl) are corresponding sections of all-silicone catheter after 7 days exposure to sterile urine, and 
A2/B2 corresponding sections of hydrogel coated latex catheter after 7 days exposure to sterile urine.
AST (eyehole) AST (lumen) HCLT (lumen)
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3.1.1.2. High vacuum SEM of crystalline biofilm development
A knowledge of the nature of the catheter surfaces that are exposed to bacterial 
colonization is basic to an understanding of how they come to be colonized by 
biofilm. The images presented in Figures 11 and 12 reveal the surface topography of 
eyehole and lumenal sites of AS, SCL, HCL and HSCL catheters. While the all­
silicone catheters have relatively smooth surfaces, irregularities were found. All of the 
latex-based catheters had irregular topographies, especially where the eye-lets had 
been cut into the latex. In addition, the common occurrence of diatomaceous skeletons 
embedded in the lumenal surfaces of the latex catheters exacerbated the surface 
roughness of the latex catheters.
All-silicone (AS), silicone-coated latex (SCL), hydrogel-coated latex (HCL) and 
hydrogel/silver-coated latex catheters (HSCL)
Figures 13-17 show HVSEM micrographs of the development of P. mirabilis NSM6 
crystalline biofilm on AS, SCL, HCL and HSCL catheters respectively. Crystalline 
material formed a comprehensive ‘foundation layer’ on the exposed eyehole surface 
and lumenal surfaces of sections B and C. Sections D on all catheter types acquired 
only isolated patches of encrusted deposits at this time. Although occasional P. 
mirabilis cells were found colonizing catheter surfaces at 2 h they were rare. By 4 h P. 
mirabilis microcolonies were observed on all catheter types. Bacterial colonization 
occurred predominantly on the foundation layer present on the catheter surfaces. It 
was clear however, that cells also bound to areas of the catheter surfaces that were 
free of encrustation.
87
Results
By 12 h all catheter types from infected models were extensively colonized with 
crystalline material and large numbers of bacterial cells. Between 12 and 18 h 
encrustation developed rapidly, and catheters removed at 18 h in infected models were 
heavily colonized by mature crystalline biofilms.
HVSEM micrographs of control catheters (including NF catheters) in models that 
were not infected with P. mirabilis are shown in Figure 19. These catheters did not 
develop the extensive encrustation observed in catheters from infected models 
although small isolated amorphous deposits were occasionally visible. In one instance 
crystalline formations were observed around the eye-let of the AS control catheter 
after 7 days exposure to sterile urine. The largest of these deposits approximately 200 
x 100 pm was composed of needle-shaped crystals aggregated into ‘rosette-like’ 
formations typical of crystalline calcium phosphate.
Nitrofurazone impregnated catheters
The overall development of encrustation on NF catheter surfaces is shown in Figure 
18. As was observed using LVSEM, HVSEM analysis showed that the initial 
encrustation process on NF catheters was delayed in comparison to that observed on 
AS, SCL, HCL and HSCL catheters. Surfaces of NF devices removed from infected 
bladder models at 1, 2 and 4 h appeared free of encrustation (except for extremely rare 
patches at the eye-hole section), and of any bacterial colonization. Encrustation and 
bacterial colonization was first observed at 12 h when accumulations of microcrystals 
formed patches of foundation layer around the eye-let of the catheter. P. mirabilis 
microcolonies were abundant around the eye-let area adhering to the mineralised layer 
and directly to the catheter surface. Encrustation was relatively rare at the lumenal
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sections B and C, but P. mirabilis microcolonies were abundant. Colonization was 
less abundant at section D. From 12 h onward, as seen in AS, SCL, HCL and HSCL 
catheters, the formation of crystalline biofilm on NF devices also developed rapidly. 
Surfaces of NF catheters after 18 h in infected bladder models had acquired a mature 
crystalline biofilm that seemed comparable to those formed on AS, SCL, HCL and 
HSCL catheters.
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Figure 11. Surface topography (eyehole region) of unused catheters fresh from packaging
The HVSEM micrographs show the surface features o f : (A + B) all-silicone catheter; (C + D) silicone-coated latex 
catheter; (E + F) hydrogel-coated latex catheter; and (G + H) hydrogel/silver-coated catheter.
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Figure 12. Surface topography (lumenal region) of unused catheters fresh from packaging
The HVSEM micrographs show the surface features of: (A +B) all-silicone catheter; (C + D) silicone-coated latex 
catheter; (E + F) hydrogel-coated latex catheter; and (H + I) hydrogel/silver-coated catheter.
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Figure 13. P. mirabilis NSM6 crystalline biofilm development on all-silicone catheters
vo The micrograph series shows: (A) the microcrystalline foundation layer on the surface o f the eyehole area after 1 h residence in bladder model; (B) lumenal area o f surface just 
below the eyehole after 2 h residence in the bladder model; (C) microcolonies o f P. mirabilis NSM6 microcolonies (arrow) on the foundation layer at a lumenal site just below the 
retention balloon at 4 h; (D) a mature crystalline biofilm at eyehole section at 18 h.
Figure 14. Crystalline biofilm development on SCL catheters in P. mirabilis NSM6 infected bladder models
The HVSEM micrographs series shows: (A) the microcrystalline foundation layer on eyehole section o f catheter after 1 h in the bladder model; (B) crystalline deposits 
accumulating on a lumenal surface just below the retention balloon at 2 h; (C) P. mirabilis cells (arrow) on encrusted lumenal surface 16 cm below the retention balloon 
after 2 h; (D) mature crystalline biofilm on lumenal section just below the retention balloon after 18 h.
Figure 15. Crystalline biofilm development on HCL catheters in P. mirabilis NSM6 infected bladder models
The HVSEM micrographs series shows: (A) the microcrystallinefoundation layer on eyehole section o f catheter after 1 h in bladder model; (B) the microcrystalline structure o f the 
g  deposits on lumenal surface just below the retention balloon at 2 h; (C) a microcolony on the foundation layer (arrow) at eyehole after 4 h; (D) mature crystalline biofilm on eyehole 
section after 18 h.
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Figure 16. Crystalline biofilm development on HSCL catheters in P. mirabilis NSM6 infected bladder models
The HVSEM micrographs series shows: (A) the foundation layer on eyehole section o f catheter after 1 h in an infected bladder model; (B) the microcrystalline deposits 
accumulating on lumenal surface just below the retention balloon at 2 h; (C) a microcolony on the foundation layer at eyehole after 4 h in bladder model. Cells also appear to have 
amorphous deposits on their surfaces; (D) a mature crystalline biofilm on eyehole section after 18 h. Proteus microcolonies (arrows) can be seen colonising needle-like crystals 
(typical o f crystalline calcium phosphate).
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Figure 17. P. mirabilis NSM6 adherence to areas of catheter surfaces not affected by encrustation
The HVSEM micrographs shows: (A) P. mirabilis cells (arrows) adhering directly to AS lumenal surface below the eyehole at 12 h in model; (B) P. mirabilis cells (arrows) 
adhering directly to SCL catheter surface below the eyehole at 4 h; (C) P. mirabilis cells (arrow) adhering directly to HCL catheter surface 16 cm from the eyehole at 4 h. 
(D) P. mirabilis cells adhering diatomaceous debris (arrow) on HSCL catheter surface below the retention balloon after 4 h.
Figure 18. HVSEM images of P. mirabilis NSM6 crystalline biofilm formation on 
nitrofurazone-impregnated catheters
The micrograph series shows: (A) the topography of unused lumenal catheter surfaces; (B) a 
lumenal section (just below the eyehole) after 2 h infected bladder model showing isolated 
encrusted deposits (arrows). Similar images (not shown) were obtained at 1 and 4 h; (C + D) 
are eyehole sections at 12 h, Proteus cells can be seen directly colonizing the catheter surface 
and the mineralised foundation layer; (E) is a mature biofilm after 18 h in the model with 
typical microcrystalline (arrow i) and large crystal formations (arrow ii); (F) mature 
crystalline biofilm at 27.5 hrs (blockage) with Proteus cells (arrows) covered in what appear 
to be mineral deposits.
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Figure 19. The condition of control catheter surfaces from bladder models 
exposed to sterile artificial urine
The HVSEM micrograph series show: (A) the crystalline formation (typical of calcium 
phosphate) found at eyehole of all-silicone catheter after 7 days exposure to sterile 
urine; (B) the lumenal surface of the same catheter shown in micrograph A. Arrows 
indicate amorphous material; (C) a hydrogel-coated latex catheter after 7 days 
exposure to the urine; (D) the silicone-coated latex catheter surface at 30 h; (E) a 
nitrofurazone impregnated catheter at 30 h; (F) the surface of HSCL catheter at 30 h. 
All arrows indicate amorphous deposits that resemble calcium phosphate.
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Triclosan loaded catheters
Crystalline biofilm did not develop on AS or HCL catheters loaded with triclosan (3 
mg/ml). The HVSEM micrographs illustrating the effect of triclosan on crystalline 
biofilm formation on these catheters are shown in Figures 20 and 21. Although 
crystalline biofilm formation did not occur in triclosan-loaded catheters, encrusted 
deposits and bacterial cells were found on catheter surfaces during the course of 
experiments. Encrusted deposits forming a foundation layer were present in AST and 
HCLT catheters around respective eye-lets after 1 h and 2 h residence in infected 
bladder models. This level of encrustation was similar to levels observed around eye­
lets in corresponding catheters not inflated with triclosan. The encrustation at the eye­
let area on triclosan loaded devices was reduced at 4 h and 12 h. It became ‘patchy’ 
and remained in a similar condition for the 7-day experimental period. Mineral 
deposits at lumenal sections did not form an extensive foundation layer on any sites 
(B-D) at any of the time periods examined. Here encrustation appeared as small 
random patches over all three lumenal sites.
P. mirabilis colonization of the triclosan loaded devices also failed to materialise to 
the extent observed in non-triclosan treated models. No evidence of bacterial 
colonization was observed on catheter sections from either AST or HCLT models up 
to 4 h. However, on sections removed after 12, 18 h and 7 days in infected models 
bacterial cells were observed. On all-silicone catheters inflated with triclosan P. 
mirabilis appeared as scattered single cells or in small groups < 5 cells. Many of these 
cells appeared ‘unhealthy’ in nature with distorted cell morphologies. P. mirabilis 
appeared to colonize hydrogel-coated latex catheters inflated with triclosan more 
efficiently than was seen in AST catheters, and was able to form patches of biofilm at
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a number of sites on catheters removed from 12 h, 18 h and 7 days. These biofilms 
were not widespread over the catheter or crystalline in nature, and were restricted to 
specific areas of the eye-lets forming biofilms approximately 200 x 150 pm in size. 
The lumenal areas of the HCLT catheter appeared less affected by colonization. In 
catheters examined after 12 h, 18 h and 7 days in infected models only relatively low 
levels of cells were found adhering to the surfaces. As with the AST catheters, cells 
on HCLT lumenal sites often appeared ‘unhealthy’.
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Figure 20. The effect of triclosan on P. mirabilis NSM6 crystalline biofilm development on AS catheters
The retention balloons were inflated with triclosan (3 mg/ml) instaed o f water. The HVSEM micrographs show: (A) an encrusted surface o f eyehole section after 1 h 
o  residence in bladder model; (B) the eyehole surface after 12 h in the bladder model; (C) an area o f the lumen (just below retention balloon) after 18 h in the bladder model;
(D) the sparse mineral deposition on catheter eyehole surface after 7 days in bladder model.
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Figure 21. The effect of triclosan on P. mirabilis NSM6 crystalline biofilm development on HCL catheters
Retention balloons o f catheters were inflated with triclosan (3 mg/ml) instead o f water. The HVSEM micrographs show: (A) the foundation layer on eyehole surface 
after 1 h in bladder model; (B) the lumenal section at 2 h in bladder model; (C) an isolated area o f eyehole colonized with non-crystalline biofilm after 12 h in bladder 
model; (D) the lumenal surface (just below eyehole) at 7 days with Proteus cells (arrows) scattered over the surface.
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3.1.1.3. Adherence of P. mirabilis to catheter surfaces
In one of the replicate experiments in which the AS, SCL, and HCL catheters were 
examined for biofilm development, the numbers of viable cells recovered from the 
four catheter sections were determined. The results are presented in Figure 22. The 
overall pattern of colonization on these catheters confirmed what was found using 
high vacuum SEM, in that sections at the eyehole and first few centimetres down the 
lumen appeared to be colonized first. Overall, numbers of viable cells recovered from 
sections of all catheters remained relatively stable over the initial 4 hours 
(approximately 104 cfu/mm), after which a steady increase in the number of cells 
adhering to sections was observed until time of blockage. Cell numbers peaked at 
approximately 107 cfu/mm at sites (A) and (B), and (C) and were approximately 106 at 
sections (D).
3.1.2. X-rav microanalvsis
The chemical nature of the crystalline material that formed on the catheter surfaces 
before bacterial colonization occurred was examined using X-ray microanalysis. 
Sections of AS and HCL catheters (1 cm) were removed from P. mirabilis NSM6 
infected models after 1, 2 and 4 h and examined in the microscope. Figures 23 and 24 
show the results of X-ray microanalysis of hydrogel-coated latex catheters after 1 h 
and an all-silicone catheter after 4 h in P. mirabilis NSM6 infected bladder models 
respectively. Results indicated that the accumulations found on the surfaces were 
relatively high in calcium and phosphorous suggesting the presence of calcium 
phosphate. The presence of other urinary constituents including potassium, 
magnesium and sodium were also found but in lower quantities.
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Figure 22. P. mirabilis NSM6 colonisation of all-silicone, silicone-coated latex and hydrogel-coated latex catheter surfaces
Experiments were concluded at 1, 2, 4 ,12 , 18 hours and at catheter blockage. Catheter sections (1 cm) were removed from: (A) eyehole, (B) just below the eyehole, (C) just 
below the balloon region and (D) 16 cm below the eyehole. Sections were processed with viable cells mm/ catheter length determined. *SCL blockage model occluded at 
12.5 hours . ** Viable cells <103 cfu/mm catheter length at 1 hour period at site D. Data from 1 replicate only for each catheter at each time interval. All models inoculated 
with 10 ml of a 4 hour NSM6 culture containing 108 cfu/rnl.
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Figure 23. X-ray microanalysis of amorphous deposits on hydrogel-coated 
latex catheter
The micrograph (top) shows the two areas of the catheter surface examined using x- 
ray microanalysis after 1 h in P. mirabilis NSM6 infected bladder models. The levels 
of calcium and phosphorous found at site 1 (matrix), and at site 2 (spectrum2) are 
shown as peaks in the generated graph.
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Figure 24. X-ray microanalysis of all-silicone catheter surface after 4 h exposure to P. mirabilis NSM6 infected urine
The figure shows: (A) ESEM image o f encrustation on lumenal section o f catheter showing 3 sample sites (labelled spectrum 1-3); (B) X-ray spectrum 
generated from foundation layer at site 1. Peaks indicated the layer was rich in calcium (Ca) and phosphorous (P); (C) X-ray spectrum generated at bare 
catheter surface at site 2, indicating presence o f silicone (Si); (D) X-ray spectrum of site 3 high in calcium and phosphorous content. Site 3 also indicated high 
silicone content probably due to the x-ray beam penetrating the foundation layer.
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3.1.3. Nucleation pH (pHr) of artificial urine
Calcium and magnesium phosphates form the bulk of urease-induced crystalline 
biofilms that encrust urinary catheters (Cox et al., 1989; Burr and Nuseibeh, 1993 & 
1997). To determine when these urinary solutes precipitated from urine used in 
bladder model experiments, levels o f Ca and Mg in the urine over an ascending pH 
range were determined using atomic absorbance spectroscopy. The pHn of urine was 
also determined. The results of AAS and regression analysis on urine are shown in 
Figure 25 A and 25 B. The pHn of artificial urine was determined at approximately pH 
6.7. AAS analysis confirmed that Ca and Mg precipitation from urine began to occur 
at approximately the same pH range.
107
6.1
The effect of pH on calcium and 
magnesium content in urine
150
6.5 7.5
pH
8 8.5
Calcium
Magnesium
B
Nucleation pH o f standard artificial urine
0.30 H
0.25-
1  0 . 20 -
0.15-
o  0 .10-
JS
<
0.05-
0 .00 -
8.07.0 7.56.56.0
Urine pH
Figure 25. (A) Calcium and magnesium precipitation from artificial urine at
elevated pH. (B) Determination of pHn
Figure 25A shows the calcium and magnesium concentrations remaining in solution 
as urine pH becomes elevated. Initial Ca and Mg precipitation occurred between pH 
6.5 and pH 7. Figure 25B shows the pHn of artificial urine determined using 
regression analysis with values based on pH v absorbance. The pHn is where the two 
regression lines meet and was determined at pH 6.7.
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3.1.4. Investigation of HSCL catheters of clinical origin
During the course of the study, the BARD IC. HSCL catheters were introduced into 
clinical use for patients undergoing long-term catheterisation in community care in the 
Bristol area. The continence advisor in the area concerned kindly collected a set of 
seven catheters that had been removed from patients. Catheters were stored at 4 °C 
until they could be processed and examined. Sections (1 cm) were cut from these 
catheters at the eyehole (A), immediately below the eyehole (B) and immediately 
below the catheter balloon (C). Sections A and C were processed for HVSEM 
analysis while section (B) was processed to determine the biofilm flora. Digital 
photographs of sections A and C were taken and are shown in Figure 26. A selection 
of HVSEM micrographs showing the crystalline biofilms on all seven catheters 
removed from patients are shown in Figures 27-31. The biofilm flora isolated from 
each catheter along with general information surrounding the catheters provided by 
the incontinence advisor is presented in Table 3.
Catheters from patients 1 and 6, and also the second catheter provided by patient 4, all 
appeared blocked at the lumen in the first few centimetres below the eyehole. 
Catheters from patient 3 and the first catheter from patient 4 did not appear blocked, 
but were heavily encrusted at the first few centimetres of lumen. Catheters from 
patients 2 and 5 appeared partially encrusted at the corresponding lumenal areas. In 
conjunction to what was observed visually and through digital photography, HVSEM 
analysis revealed the bulk of encrusted biofilm was found on the lumen sections of the 
catheters. The mineralised deposits appeared typical of the calcium phosphate and 
magnesium phosphate that are normally associated with urease-induced encrustation 
and was always associated with substantial bacterial colonization. Large areas of the
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catheter where encrusted biofilm was present appeared to possess a mineralised 
foundation layer upon which the bacterial biofilm had developed. This type of 
crystalline biofilm formation appeared similar to that observed using HVSEM in 
encrusted catheters removed from previous bladder model experiments. As in the in 
vitro models, areas where biofilm appeared to be directly colonizing the catheter 
surface were also observed in the HSCL catheters removed from patients. P. mirabilis 
and Providencia rettgeri (species known to be associated with catheter encrustation 
and blockage), were isolated from catheters 3 and 5. Although no species associated 
directly with catheter encrustation were isolated from the remaining catheters, 
HVSEM revealed species other than those isolated were present in the biofilms on 
these catheters.
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Figure 26. Digital images of hydrogel/silver-coated latex catheters removed from catheterised patients
Sections 1A-7A show eyehole regions and sections 1C-7C show regions directly below the retention balloon. Sections 1C and 3C have 
been transversely sectioned and show encrusted deposits lining the catheter lumen. Catheters 4 and 7 were two separate catheters removed 
from the same patient over a 1 month period.
Information table regarding Bard IC. Hydrogel/silver-coated latex catheters
Patient No. Type of 
cathteter
Patient
age (years)
Reason for 
removal
Catheter condition Duration in situ Biofilm flora
1 HSCL
urethral
53 Failure to drain Encrustation 
blocked below eyehole
10 days
Enterococcus faecal is 
Micrococcus luteus 
Bacilli (SEM)f
2 HSCL
urethral
Information
not
provided
Scheduled change 
(urine pH 8)
Lightly encrusted 14 days
Enterococcus faecal is 
Staphylococcus hominis 
Bacilli (SEM) t
3 HSCL
urethral
89 Scheduled change 
(urine pH 9)
Heavily encrusted 14 days Providencia rettgeri 
Cocci (SEM) t
4 HSCL
urethral
81 Scheduled change Heavily encrusted 14 days
Enterococcus faecalis 
Staphylococcus aureus 
Also bacilli (SEM) t
5 HSCL
urethral
94 Information 
not provided
Moderately encrusted 5 days Staphylococcus vitulans 
Proteus mirabilis
6 HSCL
urethral
Information
not
provided
Failure to drain Encrustation 
blocked below eyehole
14 days Enterococcus durans 
Bacilli (SEM) f
4* HSCL
urethral
81 Failure to drain Encrustation 
blocked below eyehole
11 days Enterococcus faecalis 
Staphylococcus aureus
4* 2" catheter from patient 4. f  Species not isolated from catheter but observed as part o f the biofilm flora using HVSEM analysis
Table 3. Profiles of hydrogel/silver-coated latex catheters from catheterised patients
The condition of devices that were not blocked was assessed visually. Urine pH is indicated whenever information was available.
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Figure 27. Crystalline biofilms on hydrogel/silver-coated latex catheters from catheterised patients
The micrographs show (A + B) crystalline material around eye-let o f patient 1 catheter. (C + D) illustrate a mixed community biofilm on a lumenal section just 
below the retention balloon o f a catheter also from patient 1.
Figure 28. Crystalline biofilms on hydrogel/silver coated latex catheters from catheterised patients
The micrographs show: (A) a foundation-like layer on surface of the eye-hole bevel of catheter from patient 2: (B) a microcrystal layer at also at the eyehole of catheter from patient 2; 
(C + D) are lumenal sections of catheter from patient 2 just below the retention balloon showing mature biofilm crystalline deposits.
The micrographs o f the catheter from patient 3 show: (A) the crystalline deposits in lumenal section just below the retention balloon; (B) an encrusted 
biofilm at eyehole section o f catheter; (C) a crystalline structure covered in bacterial biofilm (arrow) several layers thick; (D) a microcrystal-like layer found 
at t eyehole.
Figure 29. Crystalline biofilms on hydrogel/silver coated latex catheters from catheterised patients
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Figure 30. Crystalline biofilms on hydrogel/silver coated latex catheters from catheterised patients
The micrographs show: (A) a mixed species biofilm around eye-let o f section o f catheter from patient 4; (B) large crystalline deposits in lumenal section 
just below the retention balloon o f catheter from patient 4; (C) an encrusted mixed community biofilm at eyehole section o f catheter from patient 5. This 
crystalline material is typical o f calcium phosphate can be seen amongst the biofilm cells; (D) shows bacterial cells (bacilli and cocci) adhering to eyehole 
surface o f catheter from patient 5.
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Figure 31. Crystalline biofilms on hydrogel/silver coated latex catheters from catheterised patients
The micrographs show: (A) large crystalline structures similar to calcium phosphate crystals at the eyehole area o f catheter from patient 6; (B) typical biofilm 
structure found in lumen of catheter from patient 6; (C) large crystalline deposits found in lumen o f the 2nd catheter from patient 4; (D) high magnification of a 
mixed-species crystalline biofilm from eyehole section of the 2nd catheter from patient 4.
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3.2. Role of Mannose-Resistant Proteus-like fimbriae (MR/P fimbriae) in 
Proteus mirabilis colonization of all-silicone catheter surfaces
Results reported in Section 3.1. suggest that when a catheter is introduced into a 
bladder containing urine in which a population of P. mirabilis cells has produced 
alkaline conditions, crystalline biofilm formation on the catheter is initiated by the 
deposition of a microcrystalline foundation layer of calcium phosphate. Like many 
other bacteria P. mirabilis can produce appendages that are believed to be involved in 
attaching cells to surfaces. The most studied of these are the MR/P fimbriae 
(Mannose-Resistant Proteus-like fimbriae). There is evidence that these structures are 
involved in cell-aggregation, attachment to surfaces, colonization and invasion of the 
urinary tract (Mobley & Chippendale, 1990; Bahrani et al., 1994; Jansen et al., 2004). 
The extent to which they are involved in the encrustation of catheters however, is 
uncertain. They might be responsible for initiating attachment of cells directly to the 
catheters or to the microcrystalline foundation layer. On the other hand they might 
have no role in the process of crystalline biofilm formation.
3.2.1. MR/P expression in P. mirabilis isolates from environmental and clinical 
sources
A collection of twenty seven P. mirabilis isolates from a range of clinical and 
environmental sources were assayed for their ability to express MR/P fimbriae. 
Results of duplicate haemagglutination assays for all P. mirabilis isolates tested are 
presented in Table 4. All the test organisms were incubated under optimum conditions 
for MR/P expression and assayed for their ability to agglutinate chicken red blood 
cells (CRBC) in the presence and absence of 50 mM mannose. Figure 32 shows the
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haemagglutination profiles of the wild type P. mirabilis HI4320 and its mrpA mutant 
strain.
3.2.2. Effect of fluorofamide on pH of urine
To prevent P. mirabilis elevating the urinary pH in the bladder model experiments, a 
urease inhibitor fluorofamide (Morris & Stickler, 1998b) was used as a urine 
supplement. To determine the concentration of fluorofamide required in urine a series 
of WT P. mirabilis HI4320 urine cultures containing fluorofamide at 2, 3 and 4 pg/ml 
were incubated at 37°C with gentle aeration. After 4 h incubation the pH and viable 
cell counts were determined for each culture. Results showed mean viable cell counts 
(not shown) from cultures were not significantly different at the end of the 4 h 
incubation period (P = 0.9). The mean pH values in cultures containing 2 and 3 pg/ml 
fluorofamide were close to the nucleation pH of urine (pH 6.7), reaching pH 6.72 and 
6.68 respectively. The mean pH of cultures supplemented with 4 pg/ml fluorofamide 
was pH 6.46 after 4 h incubation. It was decided therefore that fluorofamide at 4 
pg/ml urine would be used to prevent significant pH increases in urine infected with 
P. mirabilis.
3.2.3. Preparation of the inocula of WT and mrpA P. mirabilis HI4320
To minimise disruption to fimbriae and also to synchronise cultures with experiment 
start times, P. mirabilis cultures used for bladder model inocula were grown statically 
over a 12 h period at 25°C. Growth curves were plotted for both strains in the 
presence and absence of 4 pg/ml fluorofamide with pH values of cultures also 
recorded. The results (Figure 33) show that viable cell densities reached 108 cfu/ml in
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all cultures at the end of the incubation period with no significant difference between 
means (P = 0.81). The mean pH values for WT and mrpA cultures (8.71 and 8.69 
respectively), incubated in urine only were not significantly different {P = 0.77). The 
mean urine pH’s for WT and mrpA cultures incubated in urine containing 4 pg/ml 
fluorofamide slightly exceeded the pHn reaching 6.75 and 6.78 respectively, but were 
not significantly different (P = 0.51).
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Bacterial strain Agglutination ± 
mannose
Origin
WT HI4320 + CAUTI
mrpA HI4320 - CAUTI
SMI 3 + CAUTI
SM27 + CAUTI
AO + CAUTI
AAAS (non-swarmer) + CAUTI
AAAX + CAUTI
NP5 + CAUTI
SDMI8 (non-swarmer) + Catheter biofilm
RB6 + Catheter biofilm
RB20 + Catheter biofilm
AK + Catheter biofilm
SDMI 5 + Catheter biofilm
SDMI 6 + Catheter biofilm
NSM6 + Catheter biofilm
NP41 + Catheter biofilm
NP11 + Penarth seawater
NP10 + Penarth seawater
NP31 + Swansea seawater
NP34 + Swansea seawater
NP23 + Seine river water
NP24 + Seine river water
NP21 -f Seine river water
NP39 + Cardiff seawater
NP27 + Sewage
NP29 + Sewage
NP54 + Sewage
NP40 + Sewage
NP22 + Sewage
(+) Agglutination in presence and absence o f  50 mM mannose, (-) no agglutination in presence and 
absence o f mannose. CAUTI = isolated from catheter-associated urinary tract infection
Table 4. MR/P expression in P. mirabilis isolates from a range of 
environmental and clinical sources
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Figure 32. Haemagglutination profiles of wild type and mrpA mutant Proteus mirabilis HI4320
The images show: (A) the wild type P. mirabilis HI4320 agglutination of CRBC in the absence and presence of 50 mM mannose (-M and 
+M respectively) seen as a diffuse matt of cells within the microtitre well (arrows); (B) no agglutination of CRBC in absence or 
presence of 50 mM mannose by mrpA mutant indicated by the tight button of cells formed in the microtitre wells (arrows). Tannic acid 
sensitised cells (T and MT) are agglutinated in the absence and presence of 50 mM mannose in both strains indicating the presence of 
agglutinins other than MR/P fimbriae. Bacterial suspensions 1:1 to 1:16 were used in the tests. Control wells (C1-C4) contained CRBC, 
mannose treated CRBC, tanned CRBC and mannose treated tanned CRBC and were not inoculated with P. mirabilis.
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Figure 33. Mean viable counts of WT and mrpA P. mirabilis in static cultures at 25 °C
P. mirabilis wt and mrpA HI4320 were incubated statically for 12 h in flasks containing artificial urine 
with and without 4 tig/ml fluorofamide. Viable cell numbers were recorded at various intervals up to 12 h. 
There were no significant differences (P = 0.81) in cell numbers between cultures after 12 h incubation. 
The mean values ± SE were calculated for the results of three replicated experiments.
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3.2.4. Ability of WT and mrpA P. mirabilis HI4320 to encrust all-silicone catheters
Bladder models were set up with all silicone catheters and supplied with artificial 
urine at 0.5 ml/min. Models were inoculated with 10 ml of a 4 h culture (containing 
approximately 108 cfu/ml), of either WT or mrpA P. mirabilis HI4320 incubated with 
gentle aeration at 37°C. The urinary viable cell populations and pH were recorded at 
0, 4, 8, 12, and 24 h and at the times at which catheter blockage occurred. The 
experiments were performed in triplicate and the mean times catheters took to block 
are presented in Figure 34. The mean viable cell counts and mean pH values of the 
urine samples recovered from the model chamber are presented in Figure 35. The 
mean blockage times of all-silicone catheters (29.9 ±5.61 h and 41.9 ± 1.43 h for the 
WT and mutant strains respectively) were not significantly different (P = 0.1).
For both the wild type and mutant the numbers of viable cells in the residual urine and 
the urinary pH declined over the initial 4 h period from 108cfu/ml to around 107 
cfu/ml and from > pH 8 to < pH 7 respectively. The numbers of viable cells in the 
urine then stabilized at 107 - 108 cfu/ml and at the times of catheter blockage, there 
was no significant difference between the WT and mutant populations (P = 0.28). 
After 4 h the pH of the urine rose steadily with both organisms and at the time of 
blockage had reached > pH 8. There was no significant difference between the pH’s 
generated (P = 0.98) by the two organisms at the respective blockage times.
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Figure 34. Mean* blockage times of all-silicone catheters in bladder models inoculated with wild type or mrpA Proteus 
mirabilis HI4320
Bladder models fitted with all-silicone catheters were inoculated with 10 ml (108 cfu/ml) of the test strains. Urine was supplied at 
0.5 ml/min and models were run until catheters blocked. There were no significant differences between mean blockage times (P 
= 0.1) between WT or mrpA strains. Standard error of the mean of three replicates is shown. * The mean values ± SE were 
calculated from the results of three replicate experiments.
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Figure 35. Mean* pH and viable cell counts recorded from residual urine in models 
inoculated with P. mirabilis HI4320 WT and its mrpA mutant
(A) shows the mean pH of residual urine in models; (B) the mean numbers of viable cells in the 
urine. *The mean values ± SE were calculated from the results of three replicate experiments.
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3.2.5. P. mirabilis adherence to catheters in the presence and absence of crystal 
formation in the urine
Bladder models fitted with all-silicone catheters were supplied at a 0.5 ml/min flow 
rate with either urine or urine supplemented with 4 pg/ml fluorofamide. The models 
were inoculated with 10 ml (approximately 108 cfii/ml) of cultures of either wild type 
or mrpA P. mirabilis HI4320 that had been incubated without aeration for 12 h at 
25°C. At various time intervals the supply of urine to the models was stopped and 
catheters were removed. Sections (1 cm in length) were cut from the eye-hole, just 
below the eye-holes and just below the retention balloon. The extent of crystalline 
biofilm formation was then visualized by HVSEM.
3.2.5.1. P. mirabilis adherence to catheters under alkaline conditions in which 
crystals form in the urine
The electron micrographs presented in Figures 3 6 - 4 1  illustrate the development of 
the biofilms on all-silicone catheters in the urine in which the increase in pH was not 
controlled by fluorofamide. The low magnification images (Figures 36 and 37) 
suggest that both test organisms generate crystalline biofilm on the eye-let and 
lumenal surfaces. Encrustation by the wild type however precedes that by the mrpA 
mutant. These observations are confirmed at high magnification (Figures 3 8 - 4 1 ) .  
Crystalline biofilm of the WT strain is clearly visible on both the eye-let and lumenal 
sections at 8 h, but doesn’t appear until 12 h in the case of the mutant. It is also 
apparent that at 12 -  18 h the WT biofilms have large populations of cells whereas the 
mutant biofilms are mainly crystalline in nature and contain relatively few cells. At 30
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h however, while the mutant biofilm remained mainly crystalline in nature there were 
patches that were densely populated by cells (Figure 42).
3.2.5.2. P. mirabilis adherence to catheters in acidic urine
The electron micrographs presented in Figures 43 -  48 show the development of 
biofilm on all-silicone catheters in models infected with the test P. mirabilis strains in 
which acidic pH of the urine was maintained by the urease inhibitor fluorofamide. 
The low magnification micrographs of the eye-let and lumenal surfaces (Figures 43 
and 44) suggest that extensive colonization by the wild type is not apparent until 24 h 
and that even at 48 h the mrpA mutant has produced only disperse patches of biofilm. 
At high magnification (Figures 45 - 48) there is little sign of crystalline material in the 
biofilms. In the case of the wild type the bacterial colonization at 4 and 12 h is in the 
form of micro-colonies that were associated with surface irregularities, especially in 
the eye-hole region. More extensive coverage is visible at 24 h and 48 h over both the 
eye-let and lumenal surfaces. Veiy little colonization of catheters by the mrpA strain 
was observed in the first 12 h. At 24 h micro-colonies had developed on parts of the 
eye-let and by 48 h these had formed a discontinuous, patchy, crystal-free biofilm 
several cells thick. On the lumenal surface, colonization at 48 h was limited to a 
dispersed population of single cells.
The numbers of viable cells recovered from the residual urine and the urinary pH of 
the models used in HVSEM are presented in Figure 49. It can be seen that the 
fluorofamide maintained acidic conditions in the urine, thus assuring that crystal 
formation would not have taken place in the urine throughout the experiment.
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MRP HI4320 8HR A
Figure 36. Crystalline biofilm formation of all-silicone catheters by WT and 
mrpA HI4320 P. mirabilis
Models were supplied with urine and inoculated with 108 cfu/ml of the test strains. The 
micrographs (A-C) illustrate encrustation at 4, 8 and 12 h in WT infected bladder 
models. (D-F) illustrate encrustation at 4, 8 and 12 h in mrpA infected bladder models.
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Figure 37. Crystalline biofilm formation of the lumenal surfaces of all-silicone 
catheters by WT and mrpA HI4320 P. mirabilis under alkaline conditions
Models were supplied with urine and inoculated with 108 cfii/ml of the relevant test 
organisms. The micrographs show encrustation developing at lumenal sections just below the 
eyehole regions of catheters. (A-D) illustrate encrustation at 4, 8, 12 and 18 h in WT infected 
bladder models. (E-H) illustrate encrustation at 4, 8, 12 and 18 h in mrpA infected bladder 
models.
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Fig 38. Wild type HI4320 P. mirabilis colonization of the eye-hole of all-silicone catheters in alkaline urine
The micrographs show the accumulation o f Proteus cells and microcrystals over an 18 h period.
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Fig 39. Wild type HI4320 P. mirabilis colonization of the lumenal surfaces of all-silicone catheters in alkaline urine
The micrographs show the accumulation o f Proteus cells and microcrystals over an 18 h period.Uito
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Fig 40. M utant HI4320 P. mirabilis colonization of eye-Iets of all-silicone catheters in alkaline urine
The micrographs show the accumulation o f  Proteus cells (arrows) and microcrystals over an 18 h period.
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Fig 41. M utant HI4320 P. mirabilis colonization of the lumenal surfaces of all-silicone catheters in alkaline urine
The micrographs show the accumulation o f Proteus cells (arrows) and microcrystals over an 18 h period.
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Figure 42. Mutant HI4320 colonization of the eye-let of all-silicone catheters 
in alkaline urine at 30 h
Bladder models inoculated with mrpA HI4320 were run until catheters blocked (30 h). 
The micrographs show: (A) a patch of biofilm several layers thick heavily populated 
with bacteria. Arrows indicate encrusted deposits within the biofilm; (B) shows a high 
magnification image of P. mirabilis cells and microcrystals forming the crystalline 
biofilm at the eye-let of the same catheter.
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Figure 43. Colonization of the eye-let of all-silicone catheters by WT and mrpA 
P. mirabilis HI4320 in acidic urine
Models inoculated with test strains were supplied with artificial urine supplemented 
with fluorofamide (4 pg/ml). The micrographs illustrate: (A-D) colonization around the 
eye-let area of catheter sections at 4, 12, 24 and 48 h in WT HI4320 infected bladder 
models; (E-H) colonization at 4, 12, 24 and 48 h incubation respectively with mrpA 
HI4320 infected bladder models.
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Figure 44. Colonization of the lumenal surfaces of all-silicone catheters by WT 
and mrpA P. mirabilis HI4320 in acidic urine
Models were inoculated with test strains and supplied with artificial urine supplemented 
with fluorofamide (4 pg/ml). The micrographs illustrate: (A-D) colonization of the 
lumenal surface of the catheters at 4, 12, 24 and 48 h in WT HI4320 infected bladder 
models; (E-H) colonization of the lumenal surface of the catheters at 4, 12, 24 and 48 h in 
mrpA HI4320 infected bladder models.
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Figure 45. Colonization of the eye-let of all-silicone catheter surfaces in WT HI4320 P. mirabilis infected bladder models in 
acidic urine
Models were supplied with urine supplemented with fluorofamide (4 pg/ml).
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Figure 46. Colonization of the lumenal surface of all-silicone catheters in WT HI4320 P. mirabilis infected bladder models 
in acidic urine
Models were supplied with urine supplemented with fluorofamide (4 pg/ml).
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Figure 47. Colonization of the eye-hole of all-silicone catheter surfaces in mrpA HI4320 P. mirabilis infected bladder 
models in acidic urine
Models were supplied with urine supplemented with fluorofamide (4 pg/ml). The HVSEM images show typical areas around the
eye-let o f the catheter. The image taken at 8 h shows a rough area o f the eye-let surface where P. mirabilis cells (arrow) have been
trapped.
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Figure 48. Colonization of the lumenal surfaces of all-silicone catheters in mrpA HI4320 P. mirabilis infected bladder 
models in acidic urine
Models were supplied with urine supplemented with fluorofamide (4 pg/ml). The image at 24 h shows one of the rare patches of 
biofilm just below the retention balloon.
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Figure 49. The viable cell counts (A) and pH (B) of residual urine in models 
infected with the wild type and mrpA mutant of P. mirabilis HI4320
The presence of fluorofamide in the urine supplied to the models is indicated by (F) 
after strain designation. Experiments were run for 4, 8, 12, 18, 24 and 48 h with 
fluorofamide supplemented urine and 4, 8, 12, 18 and 30 h with control urine. All 
models inoculated with 10 ml of the test organisms (£10 8 cfu/ml). The data shown is 
from one experiment in each case.
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3.2.6. Growth of WT and mrpA HI4320 in urine batch culture at 37°C
Evidence presented in Sections 3.2.4. and 3.2.5. showed that while the pH of the 
residual bladder model urine for both WT and mrpA experiments dropped initially, 
the pH of urine infected with the mutant took longer to recover to > pH 8.0. HVSEM 
observations also indicated that catheters resident in models inoculated with the WT 
became encrusted before those incubated in mrpA infected bladder models. It is 
possible therefore that the mutant lacking the fimbriae, has different growth 
characteristics and or urease activity than its parent wild type. To examine these 
possibilities the test strains were grown in urine in batch culture. Flasks containing 
100 ml of artificial urine were inoculated with 3-4 colonies of the test organisms that 
had been incubated overnight on CLED agar at 37°C. The flasks were then incubated 
without aeration at 37°C. Viable cell counts and the pH of cultures were taken at the 
start and at hourly intervals up to a maximum of 6 h.
The results of triplicate experiments are presented in Figure 50. At the end of the 6 h 
incubation both WT and mrpA strains elevated mean culture pH to approximately pH 
8.5 and had mean cell densities of > 108 cfu/ml. The mean generation times of the test 
organisms incubated under the these conditions were not significantly different (P = 
0.43) and were calculated as 1.68 ± 0.08 and 1.55 ± 0.13 h _1 for WT HI4320 and 
mrpA HI4320 strains respectively.
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Figure 50. Growth curves and urease activity of WT and mrpA HI4320 
in urine batch culture at 37°C
The mean values ± SE of the viable cell counts (A) and pH (B) were calculated 
from the results of three replicated experiments.
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3.2.7. Enumeration of WT and mrvA HI4320 cells adhering to catheters under acidic 
and alkaline conditions
Bladder models fitted with all-silicone catheters were supplied with artificial urine or 
artificial urine supplemented with 4 jig/ml fluorofamide. They were inoculated with 
10 ml of either WT or mrpA P. mirabilis HI4320 strains (108 cfu/ml) of a urine 
culture that had been incubated statically for 12 h at 25°C. The models were operated 
for 24 h before the urine supply was terminated and the catheters removed for 
processing. Catheter sections (1 cm) were cut from sites A, B, C and D (Figure 4). 
The numbers of viable bacterial cells adhering to these sections were then determined.
The results from three replicated experiments are summarized in Figure 51. The data 
was analysed to determine whether (a) maintaining acidic conditions in the urine by 
inhibiting urease activity affects the numbers of the mutant or wild type colonizing 
the catheters; (b) the adhesion of the mutant differs significantly from that of its 
parent wild type under the two experimental conditions. Analysis of variance showed 
that at 24 h there were no significant differences between the mean numbers of WT 
cells attaching to sections A-D in the presence and absence of fluorofamide (P = 0.07, 
P  = 0.08, P = 0.9 and P  = 0.14 respectively). There were no significant differences in 
the mean numbers of mrp A HI4320 viable cells attaching to catheter sections A, C and 
D under the two experimental conditions {P = 0.08, P = 0.4 and P = 0.4 respectively). 
In the case of section B however, significantly more mutant cells attached in alkaline 
than acidic urine (P = 0.007). No significant differences were recorded in the mean 
numbers of WT v mrpA HI4320 adhering to sections A-D in alkaline (P = 0.4, P = 
0.9, P = 0.5 and P  = 0.2 respectively), or acidic conditions (P = 0.2, P  = 0.6, P  = 0.9 
and P  = 0.2 respectively). When experiments were stopped mean cell densities in the
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residual urines were all 107 -  108 cfu/ml and were not significantly different for: WT 
(alkaline urine) v WT (acidic urine, P  = 0.3); mrpA (alkaline urine) v mrpA + (acidic 
urine, P  = 0.07); WT (alkaline urine) v mrpA (alkaline urine, P = 0.09); WT (acidic 
urine) v mrpA (acidic urine, P  = 0.9).
3.2.8. Expression of P. mirabilis MR/P fimbriae bv cells growing in the bladder 
models
Although WT P. mirabilis HI4320 expresses MR/P fimbriae when grown in LB broth 
under optimum conditions required for the fimbrial expression (Section 2.17), it was 
unclear if MR/P were expressed by WT HI4320 under bladder model conditions. To 
determine this, bladder models fitted with all-silicone catheters were inoculated with 
either 10 ml of cultures of WT or mutant HI4320 (approximately 108 cfu/ml) that had 
been incubated for 12 h without aeration at 25°C. Urine supplemented with 4 pg/ml 
fluorofamide was supplied to models at 0.5 ml/min. At 24 and 48 h the residual urine 
was removed from the models. The cells were harvested by centrifugation and re­
suspended in phosphate buffered saline (PBS, pH 7.2), or PBS containing 50 mM 
mannose to approximately 109 cfu/ml and the presence of MR/P fimbriae determined 
by haemagglutination testing.
Figure 52 shows the haemagglutination profiles of WT HI4320 and mrp A HI4320 at 
24 and 48 h in infected bladder models. The results indicate that MR/P fimbriae were 
not expressed in WT or mrpA cells at 24 h. At 48 h however, WT HI4320 cells 
agglutinated CRBC in the presence and absence of mannose indicating that MR/P 
fimbriae were being expressed.
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3.2.9. Auto-aggregating ability of WT and mrvA P. mirabilis HI4320 strains
Evidence presented in Section 3.2.6. suggested that the growth characteristics and 
urease production were similar between the WT and mrpA test organisms. This 
indicated that the slow recovery of pH levels in mrpA infected bladder models, and 
also the delayed encrustation of catheters in bladder models infected with the mutant 
(reported in 3.2.4 and 3.2.5.), may have been caused by other factors. As MR/P 
fimbriae have been associated with cell aggregation (Section 3.2.), it was 
hypothesized that cell aggregates forming in the bladder models may be responsible 
for the quicker recovery of urine pH in bladder model urine and earlier encrustation of 
catheters in the WT bladder models. To determine whether WT P. mirabilis 
expressing MR/P fimbriae was better at forming cell aggregates than the mutant 
HI4320 strain, auto-aggregation assays were carried out on the two test organisms. 
Strains were incubated in Luria Bertani broth at 37°C for 6 days and passaged at 48 h 
intervals for optimum conditions for MR/P expression. Subsequently, isolates were 
assessed visually (Section 2.18) for formation of cell aggregates in test tubes under 
assay conditions over a 24 h period. Known co-aggregating strains of Actinomyces 
naeslimdii ATCC 12104 and Streptococcus sanguis GW2 were used as a positive 
control to indicate the aggregation phenomenon.
The results of duplicate auto-aggregation assays are presented in Table 5. It was clear 
that the WT P. mirabilis HI4320 was able to form visible cell aggregates considerably 
better than the mutant HI4320 strain under the test conditions. Cell aggregations were 
clearly visible in the test-tubes containing WT HI4320 within 5 minutes of the 
experiment procedure. Although some evidence of auto-aggregation occurred in the 
test-tubes containing the mrpA HI4320 strain at the identical time period, it was at a
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much reduced level. Any auto-aggregation that occurred in assays did so within the 
initial 5 minute period after the experimental procedure took place and did not 
increase as time elapsed. Figure 53 shows a selection of photographs of test-tubes 
used in the auto-aggregation experiments carried out in aggregation buffer.
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Figure 51. Viable cell counts from all-silicone catheter sections after 24 h in infected bladder models
Bladder models were inoculated with 108 cfu/ml of wt or mrpA HI4320 strains and supplied with urine only or urine containing 4 
pg/ml fluorofamide (indicated as -F  and +F respectively). The mean values ± SE were calculated from the results of three 
replicated experiments.
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Figure 52. Haemagglutination patterns of wt and mrpA P. mirabilis HI4320 from residual bladder model urine
Bladder models inoculated with wt or mrpA HI4320 were supplied with urine containing 4 pg/ml fluorofamide. Cells were harvested at 24 and 48 h and tested for MR/P 
expression. The microtitre plates show: (A + B) tight button (no agglutination) o f CRBC incubated in the presence o f 50 mM mannose (arrows) with mrpA HI4320 from 
24 and 48 h bladder models respectively; (C) shows no CRBC haemagglutination in wt HI4320 cells from the 24 h bladder model (arrow) incubated with 50 mM 
mannose; (D) shows diffuse matt (agglutination) of CRBC in all wells incubated with wt HI4320 from 48 h residual bladder model urine. The agglutination o f CRBC in 
i—t the absence o f mannose or o f CRBC sensitized with tannic acid indicate the presence o f other agglutinins.
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Auto-aggregation of W T and mrpA P. mirabilis HI4320
Bacterial
Strain
5 minutes 24 h
A. naeslundii
+
S. sanguis 
(control)
+ 4 + 4
+ 4 + 4
P. mirabilis WT HI4320 (1) +2/+3 +2/+3
P. mirabilis WT HI4320 (2) + 3 + 3
P. mirabilis mrpA HI4320
( i)
+ 1 + 1
P. mirabilis mrpA HI4320 
(2 )
+ 1 + 1
+1 small uniform aggregates in turbid suspension, +2 easily visible aggregates in turbid suspension, +3 
clearly visible aggregates that settle leaving an almost clear supernatant,+4 large aggregates that settle 
almost instantaneously to leave clear supernatant
Table 5. Aggregation profiles of WT and mrpA P. mirabilis HI4320 in co- 
aggregation buffer
P. mirabilis strains were grown for 6  days in LB broth under conditions for optimum 
MR/P fimbriae expression. The results of the two aggregation assays for each strain 
along with co-aggregating controls are indicated. Visual assessment of auto­
aggregation occurring in the test-tubes from 1 - 6  h (not shown) was not different from 
observations taken at 5 minutes or 24 h.
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Figure 53. Auto-aggregation of WT and mrpA P. mirabilis HI4320
The digital images of test-tubes show: (A + B) the auto-aggregation phenomenon occurring in 
control strains (arrows indicate cell aggregates); (C) WT HI4320 after 5 minutes (arrow indicate 
prominent cell aggregates); (D) mrpA HI4320 after 5 minutes; (E) WT HI4320 at 24 h; (F) mrpA 
HI4320 at 24 h.
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3.3. Modulation of crystalline Proteus mirabilis biofilm development on 
urinary catheters
The relationship between pHv and pHn is a major factor in determining the solubility 
of calcium and magnesium phosphate in urine. When the pHv rises above the pHn, 
crystals will appear in the urine and the greater pHv exceeds the pHn, the more of 
these salts will crystallize out of solution (Choong et a i, 2001). The recent 
prospective clinical study by Mathur et al. (2006a) showed that the variation in the 
rate of catheter encrustation in individuals infected with Proteus is also a function of 
the difference between pHv and pHn. They reported that patients whose urines had 
pHv values consistently lower than their pHn’s, did not block their catheters. On the 
other hand, catheter encrustation and blockage was rapid in those patients having 
urine with no such safety margin between the mean pHv and pHn values. Mathur et al. 
(2006a) also found that the pHn of individuals urine varied widely from week to week, 
suggesting that it should be possible to devise a strategy to increase the safety margin 
between pHv and pHn by elevating pHn. In a study of urine from healthy volunteers, 
Suller et al. (2005) demonstrated that it was possible to manipulate pHn. Simply 
diluting urine by increasing the fluid intake and by raising its citrate content, the pHn 
of urine could be elevated to values that are rarely achieved even in P. mirabilis 
infected urine. The aim of experiments reported in this section was to establish 
whether the manipulation of the pHn of urine in the ways suggested by Suller et al. 
(2005) modulates the rate at which crystalline biofilm form on urinary catheters in 
laboratory models infected with P. mirabilis.
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3.3.1. The effect of diluting urine on its pHn and the rate of catheter encrustation
The composition of the artificial urine used in these studies presented in Sections 3.1 
and 3.2. was devised to represent that of the concentrated urine produced by elderly 
long-term catheterised patients who commonly drink very little. To simulate the effect 
of increasing the fluid intake, a series of dilutions of the basic urine (from 1:1 to 1:6) 
were made with de-ionized water. The pHn values of these diluted urines were 
determined and the results are presented in Table 6. It can be seen that the dilution of 
the urine has a profound effect on pHn, the values increasing from 6.7 (neat urine) to
8.4 (1:6 dilution).
Experiments were then performed in bladder models fitted with all-silicone catheters 
and inoculated with P. mirabilis NSM6 to investigate the effect of increasing fluid 
intake on the times catheters took to block. Sets of four models were supplied with 
neat, 1:1, 1:2 and 1:3 dilutions of the artificial urine at corresponding flow rates of 
720, 1440,2160 and 2880 ml/24 h. Samples of urine ffom the voided urine were taken 
at 24 h intervals for pH measurement and viable cell counting. The models were run 
until catheters blocked with crystalline biofilm. The results ffom four replicated 
experiments are summarized in Figures 54 and Tables 7 and 8.
It is clear that diluting urine and increasing its flow rate to the bladder models extends 
the times catheters took to block. Statistical analysis confirmed that the mean times to 
blockage in the four sets of models were all significantly different (P < 0.05). Figure 
54 also shows the mean time to blockage (calculated for four replicates) of catheters 
in models supplied with urine at 1:1 dilution but at the original flow rate of 720 ml/24 
h. The mean value of 50.5 ± 4.6 h was not significantly different (P > 0.9) ffom the
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value of 49.5 ± 6.0 h recorded in models supplied with 1:1 dilution of urine at 1440 
ml/24 h. This result suggests that the dilution of the urine rather than the flow rate is 
the major factor in controlling the rate of catheter encrustation. Data presented in 
Table 7 show that pH levels remained > pH 8 in all models throughout experiments. 
The mean viable cell counts from voided urine (Table 8) remained > 107 cfu/ml in all 
models throughout experiments.
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Dilutions of artificial urine Nucleation pH (pH„)
Neat 6.7
1 : 1 6.9
1 : 2 7.3
1:3 7.5
1:4 7.9
1:5 8 . 1
1 : 6 8.4
Table 6. The effect of dilution of urine on pH„
The pHn was determined using least squares regression analysis.
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Figure 54. The effect of diluting urine and increasing its flow-rate to bladder models colonized by P. mirabilis NSM6 on the 
rate of catheter blockage
The values indicated are means and standard error of the means calculated from four replicated experiments. The pH^ values of urines 
supplied to the models are also indicated.
Table 7. The nucleation pHs of urine supplied to the models and the +mean 
pH (pHv) of urine voided from the models infected with P. 
mirabilis NSM6
Urine output 
(ml/24h)
Nucleation pH 
(pHn) of urine
pH of urine voided from model at various times 
during life-span of catheters
lh 24h 48h 72h 96h 1 2 0 h
720 6.7 8.62 8.42+ - - -
1440 6.9 8.51 8.75 9.08++ - - -
2160 7.3 8.82 8.72 8.97 9.07 - -
2880 7.5 8.82 8.76 8.93 8.95 9.04 9  |***
t  Means calculated from data for four replicated experiments unless otherwise stated 
♦Mean based on 2 out of 4 replicates (2 replicates blocked before 24 h)
♦♦ Data from 1 replicate, (3 replicates blocked before 48 h)
♦♦♦Mean based on 3 out of 4 replicates (1 replicate blocked before 120 h)
- Indicates that no urine was voided at these times as the catheters had blocked
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Table 8. The tmean number of viable cells/ml of urine voided from models 
infected with P. mirabilis NSM6  and supplied with urine at 
different flow-rates
Urine output 
(ml/24h)
Viable cells (cfu x 107/ml) in urine voided ffom model at various 
times during the life-span of catheters
lh 24h 48h 72h 96h 1 2 0 h
720 2 2 . 0 5.3 * - - - -
1440 15.0 5.3 8 .0 ** - - -
2160 14.0 2.7 4.0 2.3 - -
2880 14.0 2.7 6 . 2 1 1 . 0 7.1 j 3  ***
t  Means calculated from data for four replicated experiments unless otherwise stated 
*Mean based on 2 out of 4 replicates (2 replicates blocked before 24 h)
** Data from 1 replicate, (3 replicates blocked before 48 h)
***Mean based on 3 out of 4 replicates (1 replicate blocked before 120 h)
- Indicates that no urine was voided at these times as the catheters had blocked
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3.3.2. Effect of citrate on urine pHn and the rate of catheter encrustation
Suller et al. (2005) showed that the pHn of urine could be raised by increasing its 
citrate concentration. They also demonstrated in experiments with healthy human 
volunteers that the citrate content and pHn of urine could be elevated simply by 
consuming 500 ml of orange juice on a daily basis. The aims of the following 
experiments were to determine the effect increased citrate concentrations in artificial 
urine would have on its pHn, and on the rate of catheter encrustation when the urine 
was supplied to laboratory models infected with P. mirabilis NSM6.
The artificial urine diluted to 1:1 was produced containing citrate concentrations 
ranging from 0, to 3.0 g/L. The pHn of each specific urine was determined using the 
optical density method and least squares regression analysis. Urine containing the 
different citrate concentrations was then supplied to bladder models at a rate of 1440 
ml daily urine output (flow-rate of 1.0 ml/min). The models were inoculated with 10 
ml of a 4 h culture of P. mirabilis NSM6 (approximately 108 cfu/ml). The bladder 
models were run until the all-silicone catheters blocked or up to a maximum of 7 days 
when experiments were stopped manually. Four replicated experiments were 
performed for each citrate concentration. Viable cell counts and pHs of the voided 
urine were determined at the start of the experiments and at 24 h intervals thereafter.
The data presented in Table 9 show the effect of citrate content on pHn. It can be seen 
that the pHn values increased from 6.7 (no citrate) to 9.1 (3.0 g/L citrate). The mean 
blockage times of the all-silicone catheters in the bladder models supplied with urine 
containing the various citrate concentrations are shown in Figure 55. It was apparent 
that the citrate content in the urine had a profound effect on the time it took catheters
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to block with crystalline biofilm. Catheters in models supplied with urine containing 
no citrate, 0.41 and 1.0 g/L citrate had mean blockage times that ranged ffom 32.3 ±
3.5 h, to 107.3 ± 5.5 h. Statistical analysis (ANOVA) revealed that in these bladder 
models the times to catheter blockage became significantly (P < 0.05) longer with 
each ascending citrate concentration in the urine. What was more encouraging was 
that in bladder models supplied with the urine containing 1.5, 2.0 and 3.0 g/L citrate, 
the catheters drained freely for the full 7-day experimental period.
Increasing the citrate content of urine also clearly affected the extent to which 
phosphates were precipitated in the residual urine of the infected models. Figure 56 
illustrates the relative turbidity of the urine in models supplied with urine containing 
0.41 to 3.0 g/L citrate. The data presented in Table 10 and Table 11 show that the pH 
of urine remained >pH8 and viable cell populations > 107 cfu/ml in all cases 
throughout the experimental period.
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Citrate concentration in 1:1 
diluted artificial urine
(g/L)
Nucleation pH 
(pH„)
0 7.0
0.41 7.4
1.0 8.2
1.5 8.3
2.0 8.5
3.0 9.1
Table 9. Nucleation pH values of urine containing various citrate concentrations
Citrate concentrations were adjusted by increasing the levels of tri-sodium citrate when preparin; 
the urine.
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Figure 55. Blockage times of all-silicone catheters in models inoculated with P. mirabilis NSM6 and supplied with urine 
containing various citrate concentrations
Bladder models were inoculated with 10 ml of a 4 h culture of P. mirabilis NSM6  and supplied with a 1:1 dilution of the standard 
urine supplemented with various citrate concentrations. The values indicated are the means and standard error of the means 
calculated ffom four replicated experiments. The pH„ of urines supplied to the models are also indicated.
0.41 g/L citrate
7 clays
3.0 g/L citrate
Figure 56. Appearance of urine in bladder models
The photographs illustrate the extent of crystal formation in the urine containing a range of 
citrate concentrations at various time intervals.
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[CitrateJ in 
1:1 diluted 
urine (g/L)
pH of residual urine from models at various times (h) during the life-span of catheters
0 24 48 72 96 120 144 168
0 8.49 ± 8.72 ±0.12 - - - - - -
0.41 8.53 ± 0.05 8.85 ± 0.05 8.87 ± 0.02
t
8.95 ± 0.07
t t
- - - -
1.0 8.56 ± 0.05 8.65 ±0.12 8.91 ± 0.04 9.02 ± 0.02 9.05 ±0.01
t
- - -
1.5 8.52 ± 0.03 8.47 ± 0.04 8.8 ± 0.04 8.88 ± 0.01 8.89 ± 0.02 8.96 ± 0.02 8.95 ± 0.04 8.7 ± 0.02
2.0 8.56 ± 0.05 8.48 ±0.07 8.74 ±0.01 8.91 ± 0.03 8.96 ± 0.04 8.98 ± 0.04 9.0 ± 0.03 8.82 ± 0.07
3.0 8.49 ± 0.03 8.3 ± 0.09 8.72 ±0.01 8.81 ±0.02 8.95 ± 0.03 8.97 ± 0.02 8.98 ±0.01 8.75 ±0.1
Table 10. The *mean pH of residual bladder model urine in bladder models supplied with urine containing a range of citrate 
concentrations
Models were fitted with all-silicone catheters and inoculated with 10 ml of 4 h P. mirabilis NSM6  culture. * The means ± SE of the means were 
calculated (unless otherwise stated) from the results of four replicated experiments, (t) mean based on three replicates ( f t )  mean based on two 
replicates (-) all catheters in series had blocked by this time
[Citrate] in 
1:1 diluted 
urine (g/L)
Mean viable cell populations (cfu x 107 cfu/ml) of residual bladder model urine at known time intervals (h)
0 24 48 72 96 120 144 168
0 14.3 ±1.7 8.6 ±1.2 - - - - - -
0.41 14.3 ± 2.0 15.5 ± 5.7 14.3 ±6.1
t
7.5 ± 3.6
f t
- - - -
1.0 18.0 ±1.1 4.7 ± 2.2 11.0 ±5.9 14.0 ±4.0 10.0 ±2.5
t
- - -
1.5 11.3 ±0.9 8.65 ±2.1 16.1 ±4.1 22.5 ± 1.9 12.1 ±3.8 28.2 ± 8.6 22.0 ±3.0 54.5 ± 3.7
2.0 11.0 ± 1.4 8.3 ± 2.2 11.5 ± 2.1 5.6 ± 0.59 12.1 ±6.0 23.8 ± 4.4 16.3 ±4.6 45.0 ±12.0
3.0 16.3 ±1.0 8.68 ±1.8 12.9 ±2.5 11.1 ±6.2 14.2 ±2.8 12.7 ± 2.2 22.8 ± 5.9 6.23 ± 0.65
Table 11. The * mean viable cell populations in residual bladder model urine in bladder models supplemented with various citrate 
concentrations
Models were fitted with all-silicone catheters and inoculated with 10 ml of 4 h P. mirabilis NSM6 culture. The * means ± SE of the means were 
calculated (unless otherwise stated) from the results of four replicated experiments, (f) mean based on three replicates (f t)  mean based on two 
replicates (-) all catheters in series had blocked by this time
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3.3.2.1. Electron microscopy of catheter biofilms formed in urine containing a range 
of citrate concentrations
A set of bladder models fitted with the all-silicone catheters were infected with P. 
mirabilis NSM6 and supplied with urine containing 0.41, 1.0 and 1.5 g/L citrate. 
When the catheter in the model supplied with the urine containing 0.41 g/L citrate 
blocked, catheters were removed from all three models. Additional catheters in 
bladder models supplied with urine containing 1.5, 2.0 and 3.0 g/L citrate were 
removed for examination after 7 days. Sections (1 cm in length) from the eyehole 
region and from immediately above the retention balloon were cut from each catheter 
and the extent of encrustation visualized directly by LVSEM.
The micrographs (Figures 57 and 58) show that crystalline biofilm formation was 
noticeably less developed on catheters supplied with urine containing the higher 
citrate concentrations. The crystalline biofilm that developed on the catheter supplied 
with 0.41 g/L citrate had completely blocked the eye-let of the catheter at 64 h and the 
lumenal section was also severely encrusted. Although the crystalline biofilm that had 
developed on the surfaces of the catheter supplied with 1.0 g/L citrate at a similar time 
(72 h) was significant at the eye-let area, it was however, noticeably reduced at the 
lumenal site. Relatively little encrustation was visible at 72 h on the surfaces of the 
catheter supplied with urine containing 1.5 g/L citrate. The micrographs presented in 
Figure 58 show that although the catheter from the model supplied with urine 
containing 1.5 g/L citrate was still draining freely at 7 days, significant encrustation 
had formed on its surfaces. Catheters removed from bladder models supplied with 
urine containing 2.0 and 3.0 g/L citrate at the end of the 7 day experimental period
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however, showed no signs of crystalline biofilm development. Viable cell populations 
in residual bladder urine in all experiments at time of stoppage were > 107 cfu/ml and 
the pH’s of residual urine >pH 8.
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Figure 57. Scanning electron micrographs showing encrustation on catheters from 
models supplied with urine containing 0.41,1.0 and 1.5 g/L citrate
The micrographs show the encrustation at the eye-holes and on the lumenal surface of cross- 
sections taken just above the retention balloons. A and B are of a catheter which blocked 
after 64 h in a model supplied with urine containing 0.41 g/L citrate (the outline of the eye­
hole is shown). C + D are of a catheter removed after 72 h from a model supplied with urine 
containing 1.0 g/L citrate; E and F are of a catheter removed after 72 h from a model 
supplied with urine containing 1.5 g/L citrate.
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Figure 58. Scanning electron micrographs showing encrustation on catheters from 
models supplied with urine containing 1.5, 2.0 and 3.0 g/L citrate
The micrographs reveal the extent of encrustation at the eye-holes and on the lumenal surfaces 
of cross-sections taken just below the retention balloons after 7 days incubation in the models. 
A and B are of a catheter from a model supplied with urine containing 1.5 g/L citrate. C and D 
are from a model supplied with urine containing 2.0 g/L citrate. E and F are from a model 
supplied with urine containing 3.0 g/L citrate.
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A selection of HVSEM micrographs of catheter sections removed from models 
supplied with urine supplemented with the various citrate concentrations are shown in 
Figure 59 - 66. Catheters from bladder models supplied with urine containing 0.41 
g/L citrate for 24 h were colonized with a typical P. mirabilis crystalline biofilm 
(Figure 59 A and B). In contrast, the P. mirabilis biofilms on the catheter surfaces 
from bladder models supplied with urine containing 1.0,1.5,2.0 and 3.0 g/L citrate at 
the 24 h period showed no evidence of crystalline deposits (Figures 59 C and D, 60 
and 61). By 48 h crystalline material had started to form in the biofilms on catheters 
from models supplied with urine containing 1.0 and 1.5 g/L citrate (Figure 62). There 
was no sign of crystalline biofilm on catheters examined from bladder models 
supplied with urine containing 2.0 and 3.0 g/L citrate at 48 h (Figure 63).
At 7 days the biofilm formed on catheters ffom models supplied with urine containing
1.5 g/L citrate was crystalline in nature (Figure 64). The micrographs reveal distinct 
differentiated regions within its structure. The biofilm was made up of a foundation 
layer upon which a typical crystalline P. mirabilis biofilm had formed. Above this 
was a crystal-free mass of elongated P. mirabilis swarmer-like cells. In contrast, the 
7-day biofilms colonizing catheter surfaces ffom models supplied with urine 
containing 2.0 g/L citrate (Figure 65) were almost completely ffee of microcrystalline 
structures with only rare instances of relatively small amounts of what appeared to be 
calcium phosphate present. Swarmer-like cells could not be found. The biofilm on the 
surfaces of catheters removed ffom models supplied with urine containing 3.0 g/L 
citrate at 7 days (Figure 66) was completely ffee of any microcrystalline deposits. 
Populations of viable cells in the residual bladder urine in all the experiments at time 
of stoppage were > 107 cfu/ml while the pH of residual urine was >pH 8.
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Figure 59. P. mirabilis NSM6 biofilm on all-silicone catheters in urine with various citrate concentrations
The micrographs show: (A+ B) the crystalline biofilm at the eye-let of a catheter at 24 h in an infected model supplied with 0.41 g/L 
citrate; (C+D) the non-crystalline biofilm at 24 h on the eye-let of catheter ffom model supplied with 1.0 g/L citrate.
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Figure 60. P. mirabilis NSM6 biofilm on all-silicone catheters in urine with various citrate concentrations
u> The micrographs show: (A+ B) the non-crystalline biofilm at the eye-let of a catheter at 24 h in an infected model supplied with 1.5 
g/L citrate; (C+D) the non-crystalline biofilm at 24 h on the eye-let of catheter ffom model supplied with 2.0 g/L citrate.
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Figure 61. P. mirabilis NSM6 biofilm on all-silicone catheters in urine 
with various citrate concentrations
The micrographs show: (A) the non-crystalline biofilm (arrow) at the eye-let bevel of a 
catheter at 24 h in an infected model supplied with 3.0 g/L citrate; (B) a high magnification 
image of the non-crystalline biofilm at 24 h on the eye-let of the same catheter.
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Figure 62. P. mirabilis NSM6 biofilm on all-silicone catheters in urine with various citrate concentrations
The micrographs show: (A) the micro-crystalline deposits (arrow) present at the eye-let o f a catheter at 48 h in infected bladder model; (B) the crystalline biofilm (arrow) on 
same catheter on the lumenal section just below the eyehole (models were supplied with urine containing 1.0 g/L citrate); (C+D) the non-crystalline and crystalline areas of 
biofilm respectively at 48 h on the eye-let o f a catheter from a bladder model supplied with urine containing 1.5 g/L citrate.
Figure 63. P. mirabilis NSM6 biofilm on all-silicone catheters in urine with various citrate concentrations
The micrographs show: (A+ B) the non-crystalline biofilm at the eye-let and lumenal section respectively o f a catheter at 48 h in an infected model supplied with urine 
containing 2.0 g/L citrate; (C+D) the non-crystalline biofilm on the eye-let at 48 h on a catheter from a bladder model supplied with urine containing 3.0 g/L citrate.
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Figure 64. P. mirabilis NSM6 biofilm on all-silicone catheter surfaces in urine containing 1.5 g/L citrate at 7 days
The micrographs show the differentiated nature o f the biofilm observed on catheters at 7 days. (A+B) show the rafts o f swarmer-like cells (arrows) at the lumenal 
section just below the retention balloon. (C) shows the underneath o f the ‘foundation layer’ (arrow) with crystalline biofilm visible through the fractured layer. (D) 
shows an area o f typical P. mirabilis crystalline biofilm on the catheter lumen.
oo Figure 65. P. mirabilis NSM6 biofilm on all-silicone catheter surfaces in urine containing 2.0 g/L citrate at 7 days
The micrographs show: (A+B) high and low magnification o f an area o f biofilm on the lumenal section just below the retention balloon; (C) the rare microcrystals 
observed on the lumen; (D) elongated cells at another site on the catheter lumen.
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^  Figure 66. P. mirabilis NSM6 biofilm on all-silicone catheter surfaces in urine containing 3.0 g/L citrate at 7 days
The micrographs show: (A-D) low and high magnification o f the typical crystalline-free biofilm at various sites on the catheter lumen.
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3.3.3. The effect of elevated urinary citrate levels on the rate of catheter encrustation 
caused bv other urease-producing bacteria
The results produced in Sections 3.1. and 3.2. demonstrated that by diluting urine and 
increasing its citrate content a profound effect on the rate of encrustation in P. 
mirabilis infected bladder models could be achieved. Although P. mirabilis is the 
major cause of encrustation and blockage of urinary catheters other urease producing 
organisms can be found in the urine of catheterised patients. Some have been found to 
be capable of generating crystalline biofilm (Kunin, 1989; Stickler et al., 1998b). 
Recently (Broomfield, personal communication) showed that Providencia rettgeri 
SDMI and Proteus vulgaris SDM2 were capable of encrusting and blocking catheters 
rapidly. With this in mind, the following experiments were performed to assess the 
effect of the manipulation of the pHn of urine has on the rate of catheter encrustation 
in laboratory bladder models infected with these organisms.
Bladder models fitted with all-silicone catheters were inoculated with a 10 ml 
inoculum of a 4 h culture of either Providencia rettgeri SDMI or Proteus vulgaris 
SDM2 (approximately 108 cfu/ml). The test strains had previously been isolated from 
the same encrusted catheter. Models were supplied at a flow rate of 1.0 ml/min with a 
1:1 dilution of artificial urine supplemented with 0.205 or 1.5 g/L citrate. Experiments 
were run until catheter blockage or until a maximum of 7 days. The viable cell 
populations and pH of residual bladder model mine were determined at the start of the 
experiment and every 24 h thereafter. The catheter blockage times were recorded.
The mean times the catheters took to block calculated from the results of three 
replicated experiments are presented in Figure 67. In models supplied with urine
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containing 0.205 g/L citrate the median times to catheter blockage for Pv. Rettgeri 
SDMI and P. vulgaris SDM2 were 41.28 ±1.07 h and 59.07 ±15.46 h respectively. 
Statistical analysis (Kruskal -  Wallis test) indicated that the median values were not 
significantly different (P >0.05). In the bladder models supplied with urine containing 
1.5 g/L citrate two of the three catheters in models infected with Pr. rettgeri SDMI 
drained freely for the full 7 days. The third replicate blocked at 108 h. All three 
catheters in models infected with P. vulgaris SDM2 remained patent for the whole 7 
days.
The mean viable cell populations and pHs of the residual bladder model urines (Table 
12) showed that at times Pv. rettgeri SDMI was able to reach higher cell densities and 
generate more alkaline conditions in the models than P. vulgaris SDM2. Mean viable 
cell populations in residual urine from Pv. rettgeri SDMI infected models varied 
between 108 and 109 cfu/ml, while mean viable cell populations in residual urine from 
P. vulgaris SDM2 infected models varied between 107 and 108 cfu/ml. Mean pH 
values of residual urine in Pv. rettgeri SDMI bladder models frequently exceeded pH 
9 while mean pH’s of residual urine in P. vulgaris SDM2 infected models reached 
values which exceeded pH 8.
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Did not block
Pv. rettgeri 
P. vulgaris
0.205 g/L 1.5 g/L
Citrate content of urine supplied to models
Figure 67. The effect of urinary citrate content on the rate of catheter blockage by P. vulgaris SDM2 and Pv. rettgeri SDMI
Bladder models fitted with all-silicone catheters were inoculated with 10 ml of a 4 h culture of the test strains and supplied at 1.0 ml/min 
with urine containing 0.205 and 1.5 g/L citrate. The standard error of the mean blockage times of three replicated experiments is shown.
* Two of the three catheters drained freely for the 7 day experimental period.
Test
organism
M ean viable cell population  (x 108 cfu/m l) and  pH  of residual u rine  th ro u g h o u t experim ents (h)
Start 24 48 72 96 120 144 168
P. vulgaris 
SDM2 
0.205 g/L 
citrate
4.2 ± 0.35 0.76 ± 0.04 2.1 ± 0.85 f - - - - -
pH 8.59
±0.09
pH 8.13
±0.15
pH 8.82 f
±0.05
- - - - -
Pv. rettgeri 
SDMI 
0.205 g/L 
citrate
4.0 ±0.8 3.1 ±1.2 - - - - - -
pH 8.23
±0.03
pH 9.1
±0.1
- - - - - -
P. vulgaris 
SDM2 
1-5 g/L 
citra te
4.1 ±0.47 2.9 ±1.06 3.0 ± 0.92 1.9 ± 1.15 1.5 ±0.32 0.74 ±0.11 0.82 ± 0.29 0.80 ± 0.29
pH 8.43
±0.09
pH 7.67
±0.12
pH 8.6
±0.06
pH 8.51
±0.13
pH 8.65
±0.03
pH 8.7
±0.02
pH 8.74
±0.07
pH 8.67
±0.14
Pv. rettgeri 
SDMI 
1-5 g/L 
citrate
4.7 ± 1.1 6.6 ±3.3 5.1 ± 0.86 3.7 ± 0.95 13.0 ±0.59 6.2 ± 0.9 2.5 ± 1.6 0.94 ±0.05
pH 8.27
±0.21
pH 8.75
±0.04
pH 8.89
±0.04
pH 9.04
±0.03
pH 9.09
±0.04
pH 9.14
±0.01 t
pH 9.09
± 0.12 f
pH 9.03
±0.13 f
( t )  mean based on two replicates, (-) indicates that by this time all models had blocked
u> Table 12. Mean viable cell population and pH of residual urine in P. vulgaris SDM2 and Pv. rettgeri SDMI infected bladder models
Models were fitted with all-silicone catheters and inoculated with 10 ml of a 4 h culture of P. vulgaris SDM2 or Pv. rettgeri SDMI (approximately 108 
cfu/ml). Experiments were supplied at 1.0 ml/min with 1:1 diluted artificial urine containing 0.205 or 1.5 g/L citrate. The mean ± SE of the mean 
calculated from three replicated experiments are shown.
Resul ts
3.4. The manipulation of urinary pHn through increased dietary fluid and 
citrate intake and its effect on the rate of catheter encrustation
The results reported in Section 3.3. showed that the manipulation of the pHn of 
artificial urine by its dilution and increase in its citrate content, had a significant effect 
on the rate of catheter encrustation in laboratory bladder models. Seltzer et al. (1996) 
previously reported that individuals prone to calcium nephrolithiasis who were ‘hypo- 
citraturic’ became ‘normo-citraturic’ after consuming regular lemonade drinks 
containing a high citrate content. More recently Siener et al. (2005) showed that strict 
dietary management significantly altered the urinary composition, reducing the stone 
formation in recurrent calcium oxalate stone-formers. Suller et al. (2005) showed that 
the pHn and citrate content of urine in healthy volunteers could be manipulated by 
increasing their fluid intake and by supplementing their diet with regular citrate 
containing drinks. As dietary manipulation of urinary composition can be beneficial to 
urolithiasis it may also be effective in controlling the problem of calcified formations 
on urinary catheters. The aim in this section was to investigate the effect that the 
dietary manipulation (based on the methods described by Seltzer et al., 1996 and 
Suller et al., 2005), would have on the pHn of urine and the rate of catheter 
encrustation when this urine was supplied to catheterised laboratory bladder models.
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3.4.1. Urine profiles of healthy volunteers
Initially the urine profiles of five healthy volunteers were determined. The data was 
used to examine the variability in urine composition among individuals and also to 
determine any ‘abnormalities’ in the urinary composition of the volunteer intended to 
be utilized in further experiments. There were no dietary or lifestyle restrictions 
imposed. Urine samples from each individual were collected between 0600 -  1700 
hours on three separate days. Urinary parameters including the voided pH (pHv), the 
nucleation pH (pHn), the pH safety margin (pHn - pHv), calcium, magnesium and 
citrate content were established for each urine void. The volume of urine voided on 
each occasion was also recorded.
The urinary profiles determined for all volunteers (Table 13) illustrate the variability 
of urinary parameters observed among those examined. The mean pHs of voided 
urines ranged from pH 5.75 -  6.72, mean pHns ranged from pH 6.77 -  8.02 and the 
mean pH safety margins varied between 0.29 to 1.74 pH units. The mean urine output 
among volunteers ranged from 706 to 1881 ml over the 11-hour sampling period. 
Mean magnesium concentrations recorded in urine were similar amongst volunteers 
ranging from 0.04 -  0.07 g/L, while mean calcium concentrations in urine showed 
more variability ranging from 0.05 to 0.22 g/L. The mean citrate concentrations 
among urines ranged from 0.25 -  0.37 g/L. The mean values for the amount of Ca, 
Mg and citrate excreted by individuals during the sampling period ranged from 0.08 -  
0.22 g, 0.035 -  0.09 g and 0.18 -  0.56 g respectively, an approximate 3-fold variation 
between the lowest and highest excretions in all three parameters. Volunteer 1 was 
used in all subsequent fluid and citrate intake experiments.
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U rinary  profiles o f healthy volunteers
V olunteer pHv pHn pH margin 
(pH„-pHv)
Urine
output
(ml)
[Ca]
g/L
[Mg]
g/L
|Citrate]
g/L
Ca
excreted
(g/Hh)
Mg
excreted
(g/llh)
Citrate
excreted
(g/llh)
1 5.75
±0.19
7.25
±0.07
1.5
± 0 . 2 2
706
±71.6
0.17
±0.015
0.07
± 0.008
0.25
± 0.023
0.12
± 0 . 0 2
0.049
± 0.007
0.18
±0.07
2 6.03
±0.16
7.76
±0.16
1.74
±0.19
1335
± 222.05
0.08
±0.017
0.04
± 0.007
0.31
±0.05
0.08
±0.04
0.035
± 0.008
0.34
±0.07
3 6.72
± 0 . 2 2
8.02
± 0 . 1 2
1.3
± 0 . 2 2
1881
± 162.5
0.05
± 0.008
0.049
± 0.008
0.33
±0.05
0.1
±0.06
0.09
± 0.027
0.56
±0.09
4 6.31
0.18
6.77
± 0 . 1 2
0.47
±0.15
795
±54.1
0.22
±0.016
0.051
± 0.008
0.37
±0.07
0.18
± 0 . 0 1
0.039
± 0 . 0 1 1
0.22
±0.04
5 6.5
± 0 . 1 1
6.79
± 0 . 1
0.29
±0.07
1183
± 224.5
0.19
±0.017
0.05
± 0.006
0.28
±0.04
0.22
±0.04
0.058
± 0.008
0.31
±0.06
Table 13. The * mean values of urinary constituents and parameters of 5 healthy volunteers
Urine was collected between 0600 -  1700 hours on three separate occasions for each volunteer. *The means ± SE of the means were calculated 
from the results of three replicated sampling periods.
Resul ts
3.4.2. The effect of increased citrate intake on urinary citrate and pHn
The next step was to identify a commercially available soft drink high in citrate 
content to use as a dietary supplement in the experiments to manipulate pHn. The 
citrate content of a selection of commercially available soft drinks was assessed using 
the citrate assay kit described in Section 2.16.1. Samples (1 ml) were filtered through 
a 0.2 p/m Minisart micropore filter (Sartorious) to remove any large particles from the 
sample before testing. The results of the citrate assays on the test fruit juices are 
presented in Table 14. It is clear that the juices from lemons and limes contains 
substantially more citrate than the other fruits.
A selection of juices with high citrate content were then considered for inclusion in 
the experimental citrate drink. After a series of informal tasting sessions it was 
decided that the citrate drink would consist of a mixture of lemon and orange juice at 
a ratio of 1:4 respectively. A total of 750 ml of the lemon/orange drink was consumed 
by a healthy volunteer in 250 ml aliquots at three evenly spaced intervals throughout 
the day (morning, afternoon and evening), supplementing the daily diet with 
approximately l lg  of citrate. The routine was implemented for four days with all 
urine voided between (0600 -  1700 hrs) on days two, three and four collected. No 
other restrictions on diet or lifestyle were enforced. The urinary profile of the 
volunteer was determined after the citrate drink regimen and compared with the 
urinary profile obtained previously from the same volunteer under normal dietary 
conditions (Section 3.4.1.). The mean citrate concentration in urine and also the total 
(mean) daily citrate excreted under the normal and increased citrate diets within the 
sampling period are shown in Figure 68. Comparison of mean pHv, pHn, pH safety 
margin and urine output before and after the citrate diet are shown in Figure 69.
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Although citrate concentrations (g/L urine) were consistently higher in urine samples 
obtained on the increased citrate diet compared to those on the normal diet, difference 
in the mean values were not significant (P = 0.09). The mean values of total citrate 
excreted in urine over the 11-hour sampling period were higher in urine voided on the 
citrate supplemented diet but again not significantly different (P = 0.11). There were 
no significant differences in pHv (P > 0.05 Kruskal-Wallis analysis), and no 
significant differences (P > 0.05) between mean pHn values (pH 7.26 ± 0.07 before 
citrate diet, 7.46 ± 0.09 after citrate diet). When the mean pH safety margins of urine 
before and after the citrate diet (1.50 ± 0.22 and 1.44 ± 0.2 respectively) were 
compared the values were not significantly different (P > 0.05). Comparisons of both 
Ca and Mg concentrations in urines before and after the citrate diet (not shown) also 
indicated there were no significant differences (P  > 0.05). The mean volumes of urine 
voided were 706 ± 71.6 ml and 810 ± 86.9 ml before and after consumption of the 
citrate drink respectively, and were not significantly different (P = 0.41).
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T ype o f ju ice M ean c itra te  conten t g/L
Coleman’s Lime Jif 58.7 ±4.35
Tesco Lemon Juice 44.9 ±4.15
Del Monte Pure Grapefruit Juice 12.7 ±0
Tesco Raspberry & Pear Juice 1 . 6  t
Tesco ‘Pure Florida’ Orange. & 
Grapefruit
7.2 t
Tesco Pure Pink Grapefruit Juice 12.9 ±0.2
Tesco ‘Pure Florida’ Orange Juice 7.0 ± 0.2
Table 14. The *mean citrate content of a range of commercially available 
fruit juices
* The means ± SE of the means (unless otherwise stated) were calculated from two 
replicated assays, f  result from single assay.
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Figure 68. The *mean citrate concentration and mean (total) citrate excreted in 
urine
Urine was collected between 0600 -  1700 h on three separate occasions. (A) shows the mean 
citrate concentration in voided urine under the normal and increased citrate regimen. (B) 
shows the mean of the total citrate excreted on the normal and increased citrate diets. * The 
means ± SE of the means calculated from the results of three replicated sampling periods are 
illustrated.
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Figure 69. The *mean voided urine pH, nucleation pH and volume of urine collected from a healthy volunteer during periods of 
normal and elevated intakes of citrate
All voided urines were collected between 0600 -  1700 on 3 separate occasions before and after consuming 3 daily doses of the citrate drink. 
*The means ± SE of the means calculated from the results of three replicated sampling periods are indicated.
Resul ts
The citrate drink consumed by the volunteer in the experiments reported in Figure 68 
and 69 was often consumed in place of the ‘normal’ fluid intake, the result being that 
a marked increase in fluid output was not achieved. In the case of elderly catheterised 
individuals with generally very low daily fluid intake and concentrated urine, it was 
intended that the inclusion of a citrate drink should form an addition to their normal 
fluid consumption, and not be a substitute for their normal fluid intake. With this in 
mind, experiments were performed to determine if the citrate-containing drink used in 
addition to a standardised fluid intake would have any significant effect on urinary 
parameters. The volunteer was subjected to three different fluid intake routines lasting 
a total of 4 days per regimen. The routines consisted of a standardised fluid intake of 
1300 ml per 24 h (SFI), the standardised fluid intake with 750 ml of additional water 
(2050 ml per 24 h, SFI + W), and the standardised fluid intake with an additional 750 
ml of the citrate containing drink (2050 ml per 24 h, SFI + C). No other dietary 
restrictions were enforced. Urine voided between 0600 and 1700 h on days 2 - 4  was 
collected and Ca, Mg, citrate, pHv, pHn, pH safety margin and urine volume 
determined for independent urine voids in each 11- hour period. A break of at least 
three days was allowed between the different dietary routines.
The results of the mean urinary Ca, Mg and citrate concentrations and mean pHv, pHn, 
pH safety margin and urine output are presented in Figure 70 and 71. Statistical 
analysis (ANOVA) of the data revealed there were no significant differences (P > 
0.05) in the mean calcium concentrations (g/L) or total (mean) calcium excreted (g) 
under the different dietary regimes. There was no significant difference in total 
(mean) magnesium excreted in urines under the different diets, although Kruskal- 
Wallis analysis of median values (non-parametric) indicated magnesium was
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significantly more concentrated (P < 0.05 at the 97.5% Cl level) in urine from the SFI 
diet. The mean citrate concentration in urine from the SFI + W regimen (0.17 ± 0.02 
g/L) was found to be significantly higher (P < 0.05) than that recorded in urine from 
the SFI + C regimen (0.12 ± 0.01 g/L). This may have been due to the increased 
volume of urine voided under the SFI + C diet however (1578 ± 67.23 ml), compared 
to the SFI + W diet (1266 ± 129.91 ml), because when their respective mean values of 
total citrate excreted were compared the difference was not significant (P > 0.05). The 
mean citrate excreted under SFI + W however, was significantly higher (P < 0.05) 
than citrate excreted under SFI regimen.
The mean pHs of voided urine ranged from pH 5.5 -  pH 6 and was highest in urine 
collected under the SFI + C diet. When the nucleation pHs were determined for the 
different urines the mean pHnS were 7.25 ± 0.12, 7.59 ± 0.17 and 8.05 ±0.12 from 
SFI, SFI + W and SFI + C routines respectively and was significantly higher (P < 
0.05) under the SFI + C regimen than under the SFI diet. The mean pH safety margins 
were 1.74 ± 0.12, 2.19 ± 0.14 and 2.29 ± 0.14 pH increments for urine collected 
under the SFI, SFI + W and SFI + C routines respectively. The mean value for the 
urine collected under the SFI + C regimen being significantly higher (P < 0.05) than 
that collected on the SFI diet. Statistical analysis also showed that the mean volume of 
urine voided under the SFI regimen was significantly lower (P < 0.05) than that 
voided on SFI + W and SFI + C diets.
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Figure 70. The *mean Ca, Mg and citrate concentration in urine and *mean total Ca, 
Mg and citrate excreted under different fluid intake regimens
Urines were collected between 0600 -  1700 h on three separate occasions under the different 
fluid intake regimens. (A) shows the mean Ca, Mg and citrate concentrations in the different 
urines. (B) shows the total Ca, Mg and citrate excreted during the same period. *The means ± 
SE of the means calculated from three replicated sampling periods are indicated.
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Figure 71. The *mean pHv, pHn urine output and pH safety margin of urines 
voided under different fluid intake regimens
All voided urine was collected between 0600 -  1700 hours on 3 separate occasions for each 
dietary regimen. (A) shows the mean pHv, pH„, and urine output. (B) shows the mean safety 
margin (pHn -  pHv) in pH increments. *The means ± SE of the means calculated from three 
replicated sampling periods are indicated.
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3.4.3. The effect of increased fluid and citrate intake on the rate of catheter 
encrustation
The results presented in Figure 71 show that by increasing the fluid and citrate intake 
it is possible to elevate significantly the pHn of the resulting urine and the margin 
between its pHv and pHn. It is therefore now possible to test the hypothesis that 
increasing the pHn of human urine in this way will reduce the rate at which catheters 
are encrusted by P. mirabilis.
The healthy volunteer was subjected to the three dietary regimens described in 3.4.2. 
These regimens involve an increase of fluid intake of 750 ml. This is a modest 
increase compared to that suggested by Seltzer et al. (1996) as a treatment for kidney 
stones. These authors reported that the daily consumption of an extra 2 L in the form 
of lemonade, effectively reduced stone-forming potential. A fourth regimen based on 
that devised by Seltzer et al. (1996) was therefore given to the volunteer. This 
involved a fluid intake of 140 ml lemon juice (Tesco) and 250 ml Summer fruit drink 
(Tesco, used to aid palatability), made up to a final volume of 2 L with tap water. This 
supplemented the diet with a daily citrate dose of approximately 6.0 g/L. Dietary 
routines were started 24 h before the first urine sample was collected. All voided urine 
over a 48 h period between days 2 and 3 of each regimen was collected and pooled. 
The dietary regimens were repeated on three independent occasions for each fluid 
intake routine, with a rest period of at least 4 days between the end of one routine and 
the start of another. The volunteer was encouraged not to change any other aspects of 
their dietary or lifestyle habits.
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The pooled urines were filter sterilized, firstly through cotton wool to remove large 
debris, and then through a 0.8 pm and finally 0.2 pm micro-pore filters (Sartorious). 
Aliquots (40 ml) of the filtered urine were taken for determination of pHn. A sample 
(5 ml) was removed for AAS determination of calcium and magnesium content, and a 
further 5 ml sample removed for citrate and pHv determination. Total urine output 
over the 48 h period was also recorded The sterilized urines were supplied at a 
standard flow rate of 720 ml/24 hours (0.5 ml/minute) to bladder models fitted with 
all-silicone catheters and inoculated with 10 ml of 4 h culture of P. mirabilis NSM6 
(approximately 108 cfu/ml). Experiments were based on three replicates for each urine 
type with mean times to catheter blockage recorded. Viable cell populations and pHs 
of voided bladder model urine were taken at the start of the experiment and at 24 h 
intervals thereafter.
Table 15 shows the profiles and characteristics of the urine collected during the four 
different dietary regimens. The mean values of pHv ranged from pH 5.91 to pH 6.77 
but were not significantly different (P > 0.05) from each other. The mean pH safety 
margins were also not significantly different (P > 0.05), ranging from pH units of 1.1. 
in urine collected under the SFI + C regimen to 1.81 in the urine collected under the 
lemonade diet. The mean nucleation pH of the urine however, increased significantly 
(P < 0.05) between urine voided under the SFI diet (pH 7.27 ± 0.15) compared to 
urine voided under the lemonade diet (8.10 ± 0.17). The mean urine output per 48 h 
under the different dietary conditions ranged from 3633 ± 90 ml under the SFI diet to 
7433 ± 230 ml under the lemonade diet. Statistical analysis (ANOVA) revealed that 
the mean volume of urine voided under the lemonade diet was significantly higher (P 
< 0.05) than that of the other dietary regimens. The mean urine output under the SFI + 
C regimen was also significantly higher than urine output under the SFI routine (P <
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0.05). Statistical analysis revealed the mean Ca concentration in urine (ANOVA) and 
median values of total Ca excreted under each regimen over the 48 h period (Kruskal 
-Wallis) were not significantly different {P > 0.05). The mean Mg concentration was 
significantly higher (P < 0.05) in SFI urine compared to SFI + C urine and urine 
voided under the lemonade diet, but the mean total amounts of Mg excreted over the 
three 48 h periods were not significantly different (P > 0.05) among urines. Although 
there was considerable disparity in the amount of citrate consumed among the dietary 
regimens, statistical analysis revealed there were also no significant differences (P > 
0.05) in mean citrate concentrations or in mean values of total citrate excreted over 
the 48 h periods.
The mean times all-silicone catheters took to block in bladder models supplied with 
the pooled urine from the different dietary regimens are presented in Figure 72A. The 
mean catheter blockage times were: 25.22 ±5.11 h (SFI); 35.56 ± 2.27 h (SFI + W); 
44 ± 8.14 h (SFI + C) and 118.08 ± 20.06 h (lemonade diet). Although variability was 
observed in the mean lifespan of catheters, differences were not significant (P > 0.05) 
among mean catheter blockage times in bladder models supplied with urine collected 
under the SFI, SFI + W and SFI + C regim ens The mean lifespan of catheters in 
bladder models supplied with urine from the lemonade diet however, was 
significantly (P < 0.05) longer compared to that from models supplied with urine from 
the three other regimes.
The individual blockage times of each specific catheter were plotted against the pHn 
of the urine supplied to its respective bladder model (Figure 72B). Pearson’s 
correlation performed on the log of the urine pHn versus the log of the catheter
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blockage time indicated that the correlation between urinary pHn and the rate of 
catheter encrustation was highly significant (P < 0.001, correlation coefficient value 
0.844). The mean pH and mean viable cell populations from residual bladder model 
urine during the course of experiments (Table 16) show that the mean cell densities in 
residual urine remained between 107-108 in all bladder models, while the mean pH’s 
of the bladder model urine in the experiments remained above pH 8 and were 
consistently > pH 8.5 at time of catheter blockage.
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Constituents and parameters of voided urine
U rine
type pHv pH„ pH safety margin
Urine 
output 
(ml/48 h)
|Ca]
g/L
|Mg]
g/L
[Citrate]
g/L
Excreted 
Ca 
(g/48 h)
Excreted 
Mg 
(g/48 h)
Excreted 
citrate 
(g/48 h)
SFI 5.91
±0.26
7.27
±0.15
1.36
±0.09
3633
±90
0.076
±0.03
0.059
± 0 . 0 1
0.16
± 0 . 0 2
0.28
± 0 . 1 0 1
0.21
±0.03
0.58
±0.06
SFI + W 6.1
± 0 . 2 1
7.7
±0.09
1.61
± 0 . 2 2
4116
± 160
0.046
± 0.003
0.048
± 0.008
0.19
±0.03
0.19
± 0 . 0 2
0.2
±0.04
0.78
±0.15
SFI + C 6.77
±0.05
7.86
±0.19
1.1
±0.17
4833
±320
0.093
± 0.023
0.032
± 0.004
0.23
±0.05
0.48
±0.06
0.16
± 0 . 0 1
1.1
±0.18
Lem onade
diet
6.29
±0.35
8.10
±0.17
1.81
±0.23
7433
±230
0.04
t
0.023
± 0.003
0.12
± 0 . 0 2
0.17
±0.019
0.3
± 0 . 0 1
0.88
±0.16
SFI = standardised fluid intake (1300ml/24 hours), SFI + W = standardised fluid intake + 750 ml water, SFI + C = standardised fluid intake + 750 ml citrate drink, Lemonade 
diet = 2L o f lemonade drink + any other fluid consumed t  all 3 values 0.04 g/L
Table 15. The effect of four different fluid and citrate intake routines on the characteristics of urine
Urine was collected over 48 h and pooled. This was performed on three separate occasions for each fluid and citrate intake regimen. The means 
± SE of the means were calculated from the results of three replicated sampling periods.
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Figure 72. (A) The *mean times to catheter blockage in bladder models supplied with
urine voided from various dietary conditions and infected with P. mirabilis 
NSM6 (B) correlation of the urine pHn with catheter blockage times
Bladder models fitted with all-silicone catheters and inoculated with P. mirabilis NSM6 were 
supplied with 48 h pooled urine from different dietary routines. (A) * the means ± SE of the the 
means were calculated from three replicated experiments. (B) shows the relationship between 
urinary pHn and catheter blockage time.
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Fluid intake
Mean viable cell populations (cfu x 108 cfu/ml) and pH’s of bladder model urine at various times (h) throughout experiments
0 24 48 72 96 120 144
SFI
2.3 ± 0.46 0.92 ± 0.06 
t t
- - - - -
pH 8.53 ± 0.09 pH 8.92 ±0.1 
t t
- - - - -
SFI +W
1.67 ±0.56 1.55 ±0.89 - - - - -
pH 8.4 ±0.14 pH 8.93 ± 0.05 - - - - -
SFI + C
1.36 ±0.24 1.2 ± 0.36 0.96
t
pH 8.62 ± 0.04 pH 8.95 ±0.08 pH 9.02
t
- - - -
2 L 
lem onade
1.96 ± 0.3 0.75 ± 0.03 0.65 ±0.14 0.61 ±0.14 0.99 ±0.31 
t t
3.0 ±1.5 
t t
-
pH 8.84 ±0.12 pH 8.91 ± 0.09 pH 8.9 ± 0.08 pH 8.98 ± 0.08 pH 9.02 ± 0.02
t t _____
pH 9.02 ± 0.09
t t
-
Table 16. The *mean viable cell populations and *mean pH’s of residual urine in bladder models infected with P. mirabilis NSM6 and supplied with pooled urine voided
under various fluid intake regimens
Bladder models were inoculated 10 ml of a 4 h culture of P. mirabilis NSM6. * The means ± SE of the means (unless otherwise stated) were calculated from the results o f three replicated 
experiments, (t) one replicate only ( f t )  means based on values from two replicates (-) all models had blocked.
4. Discussion
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4. Discussion
The early stages in the process of biofilm formation on indwelling urological devices 
are not well understood. In the cases of prosthetic devices implanted into the vascular 
system or as joint replacements, there is strong evidence that the initial step is their 
rapid coating with the host proteins such as albumin, fibrinogen, fibronectin and 
laminin from body fluids (Donlan and Costerton, 2002). There is some evidence to 
suggest that similar events occur when devices are exposed to urine. Ohkawa et al. 
(1990) noticed that fibrillar deposits were present on the surfaces of almost all 
indwelling urethral catheters removed from patients after <3 days. They used 
immuno-fluorescent staining and microscopy to demonstrate these deposits consisted 
of fibrin. In another study Santin et al. (1997) showed proteins including albumin and 
a-1-microglobulin were present on the surfaces of ureteral stents removed from 
patients.
A study of the early stages of catheter encrustation by crystalline biofilm in patients 
would require the insertion and removal of catheters at intervals over the first few 
hours of their placement. This would be a clinically unnecessary invasive intervention 
and ethical considerations would make such a study difficult to perform. One 
advantage of the bladder model is that catheters can be inserted and removed for 
examination at will. The experiments can also be performed under standardized, 
reproducible conditions that are impossible to achieve in a clinical investigation.
In patients suffering from recurrent catheter encrustation and blockage, catheters are 
exposed immediately on placement to alkaline urine cultures of P. mirabilis. Under 
these circumstances the urine will contain crystalline material in addition to bacterial
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cells. The conditions chosen for the experiments in the bladder model were intended 
to simulate these circumstances. The process was observed on a range of catheters 
manufactured from latex and silicone and on devices impregnated with antimicrobial 
agents. The catheterised bladder model was used in conjunction with a variety of 
scanning electron microscopy techniques and X-ray microanalysis. These methods 
provided substantial information about the early stages of P. mirabilis crystalline 
biofilm development under conditions intended to reflect the circumstances applying 
in patients who are enduring the complication of recurrent catheter encrustation.
4.1. The development of crystalline Proteus mirabilis biofilms on indwelling 
urinary catheters
The results of the initial set of experiments reported in Figure 5 and Tables 1 and 2 
show that when all the currently available catheters were inserted into bladder models 
containing residual urine at pH 8.5 and P. mirabilis at 108 cfu/ml they block within 40 
hours. These findings confirm those reported by Morris et al. (1997) and Morris and 
Stickler (1998a), that P. mirabilis rapidly blocked AS, SCL, HCL and HSCL catheters 
with crystalline biofilm. This present study demonstrated that catheters impregnated 
with nitrofurazone were also vulnerable to blockage with P. mirabilis crystalline 
biofilm. In contrast, AS and HCL catheters inflated with triclosan were not affected 
by crystalline biofilm and drained freely for the 7-day experimental period. It was also 
significant that the pH of the urine in models fitted with the triclosan impregnated 
catheters dropped rapidly from 8.5 to between 6.0 -  6.5 within 4 h and remained acid 
for the 7-day experimental period. In the case of the HCLT catheter the number of 
viable cells in the residual urine dropped from 108 cfu/ml to 103-106 cfu/ml. The AST 
catheter had an even greater bactericidal effect. While the mean number of viable
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cells present at the start of the experiment was 2 x 108 cfu/ml, at 4 h and thereafter for 
7 days no viable cells were recovered from the urine. Catheters inflated with triclosan 
are clearly able to resist P. mirabilis crystalline biofilm development, these results 
confirming the findings of Stickler et al. (2003a).
4.1.1. Observations on the development of catheter encrustation using LVSEM
The examination by LVSEM of catheters removed from the models at 1 h, 4 h, 12 h, 
and at blockage or 7 days revealed the development of the encrustation around the 
eye-lets and on the lumenal surfaces. The striking feature of the micrographs is that 
although there are signs of encrustation after 1 h on most of the catheters, little further 
accumulation of crystalline material seems to take place in the next 11 h. It is after 12 
h that the bulk of crystalline biofilm develops. The results presented in Table 2 show 
that in all cases when the supply of urine is turned on, the pH of the residual urine in 
the bladder chamber drops. It is only after 12 h that the pH rises to around 8.0 and 
above. The higher the urinary pH is above its nucleation pH (pHn) the more calcium 
and magnesium will be deposited from the urine (Suller et al., 2005), thus explaining 
the accelerated encrustation after 12 h.
The experiments with the NF catheters are interesting as they suggest little if any 
encrustation takes place in the first 12 h, by 29 h however, the eye-holes and central 
channels are blocked by extensive crystalline deposits. The results presented in Table 
2 show that from 2 - 4 h the urinary pH fell below its pHn of 6.7 (Figure 25), by 12 h 
it has recovered to 7.4 and by 18 h to 8.3. The viable cell count also drops below 107 
cfu/ml in these cultures until 18 h (Table 1). These results suggest that the 
nitrofurazone eluting from these catheters has an initial effect, perhaps temporarily
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slowing the growth of P. mirabilis in the continuous culture system. It is clear that by 
18 h the culture has recovered and encrustation is proceeding rapidly. It is possible 
that the majority of the nitrofurazone contained in these catheters elutes over the 
initial 12 h. This seemed to be the case as it was clear from observations that the 
voided urine in these experiments displayed a strong yellow pigmentation 
(nitrofurazone is yellow in colour) over this period. It is likely that most of the 
nitrofurazone eluted from the catheter in this time, after which P. mirabilis was able 
to proliferate rapidly, returning the residual urine to > pH 8.0. The micrographs of the 
triclosan-treated catheters confirm that at 7 days there was no sign of encrustation on 
the eye-lets or in the lumen. It is likely therefore that these catheters would drain 
freely for considerably longer than the 7-day experimental period.
4.1.2. Observations on the development of crystalline catheter biofilms using 
HVSEM
The surfaces of unused catheters were examined using HVSEM (Figures 11 and 12) 
and showed that a variety of surface-associated irregularities were present among the 
catheter types. The rough nature of catheter surfaces was previously described by 
Stickler et al. (2003b) who reported that rough areas of catheter surfaces encouraged 
bacterial colonization. They used HVSEM images to show that the P. mirabilis 
colonization of latex-based catheters begins in the crevices and depressions of the 
surfaces around the eye-lets of the catheter. The poor quality of the surface at the eye­
lets of catheters is caused through the mechanical insertion of the eyehole and was 
evident on all catheters in this present study. Apart from physically ‘trapping’ 
bacterial cells, it is possible that the ‘excess’ catheter material that protrudes out from 
the catheter body at the eye-let may act as a nidus for crystal nucleation. The eye-let
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of the AS, NF and HSCL catheters appeared to be much smoother than the 
corresponding areas of SCL and HCL catheters, although they did display some 
surface irregularities. The lumenal sections of the AS catheter also appeared to be 
generally smoother than other catheters. The central channel of the NF impregnated 
catheter (Figure 18A) however, was rough and had a granular appearance which may 
have been a result of the impregnated antimicrobial. The main body of latex-based 
catheters were also extremely rough and often littered with diatomaceous silica- 
skeletons. The source of these silica-skeletons is the diatomaceous earth used in the 
manufacturing process of latex-based catheters to prevent the catheter material 
sticking to specific machine parts during catheter production. If bacterial colonization 
and encrustation of catheters are to be tackled seriously it is fundamental that these 
devices are made to high standards. Stickler et al. (2003b) pointed out that the 
catheters currently available, with their roughly engineered eye-holes and narrow 
central channels are extremely vulnerable to blockage by crystalline biofilm. The 
images presented in Figures 11 and 12 confirm that there is plenty of scope to 
improve catheter design and manufacturing standards.
The HVSEM images presented in Figures 1 3 - 1 6  suggest a common sequence of 
events in the development of the crystalline biofilm on the AS, SCL, HCL and HSCL 
catheters. After only one hour in the models, the catheter surface at the eye-lets and 
the lumen just above the retention balloon is covered with a layer of material that 
seems to be comprised of aggregates of micro-crystals. The material forming this 
“foundation layer” is similar in structure to crystalline forms of calcium phosphate 
found by He et al. (2003). Calcium phosphate (hydroxyapatite) is a fundamental 
composite in the formation of bones and teeth and these workers observed the protein-
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mediated formation of this compound in vitro. The structure of calcium phosphate 
formed here was apparently identical to that of microcrystals forming the “foundation 
layer” shown in Figures 13 - 16. Subsequently X-ray microanalysis confirmed that 
this layer was comprised predominantly of calcium and phosphate (Figures 23 and 
24). There was little sign of struvite crystals in the early stage which was not 
surprising as the urine used in these experiments (like real urine) contained higher 
concentrations of calcium than magnesium. Another factor is that calcium phosphate 
precipitates from urine at a slightly lower pH than the magnesium salt (Suller et al., 
2005). Crystal formations on catheter surfaces however, were not exclusive to 
catheters removed from infected bladder models. The HVSEM micrographs of control 
catheters (Figure 19) incubated in sterile urine for seven days showed that crystal 
formations also developed on these catheters. Material resembling crystalline calcium 
phosphate was predominantly observed at the eye-let area (Figure 19 A) which is 
often the area associated with a rough topography. This adds further weight to the 
argument that rough surfaces are likely to act as a foci for crystal nucleation.
The P. mirabilis colonization of these catheters (Figures 13 - 16) also displayed a 
common theme, and microcolonies were observed on the calcified layer on all these 
four catheter types at 4 h. The “foundation layer” however, was not essential for P. 
mirabilis adherence. Isolated patches of the catheter surfaces free of microcrystalline 
deposits were also colonized by P. mirabilis (Figure 17). As was observed with the 
crystalline deposits, the eye-let and lumenal areas just above the retention balloon 
were the first areas to become colonized by bacterial cells. At 18 h these areas of the 
catheters were comprehensively covered with a densely populated P. mirabilis 
crystalline biofilm matrix. The numbers of viable cells adhering to AS, SCL, HCL
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catheter sections (Figure 22) correlated with the HVSEM observations. These 
experiments showed that colonization was heaviest at the eye-let area and first few 
centimetres down the lumen, reaching around 107 cfu/mm catheter length. The 
numbers of viable cells adhering to the lumen 16 cm down from the eye-hole 
generally remained an order of magnitude lower. The results also indicated that cells 
were recovered from the catheter surfaces between 1 -  4 h although HVSEM 
observations at these times showed only low levels of colonization. The increase in 
cell numbers visualized in the HVSEM observations from 12 h onwards generally 
correlated well with the numbers of cells recovered from the catheter sections. It was 
noticed in some instances that the surfaces of P. mirabilis cells initially colonizing the 
HSCL catheter (Figure 16) appeared extremely irregular. Winters et al. (1995) 
demonstrated that P. mirabilis cells can act as a nidus for the nucleation of calcium 
phosphate which envelope the cells as the crystalline biofilm develops. It is possible 
therefore that the uneven nature of the surface was due to calcium phosphate deposits. 
The nature of the deposits on the catheter surface surrounding these cells seemed to 
indicate this was the case. The irregular appearance of these cells however, may have 
been a result of the antibacterial effect of silver eluting from the HSCL catheter. 
Silver is active on a number of cellular targets and is known to react with the amino 
acid residues of proteins and interfere with DNA replication. They have also been 
associated with disruption to membranes, the cell envelope and the cell wall, which 
can manifest in surface abnormalities (Russell et al., 1994; Percival et al., 2005).
The HVSEM observations showing P. mirabilis crystalline biofilm development on 
NF catheters (Figure 18) suggested that encrustation and colonization on this catheter 
was initially delayed. There was no evidence of P. mirabilis colonization on these
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catheters up until 12 h, and any encrustation was negligible. The eye-let and lumenal 
section just above the retention balloon at 12 h was colonized by P. mirabilis 
microcolonies adhering directly to the catheter surface and to isolated patches of 
crystalline material that had accumulated at these sites. However, at 18 h the 
crystalline biofilm was well established and was indistinguishable from the crystalline 
biofilms observed on the other commercially available catheter types at 18 h. As the 
NF catheters went on to block at a mean time of 29.5 it appears that any effect of 
nitrofurazone on P. mirabilis is short-lived and is unable to prevent rapid crystalline 
biofilm formation on these catheter surfaces.
4.1.3. P. mirabilis crystalline biofilm development on triclosan treated catheters
The HVSEM micrographs of crystalline biofilm development on triclosan treated 
catheters (Figures 20 and 21) showed that the microcrystalline “foundation layer” did 
initially form on the surfaces of AST and HCLT catheters. The “foundation layer” 
however, appeared to be transient in its nature. It seemed to dissolve into the 
surrounding fluid as the pH of the residual urine in the bladder chamber became 
acidic. The result of this was a gradual depletion of the “foundation layer” with 
catheters removed from the infected bladder models after 7 days showing very little in 
the way of deposited crystalline material. It was interesting that corresponding 
sections of the NF catheter failed to acquire this early “foundation layer” even though 
the pH of the residual bladder model urine was similar to that observed in the 
triclosan-treated experiments over the initial 4 h. A possible reason for this could be 
due to the release of nitrofurazone from the catheter surface into the urine. If the 
catheter surface becomes unstable and degrades as the nitrofurazone is released,
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crystalline deposits and bacterial cells would be prevented from adhering as they 
would have no permanent surface to colonize.
Significant bacterial colonization of the AST and HCLT catheters failed to develop. 
P. mirabilis colonization of the surfaces of AST catheters was rarely observed and 
consisted of single cells or groups of < 5 cells. No biofilm-associated cells were 
observed on AST catheters even on those removed from 7-day experiments. The 
physical appearance of many of the cells that were present appeared ‘unhealthy’ 
however, which might have been due to the effect of triclosan. A number of cells 
colonizing the lumenal sections of the HCLT catheters also had a similar unhealthy 
appearance. Triclosan has more than one mode of action, but is known to disrupt cell 
wall integrity via inhibition of fatty-acid biosynthesis (Russell, 2004). There were 
instances however, where patches of P. mirabilis biofilm were observed on HCLT 
catheters. These were not crystalline in nature and were found consistently on the eye­
let region of catheters removed at 12 and 18 hours, and at 7 days. Cells within the 
biofilm appeared healthy, which covered small areas of around 200 x 150 pm. 
Previous work by Jones et al. (2004) demonstrated that although triclosan diffused 
through the balloons of latex-based catheters, unlike silicone catheters it did not 
impregnate the catheter material. It is possible that under these circumstances cells 
could colonize these catheters but their subsequent development into mature 
crystalline biofilms was prevented by the bacteriostatic effect of the continued 
diffusion of the triclosan from the balloon into the urine.
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4.1.4. Lessons for catheter design
The rapid development of a calcified “foundation layer” on catheters in these in vitro 
experiments is an important finding. It has implications for the design of catheter 
biomaterials resistant to encrustation. Novel catheters with surfaces aimed at 
inhibiting the formation of the protein “conditioning layer”, preventing bacterial 
adherence or with an antibacterial immobilised to the surface are likely to be 
ineffective. The “foundation layer” would immediately alter the surface property of a 
catheter and allow bacteria to colonize the device in the absence of the “conditioning 
layer”. It would also form a protective barrier between the immobilised antibacterial 
and bacterial cells. It is unlikely that a single catheter material will be developed with 
comprehensive properties allowing it to resist the adherence of host proteins, bacterial 
cells and the foundation layer. The experiments using catheters impregnated with 
triclosan suggested that P. mirabilis crystalline biofilm formation is preventable on 
currently available catheter materials. The antibacterial was effective because it 
quickly reduced bacterial populations in the residual urine, which in turn caused the 
urinaiy pH to drop below its pHn. Alternative antimicrobial catheters would have to 
have similar properties in order to produce effective results. A major concern 
surrounding the use of antimicrobial catheters however, is the persistent exposure of 
bacterial cells to sub-inhibitory doses of the antibacterial agent.
The levels of resistance to triclosan recorded for mutant strains of various species 
have not generally been a concern since when triclosan is used as a disinfectant it is 
usually applied at concentrations way above the MICs (Lear et al., 2002). The 
concentrations that elute into the urine from the catheter balloon however, are close to 
the MICs of clinical isolates (Jones et al., 2006). A strain of P. mirabilis with an MIC
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of 40 pg/ml for triclosan was obtained by exposure to the biocide in the laboratory. 
This strain was able to produce crystalline biofilm and block catheters that had been 
injected with triclosan in the bladder model (Jones et al., 2005). The selection of such 
resistant strains of P. mirabilis in clinical practise would thus undermine the strategy. 
Another potential problem is that one of the species capable of encrusting catheters 
Pv. rettgeri, and at present occasionally found in the catheterised urinary tract, is 
resistant to triclosan (MIC, 64 pg/ml, Broomfield, 2007). There is thus the potential 
that the extensive use of the triclosan strategy could select for resistant mutants of P. 
mirabilis and catheter-encrusting species that are intrinsically resistant. A less 
problematic strategy for encrustation control would be to prevent crystal formation in 
the urine by maintaining the pH of urine below that of its pHn. Achieving this without 
the use of antimicrobials would simultaneously avoid the issue of antimicrobial 
resistance and the need for novel materials that inhibit crystalline biofilm 
development.
4.1.5. Observation of HSCL catheters removed from long-term catheterised patients
The Bardex I.C. hydrogel/silver-coated latex catheter contains metallic silver in a 
gold/palladium coating. The extended and slow release of silver ions from the matrix 
into the surrounding fluid provides antibacterial activity over both internal and 
external surfaces (Davenport and Keely, 2005). Recent studies claiming that the 
antimicrobial layer stops bacterial adhesion and reduces infection have been heavily 
criticised for their poor quality and inappropriate control measures (Brosnahan et al., 
2004). For example, Aheam et al. (2000) reported that HSCL catheters were less 
prone to adherence by Ps. aeruginosa than control catheters. However, the control 
catheters were all-silicone and not a standard hydrogel-coated latex catheter. Catheter
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sections were incubated in minimal media instead of urine, and therefore failed to take 
into account the effect of any conditioning layer developing on the catheter that may 
have altered its surface properties. Furthermore, the effect of a ‘vigorous washing’ 
stage on these two very different catheter materials was also ignored. Previous bladder 
model studies carried out by Morris and Stickler (1998a) clearly demonstrated that P. 
mirabilis rapidly blocks HSCL catheters with crystalline biofilm. The colonization of 
the HSCL catheters by P. mirabilis in these present bladder model studies (Figure 16 
and Figure 17 D) firmly supports these findings. The catheters were coated in a 
calcium phosphate “foundation layer” which was rapidly colonized by P . mirabilis 
cells. The micrographs presented in Figures 27-31 confirm that in patients these 
catheters also become covered in foundation layers. Cells colonize the crystalline 
layer and extensive crystalline biofilm causes rapid catheter blockage.
The information provided in Table 3 illustrates that all the HSCL catheters from 
clinical origin were colonized with multi-species crystalline biofilm. The catheters 
removed from patients 1 and 6, and also a 2nd catheter removed from patient 4, had 
blocked rapidly with crystalline biofilm after insertion (10, 11 and 14 days 
respectively, Figures 2 6 - 1 A  + C, 6 A  + C and 7 A + C). Another catheter had 
multiple bacterial species and significant encrustation after only 5 days in situ (Figure 
30 C + D). The bacteriological examination of the catheter sections removed from the 
devices only confirmed the presence of two urease-producing species (catheters from 
patient 3 and 5). However, all catheters had been stored at 4 °C for a number of 
weeks, and it was possible that a proportion of the bacterial species present in the 
biofilm were no longer viable and could not be isolated. This appeared to be the case 
as HVSEM examination of catheter sections revealed the presence of bacilli and cocci 
shaped bacteria in the biofilm communities of all five other catheters, even though the
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bacteriological studies only resulted in the isolation of coccal species (Figures 27 - 
31). Considering the level of encrustation observed on these catheters it was likely 
that all patients were colonized by urease-producing bacteria. The pH of urine at the 
time of catheter removal from patient 2 (8.0) suggested the presence of a urease- 
producer, while patient 3 who was infected by the urease-producing Pv. rettgeri had a 
urine pH of 9.0. The crystalline material associated with these biofilms were similar 
of that found within in vitro crystalline biofilms and comprised of “rosette-like” 
formations typical of calcium phosphate (Figure 27 A and B and 31 A), and the 
microcrystalline calcium phosphate (hydroxyapatite) accumulations similar to the 
“foundation layer” (Figures 28 A and B, 29 D and 30 C). Large crystals typical of 
those formed by struvite (Figures 28 D, 30 B) were also observed on a number of the 
catheters (Harrison, 1957).
While the sensitivity of organisms such as E. coli and Ps. aeruginosa to silver is 
known (MIC of AgNCb, 8-80  mg/L) there is little information in the literature on the 
sensitivity of P. mirabilis (Chopra, 2007). It would be useful to know the MICs of 
silver ions for a range of urinary tract pathogens especially P. mirabilis and other 
potent urease producers. Chakravarti et al. (2005) reported that catheters fitted with 
silver electrodes connected to a 9 v battery released 0.25 pg/ml of silver ions into the 
residual urine of P. mirabilis infected bladder models, which had a significant effect 
on the rate of catheter encrustation. BARD has not yet provided information on the 
extent of silver released from their catheters. During the present study however, urine 
that had passed through the catheters in the bladder models was collected and assayed 
for its silver content by atomic absorbance spectroscopy. Values of only 0.01 -  0.02 
pg/ml were recorded. These are unlikely to have a significant antibacterial effect.
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4.2. The role of MR/P fimbriae in P. mirabilis crystalline biofilm formation
Little is known about the role of P. mirabilis MR/P fimbriae in the catheterised 
urinary tract especially in the development of P. mirabilis crystalline biofilm on 
catheter surfaces. Previous studies have shown that these type IV fimbriae are 
expressed in the majority of P. mirabilis isolates and are associated with cell- 
aggregation, attachment to surfaces and biofilm formation. MR/P fimbriae have also 
been shown to be an important virulence factor in the infection of the ‘normal’ urinary 
tract (Mobley and Chippendale, 1990; Bahrani et al., 1994; Caliskan, 2004; Jansen et 
al., 2004). It would improve our understanding of P. mirabilis catheter-associated 
urinary tract infection (CAUTI) if the role of these fimbriae in the colonization and 
crystalline biofilm development of urinary catheters was clear.
The availability of a wild type P. mirabilis isolate and its isogenic mrpA mutant 
enabled the investigation of the role of MR/P fimbriae in the early stages of 
crystalline and non-crystalline biofilm formation on all-silicone catheters. Initially the 
bladder model system was used to generate the alkaline conditions similar to the 
catheter replacement events discussed in Section 4.1. The crystalline biofilm on the 
catheters removed from the infected bladder models at various times were examined 
using scanning electron microscopy. In addition to this, the formation of non­
crystalline biofilms by the two test strains was also observed when urine was 
supplemented with a urease inhibitor that kept the urine acidic.
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4.2.1. Expression of MR/P fimbriae in P. mirabilis isolates
Initially twenty-seven P. mirabilis isolates from a range of environmental sources 
including river water, sewage, catheter-biofilm and CAUTI, were tested for the ability 
to produce MR/P fimbriae. The results of the haemagglutination assays presented in 
Table 4 show that all the wild type P. mirabilis isolates tested were able to express 
MR/P fimbriae. This confirmed the findings of Mobley and Chippendale (1990) and 
Caliskan (2004). The results of the haemagglutination assay presented in Figure 32, 
confirmed that the WT and the mrpA mutant P. mirabilis isolates used throughout this 
study were positive and negative for MR/P expression respectively.
4.2.2. Inhibition of urease with fluorofamide
Previously, Morris and Stickler (1998b) reported that fluorofamide is a potent 
inhibitor of P. mirabilis urease and is effective in preventing catheter encrustation 
without having bactericidal effects. It was decided that fluorofamide would be the 
urease inhibitor used in this present study to observe biofilm development by the test 
strains in the absence of crystal formation. The results of the 4 h batch culture 
experiments incubated at 37 °C (Section 3.2.2) indicated that 4 pg/ml of fluorofamide 
was able to inhibit P. mirabilis urease action. Cultures incubated under these 
conditions reached >108 cfu/ml (not shown) but remained acidic (<pH 6.5) preventing 
the urinary pH from exceeding the pHn (~pH 6.7).
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4.2.3. Preparation of WT and mrpA cultures for bladder model experiments
Cultures used in bladder model experiments that were designed to determine the role 
of MR/P fimbriae in crystalline biofilm formation were grown statically over a 12 h 
period at 25°C. The results presented in Figure 33 show that fluorofamide at 4 pg/ml 
concentration had no bactericidal affects on WT or mrpA strains incubated under 
these conditions. Cultures incubated in the presence and absence of fluorofamide were 
able to reach similar cell densities (108 cfu/ml, P = 0.81) during the incubation period. 
Although the mean pH of the WT and mutant batch cultures incubated with 
fluorofamide reached 6.75 and 6.78 respectively (similar to the pHn of the urine), no 
evidence of crystalline material was apparent in the respective cultures. When 10 ml 
of these cultures were initially inoculated into the bladder chamber the residual urine 
remained below the pHn of 6.7 (not shown) and any crystal formation in the urine was 
negligible.
4.2.4. The ability of WT and mrpA P. mirabilis to encrust all-silicone catheters
The results presented in Figure 34 demonstrated that both WT and mrpA P. mirabilis 
strains were able to block AS catheters. The mean catheter blockage times for the WT 
and mrpA strains (29.9 ± 5.61 h and 41.9 ± 1.43 h respectively were not significantly 
different {P = 0.1). It was interesting however, that the WT strain produced alkaline 
conditions in the residual urine earlier than the mrpA strain. The urinary pH and viable 
cell populations recorded during the course of the experiments (Figure 35) indicate 
that both strains were similarly affected by washout when the urine supply was turned 
on. The mean pH of the residual urine (Figure 35 A) infected with the WT strain was
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-8.3 at 24 h compared to -7.5 in the mrpA infected models. This suggests that 
extensive crystalline material would have formed earlier in the WT infected models.
4.2.5. P. mirabilis biofilm formation on catheters under conditions favouring crystal 
formation in urine
The electron micrographs presented in Figures 3 6 - 4 1  illustrated that while both 
strains form extensive crystalline biofilms on the catheters, the timing of the sequence 
of events is rather different with the mutant than the wild type. At 8 h the WT has 
produced considerable encrustation on the surfaces around the eye-holes and on the 
catheter lumen (Figures 36 and 37). At this stage there is little sign of crystalline 
material on the catheter from the models incubated with the mutant. The pH of the 
residual urine at 8 h was -  pH 7.5 and -  pH 7.0 for WT and mrpA respectively (Figure 
48), which would account for the differences in crystalline material on the catheter 
surfaces. At 12 h the pH of the residual urine in the bladder model chamber exceeded
7.5 in both cases. Although the catheter eye-let surfaces showed similar levels of 
encrustation at this time, the lumenal sections were heavily encrusted by the WT 
while those incubated with the mrpA mutant strain appeared free of crystalline 
material. It was not until 18 h that encrustation was apparent on the central channels 
of catheters incubated with the mrpA strain.
The micrographs presented in Figures 38 and 39 indicated that the WT had produced 
the typical crystalline biofilm on the eye-let and lumenal section of the catheters by 8 
h. Over this period however, few mrpA cells managed to colonize the catheters 
(Figures 40 and 41). By 12 h the mrpA mutant had generated the characteristic 
crystalline calcium phosphate “foundation layer” on catheters. Some mrpA cells were
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visibly attached to the foundation layer at 12 and 18 h, but it was not until 30 h that 
extensive colonization by cells became visible (Figure 42). This was interesting as 
viable cell counts recorded in the residual bladder model urine at the time when the 
experiments were stopped for catheter removal (Figure 49) show that population 
densities were similar between WT and mrpA strains at these times. Figure 49 also 
shows that the pH of the urine in the model inoculated with the mutant had reached
8.5 by 30 h. As this is well above the pHn of the urine supplied to the model, at this 
late stage of the process large amounts of crystalline material would be forming and 
the rate of encrustation accelerating. Thus although the ways in which the crystalline 
biofilm develops may differ, there was no significant difference in the mean times the 
wild type and its MR/P' mutant took to block catheters.
The observations made in the experiments where the urine was allowed to become 
alkaline suggest that while MR/P fimbriae are not essential for crystalline biofilm 
formation on catheters, they may have a role in cell-crystal aggregation. Stickler et al. 
(2006) reported that cell-crystal aggregations forming in alkaline urine were 
responsible for P. mirabilis adherence to agarose and agarose-hydrogel surfaces. 
These surfaces were resistant to colonization by P. mirabilis cells when the crystals 
were absent in acidic urine. Calcium phosphate is a known aggregator of bacterial 
cells (Berry et al., 1997), and it would be interesting to carry out adherence 
experiments similar to those described by Stickler et al. (2006) with the WT and 
mrpA strains on various surfaces in acidic and alkaline urine. The adhesive properties 
of bacterial cells to surfaces have been evaluated using atomic force microscopy 
(Dufrene et al., 2001). It may be possible to determine differences in the affinity of
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MR/P+ and MR/P* P. mirabilis strains to calcium phosphate and catheter surfaces 
using similar methods.
4.2.6. Biofilm formation in acidic urine
The electron micrographs shown in Figures 43 -  48 record the colonization of AS 
catheters by WT and mrpA strains in the absence of crystal formation. Even under low 
magnification (Figures 43 and 44) the differences in the extent of colonization was 
clearly visible. The eye-let and lumenal surfaces of catheters exposed to WT infected 
urine for 24 and 48 h had acquired comprehensive biofilms while catheters exposed to 
the mrpA strain had only acquired patchy colonization at the eye-let at 48 h. Under 
high magnification (Figures 45 - 48), the colonization by the two strains was much 
clearer. The WT strain was able to form isolated microcolonies on the catheter 
surfaces within 4 h with the numbers of adhered cells slowly increasing during the 
initial 12 h (Figure 45 and 46). These cells were often associated with areas of the 
catheter surface that had a rough topography, suggesting that these areas are capable 
of initiating bacterial colonization. At 24 h the WT strain had formed a 
comprehensive non-crystalline biofilm several cells deep on the eye-let and the first 
few centimetres of the lumenal area. By 48 h extensive biofilm had formed on the 
lumenal section.
In contrast, the mrpA strain (Figures 47 and 48) showed little evidence of colonization 
over the initial 12-h period in the acidic urine, and was observed as isolated cells 
which in some instances appeared trapped in rough areas of the surface. At 24 h mrpA 
colonization was relatively rare and was limited to a small area at the rim of the eye­
let approximately 200 pm x 200 pm where it formed a patchy biofilm several cells
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thick. The lumenal sections also showed rare patches of biofilm. At 48 h more 
‘patches’ of biofilm were observed at the eye-let but failed to form the continuous 
comprehensive biofilm structure of the WT strain. The lumenal section was still 
poorly colonized at this time and had not acquired a biofilm.
4.2.7. Enumeration of WT and mrvA cells adhering to catheter surfaces
The results presented in Figure 51 showed little difference in numbers of the wild type 
and mutant cells adhering to catheters under alkaline and acidic urine conditions at 24 
h. The only significant difference was observed at section B when the mean numbers 
of mrpA cells attaching to this section in alkaline conditions was significantly 
different (P = 0.007) than in acidic urine. With hindsight it would have been 
interesting to have evaluated cell adhesion at various times up to 24 h. The results at 
24 h however, do not support the conclusions from the electron microscopy that the 
WT strain adheres more effectively to catheters under both alkaline and acidic 
conditions. The main conclusions must be that cells that lack MR/P fimbriae are still 
capable of adhering to catheters under both sets of conditions.
4.2.8. MR/P expression in the bladder model
The results of the haemagglutination tests on cells growing in the urine in the bladder 
models (Figure 52) confirm that the mrpA mutant did not produce MR/P fimbriae 
during the 48 h incubation period. It was also apparent however, that the WT did not 
express the MR/P fimbriae until 48 h. The WT cells adhering to the catheter under 
acidic conditions at 24 h (Figures 45 and 46) were thus not expressing MR/P fimbriae, 
another indication that these adhesins are not necessary for catheter colonization. A
223
.................................................................................................................................Discussion
complicating issue in trying to resolve the factors involved in adherence of P. 
mirabilis to catheters is that both the WT and mutant (at 24 and 48 h) were able to 
agglutinate tannic acid-treated red blood cells in the presence and absence of 
mannose, suggesting they were expressing MR/K fimbriae (Bahrani et a l 1991). 
Mobley et al. (1988) reported that MR/K fimbriae were responsible for the adherence 
of Pv. stuartii to siliconized-latex catheters. Further experiments will be needed to 
establish whether they are involved in attaching P. mirabilis to catheters.
4.2.9. The ability of WT and mrvA to form cell-cell aggregations
The results of the auto-aggregation assays presented in Table 5 and Figure 53 
demonstrated that WT P. mirabilis cells incubated under conditions for MR/P 
expression were able to form visible aggregates in test-tubes comparable to the co- 
aggregating control species. The mrpA strain incubated under identical conditions did 
not form similar cell-cell aggregations. Previous studies with Ps. aeruginosa showed 
that similar adhesins were responsible for biofilm formation as they initiate cell-cell 
aggregation and generate microcolonies -  the basic structure of the bacterial biofilm 
(O’Toole and Kolter, 1998). The MR/P fimbriae may thus have a similar role in P. 
mirabilis.
Although all the strains of P. mirabilis found on urinary catheters seem to be capable 
of producing MR/P fimbriae, their importance in crystalline biofilm formation on 
patients’ catheters is still uncertain. It would be interesting to know if they are 
expressed by cells growing in the residual urine in the bladders of catheterised 
patients. If this is the case the ability for MR/P expressing strains to quickly form cell­
cell aggregations is a possible mechanism for persisting in environments under liquid
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shear forces. In the catheterised bladder the cell aggregations may settle out of 
suspension and avoid these forces. In addition, their ability to initiate biofilm 
development on catheter surfaces would enable them to benefit from the protection of 
the biofilm matrix. It is possible that MR/P fimbriae also allow co-aggregation with 
other genetically distinct species (Rickard et al., 2003). This would allow P. mirabilis 
cells expressing MR/P fimbriae entering an infected catheterised urinary tract to 
interact with biofilm communities already present on the indwelling device. It would 
be interesting to carry out co-aggregation assays with MR/P+ P. mirabilis strains with 
other urinary tract isolates, and also test the ability of WT and mrpA mutant strains to 
infiltrate the biofilms of other urinary tract isolates. It is possible that the expression 
of MR/P fimbriae by P. mirabilis in clinical episodes of infection is advantageous in 
allowing them to produce the recalcitrant and persistent infections associated with P. 
mirabilis CAUTI. The fact that cells lacking or not expressing MR/P fimbriae can 
also block catheters suggests that P. mirabilis can generate crystalline biofilm in a 
number of different ways. The overriding factor in the development of these biofilms 
is the generation of alkaline urine, the elevation of pHv above pHn by the bacterial 
urease and precipitation of crystalline material.
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4.3. Modulation of crystalline P, mirabilis biofilm
Nursing staff responsible for catheter management are well aware that even for 
patients designated as recurrent “blockers”, the times catheters take to block {i.e. 
catheter lifespan) varies considerably. In their prospective study with patients with P. 
mirabilis infections, Mathur et al. (2006a) reported that the times catheters took to 
block varied from 2 - 9 8  days. As catheter encrustation is brought about by the rise in 
urinary pH caused by the activity of urease, it would seem probable that the higher the 
pH generated by P. mirabilis, the more rapidly the catheters will block. Mathur et al. 
(2006a and 2006b) however, showed that the relationship between urinary pH and the 
rate of the encrustation process was rather more subtle. The data showed that in 
patients infected with P. mirabilis the nucleation pH (pHn) is the important factor in 
controlling the rate of catheter blockage. Statistical analysis showed that there was a 
highly significant {P = 0.004) positive correlation between pHn and catheter lifespan. 
Thus the higher the pHn of a patient’s urine, the slower the encrustation process and 
the longer the catheter lifespan. The study also showed that the pHn of a patient’s 
urine could vary considerably from week to week. These findings suggested that it 
might be possible to manipulate pHn as a therapeutic approach to deal with catheter 
encrustation.
Suller et al. (2005) demonstrated that it was indeed possible to manipulate pHn very 
simply. Studies using healthy volunteers showed that by increasing the fluid intake, 
thus diluting the urine, elevated its pHn. Increasing the concentration of the chelating 
agent citrate in the urine by taking citrate-containing drinks further elevated the pHn. 
These observations provided the rationale for the experiments in the bladder model 
exploring the effect of elevating urinary pHn on the rate of catheter encrustation. The
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pHn of artificial urine was manipulated in a controlled manner by dilution and by 
increasing its citrate content.
4.3.1. The effect of fluid intake on the urinary pH» and catheter encrustation
The results in Table 6 illustrate that simply diluting the urine has a profound effect on 
the pHn. The pH at which crystals formed in the urine increased from 6.7 in the neat 
urine, to 8.4 in the urine diluted to 1:6. When the neat, 1:1, 1:2 and 1:3 diluted urines 
were supplied to models the rate of catheter encrustation (estimated by mean time to 
catheter blockage), was also greatly affected. The mean blockage times were 
significantly different (P < 0.05) between each of the four dilutions (Figure 54). The 
mean catheter lifespan being extended from 24.13 ± 2.9 h in models supplied with 
neat urine, to approximately five times longer (125.5 ± 6.4 h) in bladder models 
supplied with urine at a 1:3 dilution. The analysis of the urine from these experiments 
(Table 7) showed the mean pH of the voided urine was consistently alkaline 
remaining > pH 8.4 in all cases. Furthermore, in models supplied with 1:1, 1:2 and 1:3 
diluted urines the mean pH of the urine was > pH 8.7 at 24 h and > pH 8.9 at 48 h. 
The mean viable cell populations (Table 8) recorded in the residual urine of 
experiments were also consistent and remained at 107 -  108 cfu/ml confirming they 
were heavily infected throughout the experimental period.
Burr and Nusiebeh (1997) examined the relationship between catheter blockage and 
urine composition in patients with spinal cord injuries with long-term indwelling 
catheters. They reported that patients with catheters lasting for at least 6-weeks (non­
blockers) had mean urine outputs of > 3 L/24 h. They recommended that a high 
uniform rate of fluid intake should be mandatory for those prone to catheter blockage.
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The evidence reported in this present study supports this recommendation. The flow 
rates of urine supplied to the models were increased proportionately as urine became 
more dilute, in order to simulate higher fluid intakes and increased urine production. 
Flow rates ranged from 720 ml/24 h for the neat urine to 2880 ml/24 h for the 1:3 
diluted urine. The mean blockage times of catheters in control experiments with a 
flow rate of 720 ml/24 h and supplied with 1:1 diluted urine (50.5 ± 4.6 h) was not 
significantly different (P = 0.9) from the mean blockage time of 49.5 ± 6.0 h of 
catheters from bladder models supplied with identical urine but at the higher flow rate 
of 1440 ml/24 h. These data (Figure 54) suggest that the urine concentration and its 
pHn rather than flow rate are the important modulating factors in controlling the 
formation of the crystalline biofilms.
4.3.2. The effect of citrate on the urinary pHn and catheter encrustation
The results presented in Table 9 demonstrate that elevating the citrate content of urine 
had an even more dramatic effect on pHn than simply diluting the urine. The pHn at 
which crystal formation occurred in urine increased from -pH 7.4 at 0.41g/L citrate to 
-pH 9.1 at 3.0 g/L citrate. Mean catheter blockage times (Figure 55) were 32.3 ± 3.5 
h, 66.25 ± 6.7 h and 107.3 ± 5.5 h in models supplied with urine containing 0, 0.41, 
and 1.0 g/L citrate respectively. Furthermore, in models supplied with urine 
containing 1.5, 2.0 and 3.0 g/L citrate (pHn values of 8.3, 8.5 and 9.1 respectively) 
catheters did not occlude with crystalline biofilm and drained for the full 7-day 
experimental period. The increased citrate concentrations in the urine did not affect 
the ability of P. mirabilis to elevate the pH of residual bladder model urine, or its 
ability to proliferate in the urine (Tables 10 and 11). The pH of urine was consistently 
> pH 8.0 while viable cell populations remained > 107 cfu/ml in all cases throughout
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the experimental periods. The ability of citrate to inhibit crystal formation in the urine 
was apparent in the residual bladder model urine during the course of the experiments 
(Figure 56). It was clear that urine containing the higher citrate concentrations were 
able to delay or prevent the onset of visible crystal formation occurring in the residual 
bladder model urine.
Suller et a l  (2005) previously demonstrated that urinary citrate concentrations could 
be elevated in healthy volunteers by supplementing their diet with 500 ml of orange 
juice daily. The citrate concentration of urine was raised from 0.35 to 1.2 g/L and the 
urinary pHn increased from 7.25 to 8.2. In this present study supplementing the 1:1 
dilution urine with 1.0 g/L citrate also elevated the urinary pHn to -pH 8.2. This is 
interesting as Mathur et a l (2006a) reported that the mean pHn of patients who slowly 
encrusted their catheters was 8.08. Examination of their regression analysis of pHn 
against catheter lifespan suggest that if the mean pHn of a patients’ urine is 8.2, then 
the mean catheter lifespan will be in the region of 5 weeks, even in the presence of P. 
mirabilis. This compares with the mean lifespan of catheters of 107 h in the models 
supplied with urine having a pHn of 8.2. It must be appreciated however, that the 
experiments in the models simulated a heavy pure culture P. mirabilis infection 
consistently generating alkaline urine that was between pH 8.5 - 9.0. Another 
significant observation from the Mathur et a l  2006a, 2006b papers is that the mean 
pHv of urine only exceeded 8.0 in 3 of the 21 patients studied. If the mean urinary pHn 
of patients who rapidly encrust their catheters could be consistently elevated to around 
8.2 by increasing their fluid and citrate intake the complication might be controlled in 
most sufferers. The observations in this study should encourage a clinical trial to
229
Discussion
examine the effect of increasing a patient’s fluid intake with citrate-containing drinks 
on the encrustation and blockage of catheters.
4.3.3. The development of P. mirabilis crystalline biofilm in urine containing 
various citrate concentrations
The low vacuum electron micrographs presented in Figure 57 and 58 illustrate the 
differences in the rate of catheter encrustation when urine containing the range of 
citrate concentrations was supplied to bladder models. Catheters in models supplied 
with urine containing 0.41 g/L citrate blocked at the eye-let and first few centimetres 
of the lumen with typical encrustation at 64 h. Appreciably less encrustation was 
observed on catheters that had been removed at 72 h from models supplied with urine 
containing 1.0 and 1.5 g/L citrate. Catheters in models supplied with urine containing
1.5, 2.0 and 3.0 g/L citrate drained freely for the whole 7 days. Examination of these 
catheters showed that while some encrustation was visible on the one from the model 
supplied with urine containing 1.5 g/L citrate those from models supplied with urine 
containing 2.0 and 3.0 g/L citrate appeared free of crystalline deposits. Analysis of the 
residual urine from models at the start and at conclusion (not shown), showed that all 
cases the residual urine was heavily infected by P. mirabilis, urinary pH and viable
•n
cell populations being > pH 8 and >10 cfu/ml respectively.
The HVSEM micrographs shown in Figures 59 -  66 illustrate that the manner of P. 
mirabilis crystalline biofilm development on the catheters was determined by the 
citrate content and pHn of the urine. The catheter removed from the model supplied 
with urine containing citrate at 0.41 g/L had acquired a crystalline “foundation layer” 
upon which, a ‘typical’ crystalline P. mirabilis biofilm was developing at 24 h (Figure
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59 A + B). This could be expected as the pH of the residual bladder model urine at 
this time was 8.33, and considerably higher than the urine pHn of pH 7.4, conditions 
under which crystals would have been forming readily in the urine. Catheters removed 
from models supplied with urine containing 1.0 -  3.0 g/L citrate at 24 h were 
colonized by extensive P. mirabilis biofilms, but showed no evidence of crystalline 
material (Figures 59 -  61). This was not surprising since urines containing 2.0 and 3.0 
g/L citrate have pHn values comparable or above those of the residual bladder urine 
(pH 8.52 v pHn 8.5, and pH 8.2 v pHn 9.1 respectively). In the bladder models 
supplied with urine containing 1.0 and 1.5 g/L citrate however, the pH of the residual 
urine in both these bladder models exceeded the urinary pHn (pH 8.66 v pHn 8.2, and 
pH 8.89 v pHn 8.3 respectively). At 48 h biofilms on catheters that had developed in 
urine containing 1.0 g/L citrate contained extensive crystalline deposits, while those 
that had developed in urine containing 1.5 g/L citrate comprised of distinct non­
crystalline and crystalline regions (Figure 62). In contrast to this, biofilms that 
developed on catheters in models supplied with urine containing citrate at 2.0 and 3.0 
g/L remained free of crystalline deposits at the 48 h period (Figure 63).
Mature 7-day biofilms on catheters from models supplied with urine containing 1.5 
g/L citrate comprised three distinct regions. These included what appeared to be a 
crystalline layer resembling the calcium phosphate ‘foundation layer’, a crystalline 
biofilm matrix containing integrated cells and calcium phosphate microcrystals, and a 
non-crystalline region made up of swathes of swarmer-like P. mirabilis cells. Little is 
known about the role of swarmer-cells in P. mirabilis biofilm formation, but this 
evidence suggests they may have a role in the development of P. mirabilis biofilms in 
the absence of crystalline deposits, or in elevated citrate concentrations. It was
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interesting to observe the presence of a crystalline foundation layer on the catheter 
surfaces from experiments supplied with urine containing 1.5 g/L citrate, as it was 
clear from the HVSEM analysis that at 24 h (Figure 60) initial P. mirabilis biofilm 
formation occurred in the absence of crystalline deposits. It is possible that an 
increase in localised urease concentration within these biofilms as they mature allow 
crystals to nucleate and grow at the catheter surface eventually forming a calcified 
layer between surface and biofilm. It is also possible that microcrystals forming 
within the biofilm are attracted to the silicone surface itself. This may be possible as 
microcrystals adhered readily to the catheter surfaces in experiments described in 
Section 4.1. suggesting that the nature of the catheter surface itself may attract crystals 
that have formed in the urine. The 7-day biofilms that formed on the surfaces of 
catheters in models supplied with urine with 2.0 g/L citrate were generally free of 
crystalline material, with only rare instances of crystalline deposits (Figure 65 C) 
which resembled typical amorphous calcium phosphate. The biofilms developing on 
catheters removed from bladder models supplied with urine at 3.0 g/L citrate showed 
no evidence of crystalline material (Figure 66). The evidence provided by electron 
microscopy confirms that citrate is able to delay or prevent P. mirabilis crystalline 
biofilm formation on AS catheters by elevating the urinary pHn. The possible use of 
this naturally occurring urinary constituent to prevent catheter encrustation and 
blockage should be investigated in properly controlled clinical trials.
4.3.4. The effect of citrate on the rate of catheter encrustation by Pv. rettzeri and P. 
vulsaris
Elevating the pHn of urine by increasing its citrate content also had a significant effect 
on the rate of catheter encrustation caused by clinical isolates of P. vulgaris and Pv.
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rettgeri. The results presented in Figure 67 showed that both test strains rapidly 
blocked AS catheters in models supplied with 1:1 diluted urine containing 0.205 g/L 
citrate. The mean lifespans of catheters were 59.06 ± 15.46 and 41.28 ± 1.06 in 
models infected P. vulgaris and Pv. rettgeri respectively and were not significantly 
different (Kruskal-Wallis, P >0.05). When the citrate content of the urine was 
increased to 1.5 g/L, in the case of P. vulgaris all three catheters drained freely for the 
7-day experimental period. Two of the three catheters in models infected with Pv. 
rettgeri also drained freely for the whole 7 days, while the third bladder model 
blocked with crystalline biofilm after --4.5 days. The results presented in Table 12 
show that the Pv. rettgeri isolate was a potent urease producer and quickly adapted to 
the bladder model conditions generating mean urinary pH’s consistently > pH 9.0 and 
producing mean viable cell populations of 108 -  109 cfu/ml. In contrast, the mean pH 
of the residual urine in experiments infected with P. vulgaris reached a maximum of 
pH 8.74 at 6 days, while viable cells varied from 107 -  108 c/ml over the 7-day period. 
The significant reduction in the rate of catheter encrustation is particularly important 
for Pv. rettgeri. This isolate was able to rapidly block catheters impregnated with 
triclosan solution in other bladder model experiments (Broomfield, 2007). This 
supports the theory that the antimicrobial resistance patterns of catheter encrusting 
species are unlikely to affect the efficacy of the elevated pHn strategy in preventing 
encrustation.
Elevating the urinary pHn by diluting urine and by increasing its citrate content 
significantly reduces the in vitro rate of encrustation and crystalline biofilm formation 
by a range of urease-producing organisms on all-silicone catheters. Although 
increased hydration reduces the rate of catheter encrustation, this method alone may
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not elevate urinary pHn to levels high enough to reduce or prevent catheter 
encrustation and blockage in the majority of long-term catheterised patients infected 
with P. mirabilis. Examination of the data from the clinical study by Mathur et al. 
(2006b) suggests that if the mean pHn of urine could be elevated to around 8.1, then 
catheter encrustation could be prevented in around 80% of patients infected with P. 
mirabilis. To increase the pHn of the urine to 8.1 fluid output would have to be 
approximately 4 L per 24 h (1:5 dilution). It would be very difficult to maintain this 
level of hydration in patients. However, the experiments showed that by generating a 
fluid output of -1.5 L per 24 h whilst simultaneously increasing its citrate content to 
1.0 g/L, a pHn of -8.1 could be achieved. Preventing crystalline biofilm formation by 
elevating the pHn of urine is an attractive alternative to using antimicrobial agents. It 
avoids the difficult issue of resistance and is likely to be effective whatever organisms 
are responsible for catheter encrustation and for all types of catheter.
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4.4. The effect of manipulating urinary pHn through dietary fluid and citrate 
intake
Manipulating the constituents of urine through dietary change has proved beneficial in 
reducing the metabolic risk factors associated with calcified stone formations in the 
upper urinary tract (Seltzer et al., 1996; Siener et al., 2005). Increasing urinary citrate 
excretion, whilst reducing urinary calcium concentration are some of the fundamental 
aims in these diet-related therapies. Infection-associated stone formations are similar 
in nature to the calcified deposits that affect urinary catheters, and it is possible 
therefore that similar methods may be beneficial in the prevention of catheter 
encrustation. In support of this theory, Morris and Stickler (2001) demonstrated that 
increasing fluid intake in healthy volunteers had a significant effect on the rate of 
catheter encrustation in bladder model experiments. Suller et al. (2005) demonstrated 
that the pH, of urine in healthy individuals could be favourably manipulated simply 
by increasing fluid intake and by elevating urinary citrate content. Furthermore, 
Mathur et al. (2006a) reported that the pHn of long-term catheterised patients was 
extremely variable and therefore was open to manipulation. If both the daily fluid 
intake and urinary citrate concentration in catheterised patients could be increased 
simultaneously by regularly consuming citrate-containing drinks, it may be possible 
to generate urine with an elevated pHn thus inhibiting crystal formation even in the 
presence of P. mirabilis infection. At present however, there is no evidence that this 
type of dietary intervention achieves a reduction in the rate of catheter encrustation. If 
evidence could be provided to indicate that supplementing the diet with citrate- 
containing drinks reduces the rate catheter encrustation in bladder model experiments, 
it would provide a platform to warrant proper clinical trials.
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4.4.1. Urinary profiles of healthy volunteers
The results presented in Table 13 illustrate that the urinary profiles of the healthy 
volunteers were highly variable. The mean concentrations of calcium, magnesium and 
citrate excreted in the urine of the volunteers over the study period varied by 
approximately three to four-fold, ranging from 0.05 -  0.22 g, 0.035 -  0.09 g and 0.18 
-  0.56 g respectively. The mean pHns of the urines ranged from 6.77 to 8.02, while 
the mean pH safety margins ranged from 0.29 to 1.74 pH units. It was interesting that 
on a number of occasions the pHv of urine from volunteers 4 and 5 were comparable 
to the pHn, and in one instance the pHv of the urine from volunteer 4 had a negative 
safety margin of -0.35 pH increments. In addition to this, six of the eleven urine 
samples provided by volunteer 4, and eleven of the thirteen urine samples provided by 
volunteer 5 had acidic pHn values. This is important as in these cases relatively small 
increases in urinary pH would be sufficient to cause crystalline precipitation. Overall 
the data give an indication of why the rate of encrustation among catheterised patients 
can be so variable.
In P. mirabilis infected urine the pHv will become elevated and the important safety 
margin then becomes that between the pHn and the pHv generated by the action of 
urease. In the study by Mathur et al. (2006a) the mean pHv of the urine of patients 
infected with P. mirabilis that rapidly encrusted their catheters was 7.2 and mean 
safety margins were +0.13 pH increments. If the safety margins presented in Table 13 
are re-calculated according to this mean pHv of 7.2, values of -0.43, -0.41, +0.05, 
+0.56 and +0.82 are obtained for volunteers 4,5,1,2 and 3 respectively. Extrapolating 
these data suggest volunteers 1, 4 and 5 immediately fall into the category of those 
that would rapidly encrust their catheters. The importance of maintaining a high fluid
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output to dilute urine and elevate pHn was evident in the urinary profiles of volunteers 
2 and 3. These volunteers had the two highest mean urine outputs (1335 and 1881 
ml/11 h sampling period respectively) and had the two lowest mean urinary calcium 
and magnesium concentrations and the highest pHnS. It was interesting that although 
volunteers 2 and 3 had the most dilute urines, they also had the 3rd and 2nd highest 
mean citrate concentrations respectively. This is interesting as maintaining or 
increasing citrate concentrations in urine whilst reducing calcium and magnesium 
concentrations would be advantageous in elevating urinary pHn As no dietary 
restrictions were enforced on the participants of this study however, it was not certain 
whether volunteers 2 and 3 consumed considerably more citrate as part of their diet, 
or consumed considerably less calcium and magnesium than other participants. It does 
suggest however, that increasing urinary citrate under conditions of increased 
hydration is possible.
4.4.2. The effect of citrate-containing drinks on urinary citrate content and pHn
The results of the citrate assays presented in Table 14 showed that a number of fruit 
juices and concentrates were high in citrate and had potential for use as the citrate- 
containing drink. The assays also ensured an approximate amount of consumed citrate 
could be calculated when the citrate-containing drink was taken. The drink 
subsequently used was made from a combination of lemon concentrate and orange 
juice (1:4) and was based on its citrate content and palatability. The drink was taken 
in 3 x 250 ml aliquots throughout the day supplementing the diet with ~11 g of citrate 
per 24 h. The results presented in Figure 68 show that the mean citrate concentration 
of urine increased 32 % (0.25 to 0.33 g/L respectively) after taking the citrate- 
containing drink. The mean total amount of citrate increased by 50 % (0.18 to 0.27 g
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respectively) during the sampling period. However, these differences were not 
significant (P = 0.09). Statistical analysis of the other urinary variables shown in 
Figure 69 revealed there were no significant differences in pHv, the pH safety margin 
or pHn for the two types of urine (P > 0.05). The results presented in Figure 68 and 69 
however, were based on data obtained when the citrate drink was consumed in place 
of other fluids on the ‘normal’ diet and the volumes of urine voided on the two diets 
were not significantly different (P > 0.05). If the pHn of patients’ urine is to be 
elevated increased hydration as well as increased citrate will be important.
When fluid intakes were ‘standardised’ to 1300 ml/24 h and 750 ml of the citrate 
drink consumed in addition to this, significant differences in a number of urinary 
parameters were observed (Figures 70 and 71). Importantly, the mean pHn of urine 
from the increased citrate diet (8.05) was significantly higher (P < 0.05) than the 
mean pHn of the urine from the standardised diet (7.25). It was also higher (but not 
significantly so) than the mean pHn (7.59) of the control urine (standardised fluid 
intake diet when supplemented with 750 ml of water). The reasons for the increase in 
urinary pHn after consumption of the citrate-containing drink however, could not be 
explained by increases in excreted citrate. The mean citrate concentration in urine 
collected after consuming the citrate-containing drink was significantly lower (P <
0.05) than that in urine collected in the standardised diet supplemented with 750 ml of 
water. When the mean total amounts of citrate excreted were compared between these 
two diets however, they were not significantly different (P > 0.05). It was noticed 
however, that the mean volume of urine voided under the citrate diet was higher than 
that voided in the SFI + W diet (-1600 ml/11 h v 1270 ml/11 h period respectively). 
This may have diluted the urine slightly as the mean calcium concentration in the
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urine from the increased citrate diet was basically half that observed in the standard 
and standard + water diets. It was disappointing that the levels of citrate in urine on 
the SFI + C regimen, did not reach those found by Suller et al. (2005) who reported a 
gradual increase in citrate concentrations of urine rising to ~ 1.2 g/L after a week of 
consuming 500 ml of orange juice daily. It is possible that the duration of the dietary 
regimen in this study (4 days) was not long enough to elevate citrate concentrations 
significantly in the urine. In hindsight urine could have been collected after one week 
of consuming the citrate drinks. The amount of citrate excreted in the urine of an 
individual however, will depend on a number of other factors. As an intermediate in 
the citric acid cycle, citrate is utilised according to energy requirements and will be 
affected by the day-to-day activities of an individual. Genetic factors are also involved 
in the concentration of citrate that an individual will excrete in their urine (Shah et al.,
2005). Excretion of citrate into the urine is highly regulated by the kidneys and a 
major influence is the intracellular acid-base balance in the kidney, which is affected 
by potassium concentration. Citrate excretion is reduced when potassium 
concentrations are depleted (Simpson, 1983). Various forms of potassium citrate are 
used to increase citrate excretion in patients prone to metabolic kidney stone 
formation. These dietary supplements may also be useful in the treatment of long-term 
catheterised patients infected with P. mirabilis.
4.4.3. Increasing fluid and citrate intake and its effect on pHn and the rate of catheter 
encrustation
The profiles of the urine of the healthy volunteer under four dietary routines presented 
in Table 15 show that the concentrations of urinary constituents and the parameters of 
other urinary variables altered considerably under the different dietary routines. It was
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clear that urine with low Ca and Mg concentrations, high pH safety margins and 
elevated pHns were generally associated with the increases in urine output. The urine 
from the SFI + C regimen however, had the lowest mean pH safety margin (1.1 pH 
increments), while the mean Ca concentration of -0.093 g/L was the highest 
observed. The low pH safety margin was attributed to high mean urinary pHv of 6.77, 
which may have been caused by the high citrate intake. Elevation of the pHv by high 
citrate intake may be of concern in catheterised patients. If citrate therapy was 
introduced urinary pH would have to be monitored. The higher concentration of Ca 
may have been influenced by other dietary factors. It was disappointing to find that 
both the total excreted citrate over the 48 h period and the concentration of citrate in 
these urines were not significantly different (P > 0.05) among the different urines - 
even though there was clear disparity between the amounts of citrate consumed 
through dietary fluids. This may again have been due to the relatively short dietary 
periods. The effect of the different diets on urinary pHn was substantial. Urine 
collected from the SFI + W and SFI + C and lemonade regimens all had higher mean 
pHn values compared to that of the SFI regimen (+0.43, +0.59 and +0.83 pH units 
respectively), only the pHn of the urine from the lemonade diet however, was 
significantly higher (P < 0.05). The important finding was that the mean pHn of urine 
while the volunteer was on the lemonade diet was approximately 8.1. In the recent 
study by Mathur et al. (2006a) a mean pHn of around 8.1 was high enough to prevent 
long-term catheterised patients infected with P. mirabilis from rapidly encrusting their 
catheters (mean catheter lifespan > 28 days). If a high fluid/citrate intake similar to 
the lemonade diet in this study was introduced to clinical patients infected with P. 
mirabilis that rapidly encrust their catheters, it is possible that the episodes of 
encrustation and catheter blockage would be reduced.
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When the urine collected from the different dietary routines was supplied to P. 
mirabilis infected bladder models (Figure 72 A), the mean lifespan of the all-silicone 
catheters increased in relation to their respective urinary pHns. Although the mean 
time to catheter blockage for the SFI, SFI + W and SFI + C experiments were not 
significantly different {P > 0.05), the catheters supplied with urine from the SFI + W 
(pHn 7.7) and SFI + C (pHn 7.86) routines took an average of 1.41, 1.74 times longer 
to block respectively than those supplied with urine collected from the SFI diet. 
Catheters from models supplied with urine collected from the lemonade diet however, 
drained for a mean of >118 h, an average of 4.68 times longer than those from the SFI 
experiments (P < 0.05). The results presented in Table 16 show that P. mirabilis was 
able to generate consistently alkaline conditions in the residual urine of the models 
>pH 8.5. Throughout the experimental period therefore significant amounts of 
crystalline material would have been precipitating in the urine. Mean viable cell 
populations remained between 107 — 108 cfu/ml and confirmed that the residual urine 
in bladder models remained heavily infected. As previously stated the pH of urine 
voided by long-term catheterised patients infected with P. mirabilis is quite variable 
and is rarely consistently >pH 8.5. In the study by Mathur et al. (2006b) only 3 of the 
21 patients infected with P. mirabilis had mean pHv values > 8.0. The ability to raise 
the pHn of volunteers urine to 8.1 suggests that the lemonade diet could resolve the 
problem of catheter encrustation in 85% of patients and substantially slow down the 
process in the others.
When the urinary pHn of each individual 48 h pooled urine sample was plotted against 
the individual catheter blockage times (Figure 72 B), there was a highly significant 
correlation {P < 0.001). The effect of the pHn of artificial urine on catheter blockage
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time was previously reported in Section 3.3. The correlation between the pHn of real 
urine and catheter blockage time revealed in this present section is important as it 
demonstrates that this relationship is also true in urine that has been manipulated 
through dietary intervention. Previous studies have reported that maintaining a high 
and uniform fluid intake (> 3 L/24 h) is a critical factor in reducing the rate of catheter 
encrustation (Burr and Nuseibeh, 1997; Morris and Stickler, 2001). The mean volume 
of voided urine under the lemonade diet in this study was > 7 L/48 h. It would be 
interesting to carry out further studies on generating elevated citrate concentrations in 
urine through supplementing the diet with citrate while maintaining a daily fluid 
output of 2 - 3 L in a range of volunteers. It may simply be the case that elevated 
citrate excretion occurs after longer periods on increased citrate diets (> 1 week). 
Supplementing the lemonade diet or high fluid diets with potassium citrate may be 
another option to increase citrate excretion.
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4.5. General discussion and future work
The ability to stick to surfaces and adopt the biofilm mode of growth is a basic 
survival mechanism for bacteria in aquatic environments (Donlan and Costerton, 
2002). The picture that is emerging from recent work on P. mirabilis is that this 
ingenious organism can initiate biofilm development on urinary catheters in a variety 
of ways. An important finding of the work presented in Section 3.1 of this thesis is 
that the initial process in P. mirabilis crystalline biofilm development on AS, HCL, 
SCL and HSCL catheters can begin with the formation of a coating of calcium 
phosphate on the catheter. This “foundation layer” however, was not essential for P. 
mirabilis to colonize the devices as cells were also observed adhering directly to the 
catheter. It was also apparent that cells become entrapped in the rough irregular areas 
on the catheter surface. It has previously been recognised that P. mirabilis 
colonization of polymer materials to which cells fail to attach, can occur when cell- 
crystal aggregates that form in alkaline urine are deposited on surfaces (Stickler et al.,
2006). Other studies have indicated the initial stages of biofilm development on 
indwelling devices is the formation of a “conditioning layer” derived of host proteins 
(Barbucci and Magnani, 1994; Stickler and McLean, 1995; Santin et al., 1997; Reid,
1999). Furthermore, it has recently been shown that P. mirabilis can integrate itself 
into established biofilms of other urinary pathogens such as E. coli, K. pneumoniae 
and M. morganii (Macleod, 2007).
The initial sequences in P. mirabilis adherence to catheter surfaces and subsequent 
crystalline biofilm formation may thus occur in at least six different ways:
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1. P. mirabilis cells may adhere directly onto the catheter surface possibly through 
specific adhesin-mediated attachment (Figure 73 A).
2. The inherently rough areas of a catheter surface may facilitate ‘non-specific’ P. 
mirabilis adherence by physically trapping bacterial cells (Figure 73 B).
3. Cell-crystal aggregations formed in alkaline urine promote colonization when they 
become deposited on the surface (Figure 73 C).
4. P. mirabilis cells infiltrate the existing biofilm previously formed by genetically 
distinct species to form a crystalline mixed-species biofilm (Figure 74 A).
5. Host proteins form a “conditioning layer” on the catheter surface and promote P. 
mirabilis adherence through specific adhesins and receptors (Figure 74 B).
6. Calcium phosphate microcrystals that form in the alkaline urine are deposited on 
the catheter surface and form a “foundation layer” which P. mirabilis cells colonize 
(Figure 74 C).
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Figure 73. P. mirabilis adhesion to catheter surfaces via direct, indirect 
and cell-crystal aggregation methods
A. Cells directly adhere to catheter by specific cell-catheter surface 
interactions. B. Cells become entrapped in the inherently rough areas of catheter 
surfaces. C. Cell-crystal aggregations forming in the alkaline urine become 
deposited on the surface.
245
General discussion and future work
A. Infiltration of existing biofilm
existing biofilm o f another species
generation o f alkaline urine 
and crystalline biofilm
**
conditioning layer forms
B. Attachment to host protein 
“conditioning layer”
host proteins
generation o f alkaline urine 
and crystalline biofilm
47
C. Colonization of calcium phosphate 
“foundation layer”
crystalline biofilm development
alkaline urine
*■ 47 *
4 7 foundation layer forms
Figure 74. P. mirabilis adhesion to catheter surfaces via existing biofilm, 
“conditioning layer” and “foundation layer”
4. P. mirabilis cells infiltrate an existing biofilm through specific cell-cell 
interactions. 5. Cells colonize the protein “conditioning layer” through specific 
cell-protein interactions. 6. Crystalline “foundation layer” forms on the surface 
and is subsequently colonized by P. mirabilis.
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4.5.1. The importance of the “foundation layer” and calcium phosphate in P . 
mirabilis adhesion to catheter surfaces
The development of the “foundation layer” on the catheter surface is important as it 
will mask the properties of any material it develops on by forming a physical barrier 
between the catheter and bacterial cells. As a consequence, catheter materials aimed 
specifically at inhibiting bacterial adhesion or with an antibacterial immobilized on 
the surface, may be ineffective in patients with existing P. mirabilis infections. Once 
crystalline deposits are present on the catheter surface, bacterial colonization may also 
be accelerated as calcium phosphate is known to aggregate bacterial cells (Berry and 
Siragusa, 1997). Even if a comprehensive “foundation layer” does not form on a 
catheter surface, cell-crystal aggregations will still form in the alkaline urine in the 
majority of P. mirabilis infected patients. This crystalline material will shield P. 
mirabilis cells from the catheter surface in much the same way. Developing catheter 
materials that inhibit this calcium phosphate instigated adherence will be difficult as 
larger crystals or cell-crystal aggregations are likely to be deposited via gravitational 
forces.
It would be interesting to examine the role of calcium phosphate in promoting P. 
mirabilis colonization of catheter materials. For instance, how and why does the 
calcium phosphate layer form on the surface? What are the processes involved in cell 
attachment to the crystalline coating? Are the cells passively trapped in the crystalline 
material or are there physico-chemical attractive forces between the cells and the 
crystals? Are cellular adhesins involved in the adherence of cells to calcium 
phosphate? Experiments similar to those designed by Stickler et al. (2006) using 
parallel plate flow cells could be used to try and answer these questions. The affinity
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of calcium phosphate for various catheter materials could also be assessed. This sort 
of information could help in developing catheters that do not encourage crystal 
adherence. Atomic force microscopy has been used in studies measuring the attractive 
forces between bacterial cells and various materials (Dufrene et al., 2001) and it is 
possible that these methods could be exploited in these sort of experiments.
4.5.2. Other factors promoting P. mirabilis adhesion to urinary catheters
The development of a protein “conditioning layer” would also offer protection to P. 
mirabilis in much the same way as the “foundation layer” by forming a physical 
barrier between cells and the catheter surface. Evidence suggests that adsorbed 
proteins on indwelling vascular devices specifically interact with the surface adhesins 
of S. aureus and facilitate initial adherence (Vaudaux et al., 1993; Foster and Hook, 
1998; Arrecubieta et al., 2006). It is possible that similar interactions allow P. 
mirabilis to colonize urinary catheter surfaces, and it would be interesting to evaluate 
the rate of P. mirabilis colonization of various protein-coated surfaces using flow cell 
chambers and phase-contrast microscopy. Using urease-negative mutants or urease 
inhibitors in the experiments would be a way of avoiding the generation of alkaline 
urine and crystalline material.
The deliberate introduction of non-pathogenic E. coli into the bladder has been 
reported to reduce episodes of symptomatic UTI by virulent E. coli (Darouiche et al.,
2000). In the case of catheter encrustation it might be interesting to observe whether 
infection with a urease-negative mutant P. mirabilis strain prevented subsequent 
colonization by a wild-type urease-positive encrusting strain. The acquisition of 
virulence factors from pathogenic urinary tract isolates by deliberately introduced
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non-pathogenic strains however, is something that will require stringent examination 
before this type of strategy could be implemented.
Work on the development of crystalline catheter biofilms has, up to now, largely 
concentrated on pure cultures of P. mirabilis (Morris et al., 1997; Morris and Stickler, 
1998a). Such single species biofilms can be found on catheters, but in long-term 
patients the catheter biofilms are commonly composed of polymicrobial communities 
containing other uropathogens (Ohkawa et al., 1990; Ganderton et al., 1992; 
Matsukawa et al., 2005). The development of these mixed-species biofilms on urinary 
catheters has not been studied in detail and is an area that requires attention. Recent 
work by Macleod (2007) examined the effect other species have on the rate of 
catheter encrustation by P. mirabilis. Experiments in laboratory models showed that 
co-infection with P. mirabilis and M. morganii or E. coli for example, had no effect 
on the rate at which P. mirabilis blocked catheters. Co-infection of P. mirabilis with 
Enterobacter cloacae or Ps. aeruginosa however, significantly increased the times 
catheters took to block. Further experiments showed that the growth of Ent. cloacae, 
M. morganii, K. pneumoniae or E. coli biofilms for 72 hours on catheters prior to 
super-infection with P. mirabilis delayed catheter blockage significantly. In all these 
experiments however, P. mirabilis was able to generate alkaline urine and block the 
catheters. This work suggests that while there is antagonism between P. mirabilis and 
other urinary organisms, it is temporary and whatever the pre-existing urinary flora, 
infection with P. mirabilis is likely to lead to catheter encrustation and blockage.
Notwithstanding these results it would be of interest to reconstitute the mixed 
communities of organisms found in patients who are not infected with P. mirabilis
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and do not encrust their catheters and examine their ability to inhibit the integration of 
P. mirabilis into their biofilms. Techniques such as fluorescent labelling of cells and 
scanning confocal laser microscopy has been used with great success to examine the 
distribution of cells in mixed species biofilm and could prove useful in following the 
development of these biofilm communities (Moller et al., 1998; Palmer et al., 2001). 
If bacterial factors could be identified which prevent crystalline biofilm formation, a 
biological interference strategy might be possible to control the problem. At present 
however, there are few signs that such an approach is feasible.
4.5.3. The development of catheters that resist encrustation
The realization of the many ways in which P. mirabilis can initiate crystalline biofilm 
on catheters has profound implications for the development of devices that resist 
encrustation, and indicates the enormous challenge facing manufacturers. 
Fundamentally, catheter materials will have to prevent P. mirabilis and other urinary 
pathogens from sticking. Finding a material with properties that could achieve this 
may be difficult as different bacteria may adhere differently to the same material 
(Darouiche, 2001). If only P. mirabilis adhesion is inhibited the bacterium would 
encrust catheters by infiltrating the biofilms of other species (Figure 74 A). Catheter 
materials with hydrophilic and strongly electron-donating properties that prevent P. 
mirabilis adhesion would be ineffective once the bacterium enters the bladder and 
generates alkaline urine causing cell-crystal aggregates to form and become deposited 
on the surface as shown in Figure 73 C (Downer et al., 2003, Stickler et al., 2006). 
Catheters need to be free of surface irregularities that otherwise allow P. mirabilis and 
other uropathogens to become physically entrapped or provide a favourable surface 
for cells to colonize (Figure 73 B). At present current manufacturing processes are not
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capable of producing perfectly smooth catheters, and surface irregularities especially 
around die eye-let have been identified as sites of initial bacterial adherence (Stickler 
et al., 2003b). If antimicrobial catheters are to be used it is important that the 
compounds diffuse directly into the urine, specifically target P. mirabilis and prevent 
a rise in urine pH and crystal development. It is most important that the generation of 
alkaline urine and crystal formation is prevented as crystalline biofilm will form even 
on smooth surfaces to which cells don’t stick by the ways shown in Figure 73 C and 
74 C). Furthermore, antimicrobial compounds will have to remain active for the life­
time of the device (12 weeks) at concentrations consistently higher than the MIC.
4.5.4. Using the retention balloon to delivering compounds that inhibit P. mirabilis 
crystalline biofilm
Delivering agents such as triclosan into the bladder urine through the catheter 
retention balloon may be more effective than having antimicrobials immobilised onto 
the catheter surface in the treatment of patients infected with P. mirabilis. Compounds 
that diffuse through the balloon and into the bladder urine would be less affected by a 
“foundation” or “conditioning layer”. The issues surrounding the use of triclosan 
strategies in preventing P. mirabilis crystalline biofilm development have been 
discussed in studies by Jones (2005) and Williams (2006). The main problems are 
finding materials that ensure triclosan will diffuse through the balloon at 
concentrations well above the MIC over prolonged periods (i.e. ~3 months), the effect 
of constant exposure of bladder epithelial cells to the antimicrobial and the selection 
of resistant strains. A recent study using bladder models infected with polymicrobial 
communities of urinary tract isolates showed that while triclosan eliminated 
susceptible isolates of P. mirabilis, P. vulgaris, K. pneumoniae and E. coli, it selected
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for triclosan resistant isolates of Pv. rettgeri and M. morganii that were capable of 
generating alkaline urine (Williams, 2006). It is possible that future strategies may 
have to involve a combination of triclosan and other broad spectrum antimicrobials to 
reduce the emergence of resistant strains and to be effective against the range of 
urease-producing organisms. If this strategy was implemented, close monitoring of 
the susceptibility of the urinary tract flora to triclosan and other antimicrobials would 
be required.
The catheter balloon could also be used to deliver compounds that inhibit crystalline 
biofilm formation in other ways. Williams (2006) examined the ability of 
acetohydroxamic acid and fluorofamide to diffuse through silicone balloons. 
Unfortunately there was no sign that these urease inhibitors could diffuse into the 
urine and prevent the rise in urinary pH. Other urease inhibitors are available 
however, for example Wang et a l  (2006) reported that resveratrol, a naturally 
occurring compound found in black grapes was a potent inhibitor of the production of 
urease by P. mirabilis. It would be interesting to test the diffusibility of these 
molecules through catheter balloons.
Analogues of quorum sensing (QS) molecules that are effective at disrupting biofilm 
formation offer another approach. The halogenated furanones derived from the macro 
algae Delisea pulchra have shown promise in this area, and are known to disrupt QS 
in a range of Gram-negative species. Furthermore, Gram et a l (1996) demonstrated 
that P. mirabilis swarming behaviour was inhibited on agar plates inoculated with 
these Delisea pulchra derived furanones. Unfortunately these compounds are highly 
toxic and may not be suitable for use in human subjects (Hentzer and Givskov, 2003).
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Wu et al. (2004) however, reported that synthetic furanones were effective at 
disrupting Ps. aeruginosa biofilms in the lungs of infected mice, enhancing the 
bacterial clearance rates. It may be possible that in future non-toxic synthetic QS 
analogues may be developed that prevent biofilm formation on indwelling urinary 
catheters. It would be interesting to test the deliverability of such compounds via the 
retention balloon. A successful strategy for the prevention of P. mirabilis crystalline 
biofilms forming on the catheters of patients may require a combination of QS 
analogues and antimicrobials delivered through the catheter balloon. The QS analogue 
would keep bacterial cells in their planktonic state allowing the antimicrobial to kill 
them efficiently. The recent study by Williams and Stickler (2007) showed that 
polyurethane balloons were much more permeable than silicone or latex balloons to 
antibacterial agents. If catheter manufacturers could be persuaded to use polyurethane 
in the manufacture of catheters, it might be possible to deliver a variety of interesting 
active compounds directly into the bladder.
4.5.5. The role of fimbriae in P. mirabilis crystalline biofilm formation
The role of MR/P fimbriae in crystalline biofilm development or initial colonization 
of all-silicone catheters was not clearly determined in this study and warrants further 
investigation. Although the WT strain appeared to initially colonize catheter surfaces 
and integrate with crystalline material better than the mrpA mutant strain, evidence 
showing MR/P fimbriae were being expressed when this occurred however, was 
lacking. It would be useful to repeat the experiments with a range of different catheter 
materials in acidic and alkaline urine using phase-locked P. mirabilis mutants where 
MR/P fimbriae are either constitutively expressed or not expressed at all. It was clear 
from these experiments however, that the overriding factor in catheter blockage was
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the generation of alkaline urine and not the extent of bacterial colonization. The take 
home message seems to be that preventing crystalline material from forming in the 
urine rather than preventing bacterial colonization is the most important factor in 
avoiding catheter blockage.
Cell surface adhesins are known to be important in coaggregation of oral bacterial 
species as they allow genetically diverse oganisms to co-adhere and form mutually 
beneficial biofilm communities. The autoaggregation assays in this present study 
showed that the WT P. mirabilis was able to form more obvious cell aggregations 
than the mrpA strain. It is possible that these adhesins may also have a role in the 
development of mixed-species catheter biofilms. The use of phase-locked mutants to 
determine the role of MR/P and other fimbriae in mixed-species biofilm formation 
may be one way of investigating the role of various adhesins in this phenomenon.
4.5.6. Preventing P. mirabilis crystalline biofilm development by manipulating the 
pHn of urine
Virtually all catheters that remain in place for >28 days become colonized with 
bacterial biofilm. In the majority of cases however, the individuals will avoid episodes 
of symptomatic UTI. In addition, results from experiments in this study have shown 
that catheters colonized by non-crystalline P. mirabilis biofilms drained freely until 
they were stopped manually at 7 days. These observations suggest that rather than 
trying to stop P. mirabilis colonization of the catheter, simply preventing the biofilm 
from becoming crystalline is a more realistic option for reducing episodes of catheter 
blockage. The results from this present study indicate that this can be achieved by 
elevating the pHn of urine. It is encouraging, that the preliminary results of a clinical
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study that began recently at the Biomed Centre, Southmead Hospital Bristol (U.K.) 
has indicated that the urinary pHn of long-term catheterised patients with P. mirabilis 
infection can be elevated using citrate drinks (Dr. A. Khan, personal communication). 
The mean urinary pHn of patients’ urine in three separate control periods were 7.68, 
7.55 and 7.66 compared to 7.98, 8.07 and 8.12 when a group of 13 patients were 
given an extra 1 L/24 h of water, 1 L/24 h of a citrate-containing drink or 1 L/24 h of 
water plus potassium citrate respectively. The extension of this trial to include the 
effect on the rate of catheter encrustation in these patients is obviously the next step. It 
could be difficult to persuade some elderly patients to take such large volumes of 
extra fluid. Some might have physical problems in drinking such volumes. Suitable 
automatic drink dispensers could be developed to make it easier for these patients to 
accept and comply with these regimens.
Although all long-term catheterised patients infected with P. mirabilis may not 
respond significantly to this therapy, it may be possible to elevate the urinary pHn in 
these patients by a combination of treatments. These may involve smaller increases in 
fluid intake supplemented with potassium citrate therapy whilst utilising the catheter 
balloon to deliver citrate directly into the bladder itself. The effect of citrate on 
bladder epithelial cells may have to be considered before citrate could be utilised in 
the catheter balloon. The ability of citrate to diffuse through various catheter materials 
however could be determined in bladder model experiments, while its effect on P. 
mirabilis crystalline biofilm development is determined. It is possible that in future, 
monitoring of patients’ urinary pHn will be part of their management. Dietary routines 
that elevate the pHn of patients’ urine could then be tailored to suit the individual 
needs of each person. The citrate drinks strategy will not of course eliminate the
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causative organisms of encrustation from the catheterised urinary tract. It will need to 
be a long-term suppressive therapy. Despite this it has intrinsic advantages in that it 
doesn’t involve the use of antimicrobials and it is effective whatever urease producer 
is inducing the encrustation. The selection of resistant organisms will thus not be a 
problem. Bacteria have developed many ingenious ways of overcoming the challenge 
of antimicrobial chemical agents but it is difficult to imagine that they can do 
anything about the laws of physical chemistry that govern the solubility of calcium 
and magnesium phosphates in urine.
Will the strategy be effective in the long-term? Will it create other problems? Only 
experience will answer these questions. In a retrospective study Kang et al. (2007) 
however, reported no adverse side-effects in patients who had been consuming 2 L of 
the lemonade drink to control kidney stones for up to 8 years (mean > 3 years). 
Careful watch would need to be kept of course, for adverse reactions in catheterised 
patients on the citrate drink regimen. At this stage however, it seems to offer the 
exciting prospect of control of a complication that undermines the quality of life for 
so many elderly and disabled people.
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5. Conclusions
• When all-silicone, silicone-coated latex, hydrogel-coated latex and 
hydrogel/silver-coated latex catheters are inserted into the model bladders which 
contain alkaline urine cultures of P. mirabilis, a ‘foundation-layer’ comprised 
predominantly of calcium phosphate micro-crystals is first laid down on the 
catheter surfaces. The bacterial cells then colonize the material and the formation 
of the crystalline biofilm that encrust and block catheters begins.
• The ‘foundation layer’ was not essential for the development of these biofilms as 
cells were also observed adhering directly to the catheter or being trapped in 
irregular areas on the catheter surfaces.
• The ‘foundation layer’ will immediately alter the surface properties of an 
indwelling device by creating a calcified fa5 ade. This has important consequences 
for the efficacy of materials aimed at preventing bacterial adherence or those with 
antimicrobials immobilised onto their surfaces as P. mirabilis cells will be 
shielded from the catheter surface by the layer of microciystals.
• Approaches to developing urological devices that are not vulnerable to 
encrustation need to take into account that P. mirabilis can initiate crystalline 
biofilm formation on catheters in a variety of ways depending on the prevailing 
conditions in the urinary tract.
• Currently available antimicrobial catheters impregnated with nitrofurazone or 
manufactured from hydrogel/silver-coated latex are extremely vulnerable to P.
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mirabilis adherence, colonization and crystalline biofilm formation in vitro. 
Furthermore, hydrogel/silver-coated latex catheters removed from long-term 
catheterised patients were extremely prone to multi-species crystalline biofilm 
development and rapid catheter blockage.
• Inflating the catheter balloon with triclosan solution prevents in vitro crystalline P. 
mirabilis biofilm development by a combination of its antibacterial action and 
ability to maintain the residual urine at an acidic pH preventing crystal formation 
in the urine.
• Mannose resistant (MR/P) fimbriae are not essential for P. mirabilis colonization 
of catheter surfaces or the development of crystalline P. mirabilis biofilm. 
Although the wild-type MR/P producing P. mirabilis and MR/P-negative mutant 
strains initiated biofilm formation in different ways, the overriding factor in 
catheter blockage is not bacterial colonization of the device but the generation of 
alkaline urine above that of the urine pHn.
• The pH at which crystals of calcium and magnesium phosphate form in the urine, 
the nucleation pH (pHn) of that urine can be manipulated. In vitro it can be 
achieved simply by diluting the urine and by increasing its citrate concentration. 
This effect can also be achieved by encouraging volunteers to consume citrate- 
containing drinks in addition to their normal fluid intake.
• Experiments in bladder models infected with P. mirabilis showed that raising the 
pHn of urine by dilution or adding citrate, significantly extended the times
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catheters took to block. This strategy similarly reduced the rate of encrustation by 
P. vulgaris and Pv. rettgeri.
• Data from experiments in bladder models supplied with urine from volunteers on 
different fluid intake regimens showed that the mean lifespan of catheters 
increased significantly with the rise in pHn of the urine.
• The pHn of the urine from volunteers who drank 2 L of a lemonade drink/day in 
addition to their normal fluid intake, rose to a mean value of 8.1. This is above the 
mean pHv of 85% of catheterised patients infected with P. mirabilis. Such a 
strategy should thus resolve the complication of catheter encrustation in the 
majority of patients.
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